Allianz Life Insurance Co Of New York S-1/A14 Apr 17IPO registration (amended)Financial data

Company Profile

Document and Entity Information

Document and Entity Information	12 Months Ended
Document and Entity Information	Dec. 31, 2016
Document Information [Line Items]
Document Type	S1
Amendment Flag	false
Document Period End Date	Dec. 31, 2016
Trading Symbol	CK0000080019
Entity Registrant Name	ALLIANZ LIFE INSURANCE CO OF NEW YORK
Entity Central Index Key	80,019
Entity Filer Category	Non-accelerated Filer

Balance Sheets

Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Investments:
Fixed-maturity securities, available-for-sale, at fair value	$ 751,531	$ 674,562
Policy loans	338	275
Derivative assets	32,993	15,064
Equity securities, trading	7,539	4,368
Total investments	792,401	694,269
Cash and cash equivalents	74,980	37,172
Accrued investment income	14,926	14,557
Receivables	14,666	13,202
Reinsurance recoverables	4,097	3,596
Deferred acquisition costs	129,868	134,374
Net deferred tax asset	29,554	33,660
Other assets	21,600	22,277
Assets, exclusive of separate accounts assets	1,082,092	953,107
Separate account assets	2,255,576	2,205,548
Total assets	3,337,668	3,158,655
Policyholder liabilities:
Account balances and future policy benefit reserves	879,251	762,986
Policy and contract claims	4,771	4,157
Unearned premiums	1,652	1,571
Other policyholder funds	94	1,174
Total policyholder liabilities	885,768	769,888
Derivative liabilities	15,416	7,956
Other liabilities	16,783	26,775
Liabilities, exclusive of separate account liabilities	917,967	804,619
Separate account liabilities	2,255,576	2,205,548
Total liabilities	3,173,543	3,010,167
Stockholder's equity:
Common stock, $10 par value. Authorized, issued, and outstanding 200,000 shares, at December 31, 2016 and 2015	2,000	2,000
Additional paid-in capital	72,500	72,500
Retained earnings	82,428	68,988
Accumulated other comprehensive income, net of tax	7,197	5,000
Total stockholder's equity	164,125	148,488
Total liabilities and stockholder's equity	$ 3,337,668	$ 3,158,655

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Amortized cost of fixed-maturity securities available-for-sale	$ 734,957	$ 660,954
Equity securities, trading, cost	7,464	4,383
Receivables, allowance for uncollectible	43	33
Future policy benefit reserves measured at fair value	$ 222,139	$ 72,491
Common stock, par value	$ 10	$ 10
Common stock, shares authorized	200,000	200,000
Common stock, shares issued	200,000	200,000
Common stock, shares outstanding	200,000	200,000

Statements of Operations

Statements of Operations - USD ($) $ in Thousands	12 Months Ended
Statements of Operations - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenue:
Premiums	$ 4,397	$ 4,461	$ 4,559
Policy fees	68,839	65,756	58,599
Premiums and policy fees, ceded	(1,329)	(1,347)	(1,442)
Net premiums and policy fees	71,907	68,870	61,716
Interest and similar income, net	29,558	27,387	28,859
Change in fair value of assets and liabilities	(41,554)	11,373	66,806
Realized investment (losses) gains, net	(205)	583	77
Fee, commission, and other revenue	7,051	7,221	6,864
Total revenue	66,757	115,434	164,322
Benefits and expenses:
Policyholder benefits	6,242	11,601	7,993
Change in fair value of annuity and life embedded derivatives	(13,191)	60,876	112,364
Benefit recoveries	(1,099)	(1,256)	(1,099)
Net interest credited to account values	13,660	16,290	24,635
Net benefits and expenses	5,612	87,511	143,893
Commissions and other agent compensation	22,023	23,976	25,275
General and administrative expenses	17,925	17,816	14,514
Change in deferred acquisition costs, net	4,814	(8,165)	(15,064)
Total benefits and expenses	50,374	121,138	168,618
Income (loss) from operations before income taxes	16,383	(5,704)	(4,296)
Income tax expense (benefit):
Current	21	9,567	4,774
Deferred	2,922	(14,008)	(7,907)
Income tax (benefit) expense as reported	2,943	(4,441)	(3,133)
Net income (loss)	13,440	(1,263)	(1,163)
Realized investment losses, net:
Total other-than-temporary impairment losses on securities	(387)	(184)	0
Portion of loss recognized in other comprehensive income	0	0	0
Net impairment losses recognized in realized investment losses, net	(387)	(184)	0
Other net realized gains	182	767	77
Net realized investment (losses) gains	$ (205)	$ 583	$ 77

Statements of Comprehensive Inc

Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Net income (loss)	$ 13,440	$ (1,263)	$ (1,163)
Net unrealized gain (loss) on investments, net of shadow adjustments and deferred taxes	2,197	(11,656)	6,309
Total comprehensive income (loss)	$ 15,637	$ (12,919)	$ 5,146

Statements of Stockholder's Equ

Statements of Stockholder's Equity - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Retained earnings	Accumulated other comprehensive income
Beginning balance at Dec. 31, 2013	$ 156,261	$ 2,000	$ 72,500	$ 71,414	$ 10,347
Comprehensive income (loss):
Net income (loss)	(1,163)			(1,163)
Net unrealized gain (loss) on investments, net of shadow adjustments and deferred taxes	6,309				6,309
Total comprehensive income (loss)	5,146
Ending balance at Dec. 31, 2014	161,407	2,000	72,500	70,251	16,656
Comprehensive income (loss):
Net income (loss)	(1,263)			(1,263)
Net unrealized gain (loss) on investments, net of shadow adjustments and deferred taxes	(11,656)				(11,656)
Total comprehensive income (loss)	(12,919)
Ending balance at Dec. 31, 2015	148,488	2,000	72,500	68,988	5,000
Comprehensive income (loss):
Net income (loss)	13,440			13,440
Net unrealized gain (loss) on investments, net of shadow adjustments and deferred taxes	2,197				2,197
Total comprehensive income (loss)	15,637
Ending balance at Dec. 31, 2016	$ 164,125	$ 2,000	$ 72,500	$ 82,428	$ 7,197

Statements of Cash Flows

Statements of Cash Flows - USD ($) $ in Thousands		12 Months Ended
Statements of Cash Flows - USD ($) $ in Thousands		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows provided by operating activities:
Net income (loss)		$ 13,440	$ (1,263)	$ (1,163)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Realized investment gains (losses) and change in fair value of equity securities, net		115	(564)	(77)
Change in annuity-related options, derivatives, and gross reserves		3,974	(12,437)	(71,181)
Purchase of trading securities		(134,228)	(36,109)	(4,780)
Sale of trading securities		131,147	33,580	2,927
Deferred income tax expense (benefit)		2,922	(14,008)	(7,907)
Charges to policy account balances		(1,863)	(604)	(173)
Interest credited to policy account balances		25,624	17,342	24,336
Amortization of discount, net		493	764	(409)
Change in:
Accrued investment income		(369)	(6,427)	665
Receivables and other assets		(686)	(5,751)	(4,777)
Reinsurance recoverables		(501)	(505)	(590)
Deferred acquisition costs	[1]	4,814	(8,165)	(15,064)
Future policy benefit reserves		(10,888)	70,637	121,202
Policy and contract claims		614	1,370	1,259
Unearned premiums		87	(9)	(17)
Other policyholder funds		(1,080)	(1,029)	402
Other liabilities		(7,892)	16,239	437
Total adjustments		12,283	54,324	46,253
Net cash provided by operating activities		25,723	53,061	45,090
Cash flows used in investing activities:
Purchase of fixed-maturity securities		(211,621)	(176,948)	(62,126)
Sale and other redemptions of fixed-maturity securities		112,237	113,930	57,669
Matured fixed-maturity securities		24,681	15,600	6,510
Purchase of derivatives securities, net		(8,369)	(5,546)	(174)
Sale of derivatives securities, net		(7,762)	5,205	0
Net change in short-term securities		0	13,728	(13,728)
Other, net		(61)	(22)	10
Net cash used in investing activities		(90,895)	(34,053)	(11,839)
Cash flows provided by (used in) financing activities:
Policyholders' deposits to account balances		140,426	56,693	17,043
Policyholders' withdrawals from account balances		(36,238)	(67,832)	(45,731)
Policyholders' net transfers between account balances		892	1,031	182
Change in amounts drawn in excess of bank balances		(2,100)	633	184
Net cash provided by (used in) financing activities		102,980	(9,475)	(28,322)
Net change in cash and cash equivalents		37,808	9,533	4,929
Cash and cash equivalents at beginning of year		37,172	27,639	22,710
Cash and cash equivalents at end of year		$ 74,980	$ 37,172	$ 27,639

[1]	** See note 9 for aggregate gross amortization of deferred acquisition costs.

Organization

Organization	12 Months Ended
Organization	Dec. 31, 2016
Organization	(1) Organization Allianz Life Insurance Company of New York (the Company) is a wholly owned subsidiary of Allianz Life Insurance Company of North America (Allianz Life), which is a wholly owned subsidiary of Allianz of America, Inc. (AZOA). AZOA is a wholly owned subsidiary of Allianz Europe B.V., which is a wholly owned subsidiary of Allianz SE. Allianz SE is a European company registered in Munich, Germany. The Company is a life insurance company licensed to sell annuity, group and traditional life, individual long-term care, and group accident and health policies in six states and the District of Columbia. Based on 2016 statutory net premium written, 99% of the Company’s business is annuity. Accident and health, and life insurance combined, amount to 1% of the Company’s business. The annuity business consists of variable-indexed and variable annuities representing 57% and 43% of 2016 statutory annuity net premium written, respectively. Accident and health business comprises primarily long-term care (LTC) insurance. The Company has discontinued selling fixed annuity, life, and LTC products. The Company’s primary distribution channel is through broker-dealers.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2016
Summary of Significant Accounting Policies	(2) Summary of Significant Accounting Policies (a) Basis of Presentation The Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which vary in certain respects from accounting practices permitted or prescribed by the New York State Department of Financial Services (the Department). (b) Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect reported amounts of assets and liabilities, including reporting or disclosure of contingent assets and liabilities as of the balance sheet date, and the reported amounts of revenues and expenses during the reporting period. Future events, including changes in mortality, morbidity, interest rates, capital markets, and asset valuations could cause actual results to differ from the estimates used in the Financial Statements. Such changes in estimates are recorded in the period they are determined. (c) Investment Products and Universal Life Business Investment products consist primarily of fixed and variable annuity products. Premium receipts are reported as deposits to the contractholders’ accounts. Policy fees in the Statements of Operations represent asset fees, cost of insurance charges, administrative fees, charges for guarantees on investment products, and surrender charges for investment products and universal life insurance. These fees have been earned and assessed against contractholders on a daily or monthly basis throughout the contract period and are recognized as revenue when assessed and earned. Amounts assessed that represent compensation to the Company for services to be provided in future periods are not earned in the period assessed. Such amounts are reported as unearned premiums and recognized in operations over the period benefited using the same assumptions and factors used to amortize capitalized acquisition costs. Surrender charges are recognized upon surrender of a contract in accordance with contractual terms. Derivatives embedded in fixed-indexed and variable products are recorded at fair value and changes in value are included in Change in fair value of annuity and life embedded derivatives in the Statements of Operations. Benefits consist of interest credited to contractholders’ accounts and claims incurred in excess of the contractholders’ account balance and are included in Net interest credited to account values and Policyholder benefits, respectively, within the Statements of Operations. The Company offers a variable-indexed annuity product that combines a separate account option with a general account option that is similar to a fixed-indexed annuity. The Company has elected the fair value option to account for the entire insurance contract liability and the variable investment option assets backing the separate account. The insurance contracts’ reserves are reported in Account balances and future policy benefit reserves and the variable investment option assets within the separate account are reported in Equity securities, trading on the Balance Sheets. Electing the fair value option for an insurance contract liability requires that the Company account for that liability as a financial instrument and also requires that acquisition costs be recognized immediately in expense. (d) Life and Accident and Health Insurance Premiums on traditional life products are recognized as revenue over the premium-paying periods of the contracts when due from contractholders. Premium revenue generally exceeds expected policy benefits in the early years of the contracts and it is necessary to accrue, as premium is recognized, a liability for costs that are expected to be paid in the later years of the contracts. Accident and health premiums are recognized as earned on a pro rata basis over the risk coverage periods. Benefits and expenses are recognized as incurred. (e) Investments Fixed-maturity Securities and Equity Securities The Company has portfolios of fixed-maturity securities classified as “available-for-sale.” Accordingly, these securities are carried at fair value, and related unrealized gains and losses are credited or charged directly to accumulated other comprehensive income (AOCI) in stockholder’s equity, net of tax and related shadow adjustments. The adjustments to deferred acquisition costs (DAC) and deferred sales inducements (DSI) represent the change in amortization that would have been required as a charge or credit to operations had such unrealized amounts been realized. The adjustment to reserves represents the increase or decrease in the reserve balance that would have been required as a charge or credit to operations had such unrealized amounts been realized. The Company has a portfolio of equity securities classified as “trading”. These securities are carried at fair value, and their respective related unrealized gains and losses are reflected in Change in fair value of assets and liabilities within the Statements of Operations. Dividends are accrued on the date they are declared, and interest is accrued as earned. Premiums or discounts on fixed-maturity securities are amortized using the constant yield method. Realized gains and losses are computed based on the average cost basis of all lots owned of each security. Mortgage-backed securities and structured securities are amortized using, among other assumptions, anticipated prepayments. Prepayment assumptions for loan-backed securities are obtained from various external sources or internal estimates. The Company believes these assumptions are consistent with those a market participant would use. The Company recognizes income using a constant effective yield method based on prepayment assumptions and the estimated economic life of the securities. For all structured securities without expected credit deterioration, when actual prepayments differ significantly from anticipated prepayments, the effective yield is recalculated to reflect actual payments to date and anticipated future payments using the retrospective method. Any resulting adjustment is included in Interest and similar income, net in the Statements of Operations. For structured securities with expected credit deterioration, when adjustments are anticipated for prepayments and other expected changes in future cash flows, the effective yield is recalculated using the prospective method. The fair value of fixed-maturity securities and equity securities is obtained from third-party pricing sources whenever possible. Management completes its own Independent Price Verification (IPV) process, which ensures security pricing is obtained from a third-party source other than the sources used by the internal and external investment managers managing the investments held by the Company. The IPV process supports the reasonableness of price overrides and challenges by the internal and external investment managers and reviews pricing for appropriateness. Results of the IPV are reviewed by the Company’s Pricing Committee. The Company reviews the available-for-sale investment portfolio to determine whether or not declines in fair value are other than temporary. The Company continues to evaluate factors in addition to average cost and fair value, including credit quality, the extent and duration of the decline, market analysis, current events, recent price declines, changes in risk-free interest rates, likelihood of recovery in a reasonable period of time, and management’s judgment, to determine whether fixed-income securities are considered other-than-temporarily impaired. When the fair value of a fixed-maturity security is less than its amortized cost, the Company assesses whether or not (i) it has the intent to sell the security or (ii) it is more likely than not that the Company will be required to sell the security before its anticipated recovery. The Company evaluates these factors to determine whether the Company or any of its internal and external investment managers have the intent to sell a security or a group of securities. Additionally, the Company performs a cash flow projection for several years into the future to determine whether cash needs would require the sale of any securities in an unrealized loss position. If either of these conditions is met, the Company must recognize an other-than-temporary-impairment (OTTI) for the difference between the investment’s amortized cost basis and its fair value through earnings. For securities that do not meet the above criteria, and the Company does not expect to recover a security’s amortized cost basis, the security is considered other-than-temporarily impaired. For these securities, the Company separates the total impairment into the credit loss component and the amount of the loss related to other factors. The amount of the total impairment related to credit loss is considered an OTTI and is recognized in Realized investment (losses) gains, net in the Statements of Operations. The amount of the total impairment related to other factors is recognized in other comprehensive income (OCI), net of impacts to DAC, DSI, reserves, and deferred income taxes. For available-for-sale securities that have recognized an OTTI through earnings, if through subsequent evaluation there is a significant increase in the cash flow expected, the difference between the amortized cost basis and the discounted cash flows expected to be collected is accreted as interest income. Subsequent increases and decreases not related to additional credit losses in the fair value of available-for-sale securities are included in the Statements of Comprehensive Income (Loss). The Company evaluates whether a credit loss exists by considering primarily the following factors: (a) the length of time and extent to which the fair value has been less than the amortized cost of the security; (b) changes in the financial condition, credit rating, and near-term prospects of the issuer; (c) whether the issuer is current on contractually obligated interest and principal payments; (d) changes in the financial condition of the security’s underlying collateral, if any; and (e) the payment structure of the security. The Company uses a probability-weighted cash flow model for corporate bonds to determine the credit loss amount. This measurement is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions and significant judgments regarding the future performance of the security. The Company’s probability-weighted cash flow model involves assumptions including, but not limited to, various performance indicators, such as historical and projected default and recovery rates, credit ratings, and current delinquency rates. For structured securities, the Company selects a probability-weighted or best estimate cash flow model depending on the specifics of the individual security and the information available to measure the expected cash flows of the underlying collateral. In the event that sufficient information is not available to measure the expected cash flows of a structured security in a timely manner due to a lack of available information on the valuation date, the entire decline in fair value is considered to be related to credit loss. The Company provides a supplemental disclosure within the Statements of Operations that presents the total OTTI losses recognized during the period less the portion of OTTI losses recognized in OCI to equal the credit-related portion of OTTI that was recognized in earnings during the period. The portion of OTTI losses recognized in OCI includes the portion of OTTI losses related to factors other than credit recognized during the period, offset by reclassifications of OTTI losses previously determined to be related to factors other than credit that are determined to be credit-related in the current period. The amount presented in the supplemental disclosure within the Statements of Operations represents the portion of OTTI losses recognized in OCI and excludes subsequent increases and decreases in the fair value of these securities. The Company evaluates whether equity securities are other-than-temporarily impaired through a review process which includes, but is not limited to, market analysis, analyzing current events, assessing recent price declines, and management’s judgment related to the likelihood of recovery within a reasonable period of time. All previously impaired equity securities will incur additional OTTI should the fair value fall below the book value. Impairments in the value of securities held by the Company, considered to be other than temporary, are recorded as a reduction of the cost of the security, and a corresponding realized loss is recognized in the Statements of Operations. The Company adjusts DAC and DSI for impairments on securities, as discussed in their respective sections of this note. Variable Interest Entities In the normal course of business, the Company enters into relationships with various entities that are deemed to be a variable interest entity (VIE). A VIE is an entity that either (1) has equity investors that lack certain essential characteristics of a controlling financial interest (including the ability to control activities of the entity, the obligation to absorb the entity’s expected losses, and the right to receive the entity’s expected residual returns) or (2) lacks sufficient equity to finance its own activities without financial support provided by other entities, which in turn would be expected to absorb at least some of the expected losses of the VIE. The Company consolidates a VIE if it is determined to be the primary beneficiary. Those entities which do not meet the requirements to be a VIE are voting interest entities (VOEs). The Company consolidates a VOE if it holds a voting interest that is greater than 50%. Policy Loans Policy loans, which are supported by the underlying cash value of the policies, are carried at unpaid principal balances, which approximate fair value. (f) Derivatives The Company utilizes derivatives within certain actively managed investment portfolios. Within these portfolios, derivatives can be used for hedging, replication, and income generation only. The financial instruments are valued and carried at fair value and the unrealized gains and losses on the derivatives are reflected in Change in fair value of assets and liabilities in the Statements of Operations. Options and Futures Contracts The Company provides additional benefits through certain life and annuity products, which are linked to the fluctuation of various United States and international stock and bond market indices. In addition, certain variable annuity contracts provide minimum guaranteed benefits. The Company has analyzed the characteristics of these benefits and has entered into over-the-counter (OTC) option contracts and exchange-traded futures contracts tied to an appropriate underlying index with similar characteristics with the objective to economically hedge these risks. The Company uses exchange-traded futures contracts with the objective to increase the effectiveness of the economic hedge. Management monitors in-force amounts and option and futures contract values to ensure satisfactory matching and to identify unsatisfactory mismatches. If persistency assumptions were to deviate significantly from anticipated rates, management would purchase or sell option and futures contracts as deemed appropriate or take other actions. The OTC option contracts are reported at fair value as Derivative assets and Derivative liabilities on the Balance Sheets. The fair value of the OTC options is derived internally and deemed by management to be reasonable via performing an IPV process. The process of deriving internal derivative prices requires the Company to calibrate Monte Carlo scenarios to actual market information. The calibrated scenarios are applied to derivative cash flow models to calculate fair value prices for the derivatives. Changes in unrealized gains and losses on the OTC option contracts and incremental gains and losses from expiring contracts are recorded within Change in fair value of assets and liabilities in the Statements of Operations. Futures contracts do not require an initial cash outlay, and the Company has agreed to daily net settlement based on movements of the representative index. Therefore, no asset or liability is recorded on the Balance Sheets. Gains and/or losses on futures contracts are included in Change in fair value of assets and liabilities in the Statements of Operations. Interest Rate Swaps and Total Return Swaps The Company utilizes interest rate swaps (IRS) to hedge market risks embedded in certain annuities. Beginning in 2016, the Company began transacting in total return swaps (TRS) also to hedge market risks in certain annuities. The IRS and TRS are reported at fair value in Derivative assets and Derivative liabilities on the Balance Sheets. The fair value of the IRS are derived using a third-party vendor software program and deemed by management to be reasonable. The fair value of the TRS is based on counterparty pricing and deemed by management to be reasonable. The unrealized gains and losses on the swaps are recorded in Change in fair value of assets and liabilities in the Statements of Operations. (g) Cash and cash equivalents Cash and cash equivalents includes cash on hand, demand deposits, overnight commercial paper, and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the recorded value is deemed to approximate fair value. (h) Receivables Receivable balances (contractual amount less allowance for doubtful accounts) are based on pertinent information available to management as of year-end, including the financial condition and creditworthiness of the parties underlying the receivables. Receivable balances are monitored and allowances for doubtful accounts are maintained based on the nature of the receivable, and the Company’s assessment of the ability to collect. The allowance is estimated by aging the balances due from individual parties and generally setting up an allowance for any balances that are more than 90 days old. (i) Reinsurance The Company cedes business with other insurers. Reinsurance premium and benefits paid or provided are accounted for in a manner consistent with the basis used in accounting for original policies issued and the terms of the reinsurance contracts and are included in Premiums and policy fees, ceded, and Benefit recoveries, respectively, in the Statements of Operations. Insurance liabilities are reported before the effects of reinsurance. Account balances and future policy benefit reserves and policy and contract claims covered under reinsurance contracts are recorded in Reinsurance recoverable on the Balance Sheets. Amounts paid or deemed to have been paid for claims covered by reinsurance contracts are recorded as Receivables on the Balance Sheets. Reinsurance recoverables are recognized in a manner consistent with the liabilities related to the underlying reinsured contracts. Amounts due to other insurers on assumed business are recorded as a reinsurance payable, and are included in Other liabilities on the Balance Sheets. A gain recognized when the Company enters into a coinsurance agreement with a third-party reinsurer is deferred and recorded in Other liabilities on the Balance Sheets. Such gains are amortized into operations over the revenue-producing period or the claims run-off period, of the related reinsured policies. These amortized gains are recorded in Fee, commission and other revenue in the Statements of Operations. (j) Deferred Acquisition Costs Acquisition costs consist of commissions and other incremental costs that are directly related to the successful acquisition of insurance contracts. Acquisition costs are deferred to the extent recoverable from future policy revenues and gross profits. However, acquisition costs associated with insurance contracts recorded under the fair value option are not deferred as guidance related to the fair value option requires that transaction costs are recorded immediately as an expense. For interest-sensitive products (all issue years) and variable annuity contracts (issued in 2010 and after), acquisition costs are amortized in relation to the present value of expected future gross profits from investment and mortality, morbidity, and expense charges. For variable annuity contracts issued prior to 2010, acquisition costs are amortized in relation to the present value of estimated gross revenues from investment and mortality, morbidity, and expense charges. Acquisition costs for accident and health insurance policies are deferred and amortized over the lives of the policies in the same manner as premiums are earned. For traditional life and group life products, such costs are amortized over the projected earnings pattern of the related policies using the same actuarial assumptions used in computing future policy benefit reserves. DAC are reviewed for recoverability and loss recognition, at least annually, and adjusted when necessary. The evaluation is a two-step process where current policy year issues are evaluated for recoverability, and then in-force policies are evaluated for loss recognition. Before assessing recoverability and loss recognition, DAC are capped, if necessary, such that the balance cannot exceed the original capitalized costs plus interest. Changes in assumptions can have an impact on the amount of DAC reported for annuity and life insurance products and their related amortization patterns. In the event experience differs from assumptions or assumptions are revised, the Company is required to record an increase or decrease in DAC amortization expense, which is referred to as DAC unlocking. In general, increases in the estimated investment spreads and fees result in increased expected future profitability and may decrease the rate of DAC amortization, while increases in costs of product guarantees, and lapse/surrender and mortality assumptions reduce the expected future profitability of the underlying business and may increase the rate of DAC amortization. The Company formally evaluates the appropriateness of the best-estimate assumptions on an annual basis. If the economic environment or policyholder behavior changes quickly and substantially, assumptions will be reviewed more frequently to affirm best estimates. Any resulting DAC unlocking is reflected prospectively as a Change in deferred acquisition costs, net in the Statements of Operations. Adjustments to DAC are made to reflect the corresponding impact on the present value of expected future gross profits and revenue from unrealized gains and losses on available-for-sale investments used to support policyholder liabilities (commonly known as shadow DAC). These adjustments are included in AOCI and are explained further in the Investments section of this note. Adjustments may also be made to the estimated gross profits (EGP) or estimated gross revenues related to DAC that correspond with deferred annuities and universal life products for investment activity, such as write-downs on other-than-temporarily impaired fixed-maturity securities, and realized gains and losses. Management action may include assumption changes in the DAC models, such as adjustments to expected future gross profits or revenues used, as well as in-force management action such as crediting rate changes or index rate cap adjustments. This approach applies to fixed-maturity securities purchased as investment-grade only and not noninvestment-grade items that were purchased with other yield considerations. See further discussion of DAC unlocking in note 9. The Company assesses internal replacements on insurance contracts to determine whether such modifications significantly change the contract terms. An internal replacement represents a modification in product benefits, features, rights, or coverage that occurs by the exchange of an in-force insurance contract for a new insurance contract, or by amendment, endorsement, or rider to a contract. If the modification substantially changes the contract, the remaining DAC on the original contract are immediately expensed and any new DAC on the replacement contract are deferred. If the contract modification does not substantially change the contract, DAC amortization on the original contract continues and any new acquisition costs associated with the modification are immediately expensed. (k) Deferred Sales Inducements Sales inducements are product features that enhance the investment yield to the contractholder on the contract. The Company offers two types of sales inducements on certain universal life and annuity contracts. The first type, an immediate bonus, increases the account value at inception, and the second type, a persistency bonus, increases the account value at the end of a specified period. Annuity sales inducements are deferred when credited to contractholders, and life sales inducements are deferred and recognized as part of the liability for policy benefits. DSI are reported in Other assets on the Balance Sheets. They are amortized over the expected life of the contract in a manner similar to DAC and are reviewed annually for recoverability. DSI capitalization and amortization is recorded in Policyholder benefits within the Statements of Operations. Adjustments to DSI are made to reflect the estimated corresponding impact on the present value of expected future gross profits and revenues from unrealized gains and losses on available-for-sale investments used to support policyholder liabilities (commonly known as shadow DSI). These adjustments are included in AOCI and are explained further in the Investments section of this note. Adjustments may also be made to DSI related to deferred annuities for investment activity, such as write-downs on other-than-temporarily impaired fixed-maturity securities, and realized gains and losses. Management action may include assumption changes in the DSI models, such as adjustments to expected future gross profits used, as well as policyholder changes, such as credited rate changes. This approach applies to fixed-maturity securities purchased at investment grade only and not noninvestment grade items that were purchased with other yield considerations. (l) Income Taxes The Company and the Company’s parent, Allianz Life, file a consolidated federal income tax return with AZOA and many of its wholly owned subsidiaries. The consolidated tax allocation agreement stipulates that each company participating in the return will bear its share of the tax liability pursuant to certain tax allocation elections under the Internal Revenue Code and its related regulations, and that reimbursement will be in accordance with an intercompany tax reimbursement arrangement. The Company generally will be paid for the tax benefit on its losses and any other tax attributes to the extent it could have obtained a benefit against the Company’s post-1990 separate return tax liability. The Company provides for federal income taxes based on amounts the Company believes it ultimately will owe. Inherent in the provision for federal income taxes are estimates regarding the deductibility of certain items and the realization of certain tax credits. In the event the ultimate deductibility of certain items or the realization of certain tax credits differs from estimates, the Company may be required to significantly change the provision for federal income taxes recorded on the Balance Sheets. Any such change could significantly affect the amounts reported in the Statements of Operations. Management uses best estimates to establish reserves based on current facts and circumstances regarding tax exposure items where the ultimate deductibility is open to interpretation. Quarterly, management evaluates the appropriateness of such reserves based on any developments specific to their fact patterns. Information considered includes results of completed tax examinations, Technical Advice Memorandums, and other rulings issued by the Internal Revenue Service or the tax courts. The Company utilizes the asset and liability method of accounting for income tax. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. Valuation allowances are established when it is determined that it is more likely than not that the deferred tax asset will not be fully realized or that the related temporary differences, such as OTTI, will not reverse over time (see further discussion in note 11). (m) Separate Accounts and Annuity Product Guarantees The Company issues variable annuity contracts through its separate accounts for which investment income and investment gains and losses accrue directly to, and investment risk is borne by, the contractholder. The Company also issues variable-indexed annuity contracts to its customers. These products have investment options similar to fixed-indexed annuities, but allow contractholders to invest in a variety of variable separate account investment options. The Company recognizes gains or losses on transfers from the general account to the separate accounts at fair value to the extent of contractholder interests in separate accounts, which are offset by changes in contractholder liabilities. The Company also issues variable annuity contracts through its separate accounts, where the Company provides certain contractual guarantees to the contractholder. These guarantees are in the form of a guaranteed minimum death benefit (GMDB), a guaranteed minimum income benefit (GMIB), a guaranteed minimum accumulation benefit (GMAB), and a guaranteed minimum withdrawal benefit (GMWB). The investments backing the guarantees are held in the general account. These guarantees provide for benefits that are payable to the contractholder in the event of death, annuitization, exercise of the living withdrawal benefit, or at specified dates during the accumulation period. Separate account assets supporting variable annuity contracts represent funds for which investment income and investment gains and losses accrue directly to contractholders. Each fund has specific investment objectives, and the assets are carried at fair value. The assets of each account are legally segregated and are not subject to claims that arise out of any of the other business of the Company. Separate account assets and liabilities are reported as summary totals on the Balance Sheets. Amounts charged to the contractholders for mortality and contract maintenance are included in Policy fees in the Statements of Operations. These fees have been earned and assessed against contractholders on a daily or monthly basis throughout the contract period and are recognized as revenue when assessed and earned. Changes in GMDB and GMIB are calculated in accordance with the Financial Services – Insurance Topic of the Accounting Standards Codification (Codification), and are included in Policyholder benefits in the Statements of Operations. GMAB and GMWB are considered to be embedded derivatives under the Derivatives and Hedging Topic of the Codification, and the changes in these embedded derivatives are included in Change in fair value of annuity and life embedded derivatives in the Statements of Operations. The GMDB net amount at risk is defined as the guaranteed amount that would be paid upon death, less the current accumulated contractholder account value. The GMIB net amount at risk is defined as the current amount that would be needed to fund expected future guaranteed payments less the current contractholder account value, assuming that all benefit selections occur as of the valuation date. The GMAB net amount at risk is defined as the current guaranteed value amount that would be added to the contracts less the current contractholder account value. The GMWB net amount at risk is defined as the current accumulated benefit base amount less the current contractholder account

Risk Disclosures

Risk Disclosures	12 Months Ended
Risk Disclosures	Dec. 31, 2016
Risk Disclosures	(3) Risk Disclosures The following is a description of the significant risks facing the Company and how the Company attempts to mitigate those risks: (a) Credit Risk Credit risk is the risk that issuers of fixed rate and variable rate income securities, mortgages on commercial real estate, or other parties with whom the Company has transactions, such as reinsurance and derivative counterparties, default on their contractual obligations, resulting in unexpected credit losses. The Company mitigates this risk by adhering to investment policies and limits that provide portfolio diversification on an asset class, asset quality, creditor, and geographical basis, and by complying with investment limitations governed by state insurance laws and regulations, as applicable. The Company considers all relevant objective information available in estimating the cash flows related to structured securities. The Company actively monitors and manages exposures, and determines whether any securities are impaired. The aggregate credit risk taken in the investment portfolio is influenced by management’s risk/return preferences, the economic and credit environment, and the ability to manage this risk through liability portfolio management. For derivative counterparties, the Company mitigates credit risk by tracking and limiting exposure to each counterparty through limits that are reported regularly and, once breached, restricts further trades; establishing relationships with counterparties rated BBB+ and higher; and monitoring the credit default swap (CDS) of each counterparty as an early warning signal to cease trading when CDS spreads imply severe impairment in credit quality. The Company executes Credit Support Annexes (CSA) with all active and new counterparties which further limits credit risk by requiring counterparties to post collateral to a segregated account to cover any counterparty exposure. (b) Credit Concentration Risk Credit concentration risk is the risk of increased exposure to significant asset defaults (of a single security issuer or class of security issuers); economic conditions (if business is concentrated in a certain industry sector or geographic area); or adverse regulatory or court decisions (if concentrated in a single jurisdiction) affecting credit. Concentration risk exposure is monitored regularly. The Company’s Finance Committee, responsible for asset/liability management (ALM) issues, recommends an investment policy to the Company’s Board of Directors (BOD). The investment policy and accompanying investment mandates specify asset allocation among major asset classes and the degree of asset manager flexibility for each asset class. The investment policy complies, at a minimum, with state statutes. Compliance with the policy is monitored by the Finance Committee who is responsible for implementing internal controls and procedures. Deviations from the policy are monitored and addressed. The Finance Committee and subsequently the BOD review the investment policy at least annually. To further mitigate this risk, internal concentration limits based on credit rating and sector are established and are monitored regularly by Allianz Life on a consolidated basis. Any ultimate obligor group exceeding these limits is placed on a restricted list to prevent further purchases, and the excess exposure may be actively sold down to comply with concentration limit guidelines. Any exceptions require Chief Risk Officer approval and monitoring by the Risk Committee. Further, the Company performs a quarterly concentration risk calculation to ensure compliance with the State of New York basket clause. (c) Liquidity Risk Liquidity risk is the risk that unexpected timing or amounts of cash needed will require liquidation of assets in a market that will result in a realized loss or an inability to sell certain classes of assets such that an insurer will be unable to meet its obligations and contractual guarantees. Liquidity risk also includes the risk that in the event of a company liquidity crisis refinancing is only possible at higher interest rates. Liquidity risk can be affected by the maturity of liabilities, the presence of withdrawal penalties, the breadth of funding sources, and terms of funding sources. It can also be affected by counterparty collateral triggers as well as whether anticipated liquidity sources such as credit agreements are cancelable. The Company manages liquidity within four specific domains: (1) monitoring product development, product management, business operations, and the investment portfolio; (2) setting ALM strategies; (3) managing the cash requirements stemming from the Company’s derivative dynamic hedging activities; and (4) establishing a liquidity facility with Allianz Life to provide additional liquidity. The Company has established liquidity risk limits, which are approved by the Company’s Risk Committee, and the Company monitors its liquidity risk regularly. (d) Interest Rate Risk Interest rate risk is the risk that movements in interest rates or interest rate volatility will cause a decrease in the value of an insurer’s assets relative to the value of its liabilities and/or an unfavorable change in prepayment activity resulting in compressed interest margins. The Company has an ALM strategy to align cash flows and duration of the investment portfolio with policyholder liability cash flows and duration. The Company further limits interest rate risk on variable annuity guarantees through interest rate hedges. (e) Equity Market Risk Equity market risk is the risk that movements in the equity prices or equity volatility will cause a decrease in the value of an insurer’s assets relative to the value of its liabilities. The policy value of the fixed-indexed annuity products is linked to equity market indices. The Company economically hedges this exposure with derivatives. Variable annuity products may provide a minimum guaranteed level of benefits irrespective of market movements. The Company has adopted an economic hedging program to manage the equity risk of these products. Allianz Life monitors the economic and accounting impacts of equity stress scenarios on assets and liabilities on a consolidated basis regularly and on the Company’s specific basis periodically. Basis risk is the risk that the variable annuity hedge asset value changes unexpectedly relative to the value of the underlying separate account funds of the variable annuity contracts. Basis risk may arise from the Company’s inability to directly hedge the underlying investment options of the variable annuity contracts. The Company mitigates this risk through regular review and synchronization of fund mappings, product design features, and hedge design. (f) Operational Risk Operational risk is the risk of loss resulting from inadequate or failed internal processes and systems, from human misbehavior or error, or from external events. Operational risk is comprised of the following seven risk categories: (1) internal fraud; (2) external fraud; (3) employment practices and workplace safety; (4) client/third party products and business practices; (5) damage to physical assets; (6) business disruption and system failure; and (7) execution, delivery, and process management. Operational risk is comprehensively managed through a combination of core qualitative and quantitative activities. The Operational Risk Management framework includes the following key activities: (1) loss data capture identifies historical operational events that meet a designated threshold to ensure transparency and remediation of each event; (2) risk-based integrated control system is performed to proactively manage significant operational risk scenarios throughout the organization; and (3) scenario analyses are conducted to quantify operational risk capital. (g) Legal/Regulatory Risk Legal/regulatory risk is the risk that changes in the legal or regulatory environment in which the Company operates may result in reduced demand for its products or additional expenses not assumed in product pricing. Additionally, the Company is exposed to risk related to how the Company conducts itself in the market and the suitability of its product sales to contractholders. The Company mitigates this risk by actively monitoring all market-related exposure and participating in national and international discussions relating to legal, regulatory, and accounting changes that may impact the business. A formal process exists to assess the Company’s risk exposure to changes in regulation including monitoring by the Compliance and Legal departments and regular reporting to the BOD of all known compliance risks and the effectiveness of the approach used to mitigate such risks. In addition, the Company has implemented suitability standards to mitigate suitability risk. On April 6, 2016, the Department of Labor (DOL) issued a final rule that will significantly expand the definition of “investment advice” and increase the circumstances in which companies and broker- dealers, insurance agencies, and other financial institutions that sell the Company’s products could be deemed a fiduciary when providing investment advice with respect to plans under the Employee Retirement Income Security Act of 1974 (ERISA) or individual retirement accounts (IRAs). It is not yet certain how, if at all, the implementation of this rule will change the Company’s business, results of operations, or financial condition. The DOL has extended the implementation of the rule until April 2017. The DOL also introduced amendments to longstanding exemptions from the prohibited transaction provisions under ERISA that would increase fiduciary requirements in connection with transactions involving ERISA plans, plan participants and IRAs, and that would apply more onerous disclosure and contract requirements to such transactions. The DOL has introduced an additional transition period for these amendments until January 2018. It may be necessary to change sales representative and/or broker compensation, limit the assistance or advice provided to owners of Company annuities, or otherwise change the manner of design and sales support of the annuities. These changes could have an adverse impact on the level and type of services provided and compliance with the rule could also increase the overall operational costs for the services currently provided. (h) Ratings Risk Ratings risk is the risk that rating agencies change their outlook or rating of the Company. The rating agencies generally utilize proprietary capital adequacy models in the process of establishing ratings for the Company. The Company is at risk of changes in these models and the impact that changes in the underlying business that the Company is engaged in can have on such models. To mitigate this risk, the Company maintains regular communications with the rating agencies and evaluates the impact of significant transactions on such capital adequacy models and considers the same in the design of transactions to minimize the adverse impact of this risk. Stress tests are performed regularly to assess how rating agency capital adequacy models would be impacted by severe economic events. (i) Mortality/Longevity Risk Mortality/longevity risk is the risk that mortality experience is different than the life expectancy assumptions used by the Company to price its products. The Company mitigates mortality risk primarily through reinsurance, whereby the Company cedes a significant portion of its new and existing mortality risk to third parties. The Company also manages mortality risk through the underwriting process. Both mortality and longevity risks are managed through review of the life expectancy assumptions and experience in conjunction with active product management. (j) Lapse Risk Lapse risk is the risk that actual lapse experience evolves differently than the assumptions used for pricing and valuation exercises leading to a significant loss in Company value and/or income. The Company mitigates this risk by performing sensitivity analysis at the time of pricing to affect policy design, regular ALM analysis, and exercising management levers at issue, as well as post- issue as experience evolves. Policyholder experience is monitored regularly. (k) Cyber Security Risk Cyber security risk is the risk of losses due to external and/or internal attacks impacting the confidentiality, integrity and/or availability of key systems, data, and processes reliant on digital technology. The Company has implemented preventative, detective, response, and recovery measures including advanced malware detection, spyware and anti-virus software, phishing filters, email and laptop encryption, web content filtering, and regular scanning of all servers and network devices to identify vulnerabilities. Controls are implemented to prevent and review unauthorized access. (l) Reinsurance Risk Reinsurance risk is the risk that reinsurance companies default on their obligation where the Company has ceded a portion of its insurance risk. The Company uses reinsurance to limit its risk exposure to certain business lines and to enable better capital management. Reinsurance contracts do not relieve the Company from its obligations to policyholders. Failure of reinsurers to honor their obligations could result in losses to the Company. The Company mitigates this risk by requiring certain counterparties to meet thresholds related to the counterparty’s credit rating, exposure, or other factors. If the thresholds are not met, the counterparties are required to establish a trust or letter of credit backed by assets meeting certain quality criteria. All arrangements are regularly monitored to determine whether trusts or letters of credit are sufficient to support the ceded liabilities and that their terms are being met. Also, the Company regularly reviews the financial standings and ratings of its reinsurance counterparties and monitors concentrations of credit risk to minimize its exposure to significant losses from reinsurer insolvencies.

Investments

Investments	12 Months Ended
Investments	Dec. 31, 2016
Investments	(4) Investments (a) Fixed-maturity Securities At December 31, 2016 and 2015, the amortized cost, gross unrealized gains, gross unrealized losses, and fair values of available-for-sale securities are as shown in the following tables: Amortized Gross Gross Fair 2016: Fixed-maturity securities: U.S. government $ 48,676 644 103 49,217 States and political subdivisions 10,546 285 187 10,644 Corporate securities 491,518 21,500 3,739 509,279 Mortgage-backed securities 184,217 1,732 3,558 182,391 Total $ 734,957 24,161 7,587 751,531 Amortized Gross Gross Fair 2015: Fixed-maturity securities: U.S. government $ 72,035 1,188 — 73,223 States and political subdivisions 11,112 214 282 11,044 Foreign government 505 5 — 510 Corporate securities 443,449 21,219 10,486 454,182 Mortgage-backed securities 133,853 2,909 1,159 135,603 Total $ 660,954 25,535 11,927 674,562 At December 31, 2016 and 2015, the Company did not have any OTTI losses in AOCI. The net unrealized gains on available-for-sale securities consist of the following at December 31: 2016 2015 2014 Available-for-sale: Fixed-maturity securities $ 16,574 13,608 41,419 Adjustments for: Shadow adjustments (5,501) (5,916 ) (15,794 ) Deferred taxes (3,876 ) (2,692 ) (8,969 ) Net unrealized gains $ 7,197 5,000 16,656 The amortized cost and fair value of available-for-sale fixed-maturity securities at December 31, 2016, by contractual maturity, are shown below: Amortized Fair value Available-for-sale fixed-maturity securities: Due in one year or less $ 23,313 23,685 Due after one year through five years 226,927 234,973 Due after five years through ten years 176,086 176,051 Due after ten years 119,112 128,731 Structured securities 189,519 188,091 Total available-for-sale fixed-maturity securities $ 734,957 751,531 Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Structured securities, which include mortgage-backed and asset-backed securities, are shown separately as they are not due at a single maturity. As of December 31, 2016 and 2015, investments with a fair value of $1,699 and $1,713, respectively, were pledged to the New York Superintendent of Insurance, as required by statutory regulation. The Company’s available-for-sale securities portfolio includes mortgage-backed securities. Due to the high quality of these investments and the lack of subprime loans within the securities, the Company does not have a material exposure to subprime mortgages. (b) Unrealized Investment Losses The following table summarizes the fair value and related unrealized losses on available-for-sale securities that have been in a continuous loss position for the respective years ended December 31 are shown below: 12 months or less Greater than 12 months Total Fair value Unrealized Fair value Unrealized Fair value Unrealized 2016: Fixed-maturity securities: U.S. government $ 11,713 103 — — 11,713 103 States and political subdivisions 4,286 187 — — 4,286 187 Corporate securities 132,387 3,313 7,253 426 139,640 3,739 Mortgage-backed securities 102,435 3,483 1,622 75 104,057 3,558 Total temporarily impaired available-for-sale securities $ 250,821 7,086 8,875 501 259,696 7,587 12 months or less Greater than 12 months Total Fair value Unrealized Fair value Unrealized Fair value Unrealized 2015: Fixed-maturity securities: States and political subdivisions $ 4,206 282 — — 4,206 282 Corporate securities 118,027 5,912 12,707 4,574 130,734 10,486 Mortgage-backed securities 52,731 1,036 2,985 123 55,716 1,159 Total temporarily impaired available-for-sale securities $ 174,964 7,230 15,692 4,697 190,656 11,927 As of December 31, 2016 and 2015, there were 149 and 104 available-for-sale fixed-maturity securities that were in an unrealized loss position, respectively. As of December 31, 2016 and 2015, of the total amount of unrealized losses, $7,250 or 95.6% and $11,586 or 97.1%, respectively, are related to unrealized losses on investment grade securities. Investment grade is defined as a security having a credit rating of Aaa, Aa, A, or Baa from Moody’s or a rating of AAA, AA, A, or BBB from S&P, or a NAIC rating of 1 or 2 if a Moody’s or S&P rating is not available. Unrealized losses on securities are principally related to changes in interest rates or changes in sector spreads from the date of purchase. As contractual payments continue to be met, management continues to expect all contractual cash flows to be received. As mentioned in note 2, the Company reviews these securities regularly to determine whether or not declines in fair value are other-than-temporary. Further, as the Company neither has an intention to sell nor does it expect to be required to sell the securities outlined above, the Company does not consider these investments to be other-than-temporarily impaired. (c) OTTI Losses The following table presents a rollforward of the Company’s cumulative credit impairments on fixed-maturity securities held at December 31: 2016 2015 Balance as of January 1 $ — — Additions for credit impairments recognized on: Securities not previously impaired 387 184 Reductions for credit impairments previously on: Securities that matured or were sold during the period (387) (184 ) Balance as of December 31 $ — — (d) Realized Investment (Losses) Gains Gross and net realized investment (losses) gains for the respective years ended December 31 are summarized as follows: 2016 2015 2014 Fixed-maturity securities: Gross gains on sales $ 1,130 895 277 Gross losses on sales (949 ) (133 ) (206 ) OTTI (387 ) (184 ) — Other 1 5 6 Net realized investment (losses) gains $ (205 ) 583 77 Proceeds from sales of available-for-sale investments for the years ended December 31 are presented in the following table: 2016 2015 2014 Available-for-sale: Fixed-maturity securities proceeds from sales $ 59,031 54,740 22,808 (e) Interest and Similar Income Major categories of Interest and similar income, net, for the respective years ended December 31 are shown below: 2016 2015 2014 Interest and similar income: Fixed-maturity securities $ 30,189 27,699 29,131 Trading securities 16 24 24 Policy loans 22 18 17 Other invested assets, includes cash and cash equivalents 165 24 7 Total 30,392 27,765 29,179 Less: Investment expenses 834 378 320 Total interest and similar income, net $ 29,558 27,387 28,859 (f) Variable Interest Entities The Company invests in structured securities which represent interests in VIEs. The Company has carefully analyzed the VIEs to determine whether the Company is the primary beneficiary, taking into consideration whether the Company, or the Company together with its affiliates, has the power to direct the activities of the VIE, that most affect its economic performance and whether the Company has the right to benefits from the VIE. Based on that analysis, the Company has concluded that it is not the primary beneficiary for all of the Company’s VIEs. The carrying amount and maximum exposure to loss relating to the VIEs which the Company holds a variable interest but is not the primary beneficiary and which have not been consolidated were as follows: December 31, 2016 December 31, 2015 Carrying amount Maximum exposure to loss (1) Carrying amount Maximum exposure to loss (1) Fixed-maturity securities: Corporate securities $ 5,700 5,700 6,451 6,451 Mortgage-backed securities 182,391 182,391 135,603 135,603 Total fixed-maturity securities $ 188,091 188,091 142,054 142,054 (1) The maximum exposure to loss is equal to the carrying amount for fixed-maturity securities.

Derivative and Hedging Instrume

Derivative and Hedging Instruments	12 Months Ended
Derivative and Hedging Instruments	Dec. 31, 2016
Derivative and Hedging Instruments	(5) Derivative and Hedging Instruments The Company uses derivatives as a risk management strategy to economically hedge its exposure to various market risks associated with both its products and operations. Derivative assets and liabilities are recorded at fair value in the Financial Statements using valuation techniques further discussed in note 6. None of the derivative investments held by the Company qualify as hedging instruments for accounting purposes. Option Contracts The Company utilizes OTC options with the objective to economically hedge certain variable annuity guaranteed benefits. These options are not used for speculative or income generating purposes. These options are cleared through the Options Clearing Corporation (OCC), which operates under the jurisdiction of both the Securities and Exchange Commission (SEC) and the Commodities Futures Trading Commission. The credit rating on the OCC is currently AA+ from S&P. The fair values of the collateral posted for OTC options and exchange-traded derivatives are discussed in the derivative collateral management section below. Futures The Company utilizes exchange-traded futures to economically hedge fixed-indexed annuity and variable annuity guarantees. The futures contracts do not require an initial investment except for the initial margin described below and the Company is required to settle cash daily based on movements of the representative index. Therefore, no asset or liability is recorded as of December 31, 2016 and 2015. The fair value of the collateral posted for exchange-traded derivatives is discussed in the derivative collateral management section below. Interest Rate Swaps The Company utilizes OTC and exchange-traded IRS to economically hedge certain variable and fixed-indexed annuity guarantee benefits. The Company can receive the fixed or variable rate. The IRS are traded in varying maturities. The Company only enters into OTC IRS contracts with counterparties rated BBB+ or better. IRS are centrally cleared through an exchange. The fair values of the collateral posted for OTC and exchange-traded derivatives are discussed in the derivative collateral management section below. Total Return Swaps The Company engages in the use of OTC TRS which allow the parties to exchange cash flows based on a variable reference rate such as the three month LIBOR and the return of an underlying index. The Company uses the OTC TRS with the intent to economically hedge fixed-indexed annuity and variable annuity guarantees. The fair value of the collateral posted for OTC TRS is discussed in the derivative collateral management section below. The following table presents a summary of the aggregate notional amounts and fair values of the Company’s freestanding derivative instruments as of December 31: December 31, 2016 December 31, 2015 Gross Fair Value Gross Fair Value Notional (1) Assets Liabilities Notional (1) Assets Liabilities OTC Options $ 1,480,324 27,147 (14,073 ) 1,088,207 8,553 (7,112 ) IRS 502,000 5,846 (1,343 ) 508,000 6,511 (844 ) Futures 165,112 — — 494,534 — — TRS 23,000 — — — — — Total freestanding derivative instruments $ 32,993 (15,416 ) 15,064 (7,956 ) (1) Notional amounts are presented on a gross basis. Derivative Collateral Management The Company manages separate collateral for exchange-traded and OTC derivatives. The total collateral posted for exchange-traded derivatives at December 31, 2016 and 2015, had a fair value of $55,611 and $49,007, respectively, and is included in Fixed-maturity securities on the Balance Sheets. The Company retains ownership of the exchange-traded collateral, but the collateral resides in an account designated by the exchange. The collateral is subject to specific exchange rules regarding rehypothecation. The total collateral posted for OTC derivatives at December 31, 2016 and 2015, had a fair value of $0 and $1,866, respectively, and is included in Fixed-maturity securities on the Balance Sheets. The Company posts collateral to OTC counterparties based upon exposure amounts. The Company retains ownership of the OTC collateral. Embedded Derivatives The Company issues certain variable annuity products with guaranteed minimum benefit riders, including GMWB and GMAB, which are measured at fair value separately from the host variable annuity contract, with changes in fair value reported in Change in fair value of annuity and life embedded derivatives in the Statements of Operations. These embedded derivatives are classified within Account balances and future policy benefit reserves on the Balance Sheets. Certain fixed-indexed annuity products and universal life policies include a market value liability option (MVLO), which is essentially an embedded derivative with equity-indexed features. This embedded derivative is reported within Account balances and future policy benefit reserves on the Balance Sheets with changes in fair value reported in Change in fair value of annuity and life embedded derivatives in the Statements of Operations. The following table presents a summary of the fair values of the Company’s embedded derivative instruments as of December 31: 2016 2015 GMWB $ (144,631 ) (147,290 ) GMAB (16,594 ) (27,579 ) MVLO (15,896 ) (18,525 ) Total embedded derivative instruments (177,121) (193,394 ) The following table presents the gains or losses recognized in income on the various freestanding derivative instruments and embedded derivatives: Location in statements of operations Amount of gains (losses) on years ended December 31 2016 2015 2014 GMWB Change in fair value of annuity and life embedded derivatives $ 2,659 (54,413 ) (101,961 ) GMAB Change in fair value of annuity and life embedded derivatives 8,844 (11,755 ) (14,372 ) MVLO Change in fair value of annuity and life embedded derivatives 1,688 5,292 3,969 Total change in fair value of annuity and life embedded derivatives 13,191 (60,876 ) (112,364 ) MVLO Policy fees 745 534 681 MVLO Policyholder benefits 196 127 98 IRS Change in fair value of assets and liabilities 5,690 23,296 93,758 Futures Change in fair value of assets and liabilities (32,111 ) (11,861 ) (26,878 ) TRS Change in fair value of assets and liabilities 1,105 — — OTC options Change in fair value of assets and liabilities (4,497 ) 692 232 Total derivative loss $ (15,681 ) (48,088 ) (44,473 ) Offsetting Assets and Liabilities Certain financial instruments and derivative instruments are eligible for offset on the Balance Sheets under GAAP. The Company’s derivative instruments are subject to master netting arrangements and collateral arrangements. A master netting arrangement with a counterparty creates a right of offset for amounts due to and from that same counterparty that is enforceable in the event of a default or bankruptcy. The Company’s policy is to recognize amounts subject to master netting arrangements on a gross basis on the Balance Sheets. The following tables present additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of the dates indicated: December 31, 2016 Gross amounts not offset in the Balance Sheet Gross Gross Net amounts Financial (1) Collateral Net amounts Derivative assets $ 32,993 — 32,993 (15,416 ) (10,674 ) 6,903 Derivative liabilities $ (15,416) — (15,416 ) 15,416 — — Net derivatives $ 17,577 — 17,577 — (10,674 ) 6,903 December 31, 2015 Gross amounts not offset in the Balance Sheet Gross Gross Net amounts in the Balance Sheet Financial (1) Collateral Net amounts Derivative assets $ 15,064 — 15,064 (7,907 ) (4,121 ) 3,036 Derivative liabilities $ (7,910 ) — (7,910 ) 7,907 — (3 ) Net derivatives $ 7,154 — 7,154 — (4,121 ) 3,033 (1) Represents the amount of assets or liabilities that could be offset by liabilities or assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Balance Sheets. In the tables above, the gross amounts of assets or liabilities as presented on the Balance Sheets are offset first by financial instruments that have the right of offset under master netting or similar arrangements, then any remaining amount is reduced by the amount of cash and securities collateral.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Dec. 31, 2016
Fair Value Measurements	(6) Fair Value Measurements The Fair Value Measurements and Disclosures Topic of the Codification establishes a fair value hierarchy that prioritizes the inputs used in the valuation techniques to measure fair value. Level 1 – Unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date Level 2 – Valuations derived from techniques that utilize observable inputs, other than quoted prices included in Level 1, which are observable for the asset or liability either directly or indirectly, such as: (a) Quoted prices for similar assets or liabilities in active markets. (b) Quoted prices for identical or similar assets or liabilities in markets that are not active. (c) Inputs other than quoted prices that are observable. (d) Inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 – Valuations derived from techniques in which the significant inputs are unobservable. Level 3 fair values reflect the Company’s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). The Company has analyzed the valuation techniques and related inputs, evaluated its assets and liabilities reported at fair value, and determined an appropriate fair value hierarchy level based upon trading activity and the observability of market inputs. Based on the results of this evaluation and investment class analysis, each valuation was classified into Level 1, 2, or 3. The following tables present the assets and liabilities measured at fair value on a recurring basis and their corresponding level in the fair value hierarchy at December 31: Total Level 1 Level 2 Level 3 2016: Assets Fixed-maturity securities: U.S. government $ 49,217 49,217 — — States and political subdivisions 10,644 — 10,644 — Corporate securities 509,279 — 508,237 1,042 Mortgage-backed securities 182,391 — 182,391 — Derivative assets 32,993 — 32,993 — Equity securities, trading 7,539 7,539 — — Separate account assets 2,255,576 2,255,576 — — Total assets $ 3,047,639 2,312,332 734,265 1,042 Liabilities Derivative liabilities $ 15,416 — 15,416 — Separate account liabilities 2,255,576 2,255,576 — — Reserves at fair value (1) 399,260 — — 399,260 Total liabilities $ 2,670,252 2,255,576 15,416 399,260 Total Level 1 Level 2 Level 3 2015: Assets Fixed-maturity securities: U.S. government $ 73,223 73,223 — — States and political subdivisions 11,044 — 11,044 — Foreign government 510 — 510 — Corporate securities 454,182 — 453,135 1,047 Mortgage-backed securities 135,603 — 135,603 — Derivative assets 15,064 — 15,064 — Equity securities, trading 4,368 4,368 — — Separate account assets 2,205,548 2,205,548 — — Total assets $ 2,899,542 2,283,139 615,356 1,047 Liabilities Derivative liabilities $ 7,956 — 7,956 — Separate account liabilities 2,205,548 2,205,548 — — Reserves at fair value (1) 265,884 — — 265,884 Total liabilities $ 2,479,388 2,205,548 7,956 265,884 (1) Reserves at fair value are reported in Account balances and future policy benefit reserves on the Balance Sheets. The following is a discussion of the methodologies used to determine fair values for the assets and liabilities listed in the above table. These fair values represent an exit price (i.e., what a buyer in the marketplace would pay for an asset in a current sale or charge to transfer a liability). (a) Valuation of Fixed-maturity Securities and Equity Securities The fair value of fixed-maturity securities and equity securities is based on quoted market prices in active markets when available. Based on the market data, the securities are categorized into asset class, and based on the asset class of the security, appropriate pricing applications, models and related methodology, and standard inputs are utilized to determine what a buyer in the marketplace would pay for the security in a current sale. When quoted prices are not readily available or in an inactive market, standard inputs used in the valuation models, listed in approximate order of priority, include, but are not limited to, benchmark yields, reported trades, municipal securities rulemaking board reported trades, nationally recognized municipal securities information repository material event notices, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, reference data, and industry and economic events. In some cases, including private placement securities as well as certain difficult-to-price securities, internal pricing models may be used that are based on market proxies. Generally, U.S. Treasury securities and exchange-traded stocks are included in Level 1. Most bonds for which prices are provided by third-party pricing sources are included in Level 2 because the inputs used are market observable. Bonds for which prices were obtained from broker quotes, certain bonds without active trading markets and private placement securities that are internally priced are included in Level 3. The Company is responsible for establishing and maintaining an adequate internal control structure to prevent or detect material misstatements related to fair value measurements and disclosures. This responsibility is especially important when using third parties to provide valuation services. The Company’s control framework around third-party valuations begins with obtaining an understanding of the pricing vendor’s methodologies. A Pricing Committee is in place that meets quarterly to establish and review a pricing policy, which includes approving any changes to pricing sources, assessing reasonableness of pricing services, and addressing any ad hoc valuation issues that arise. The pricing methodologies used by the service providers and internal control reports provided by the service providers are reviewed by management. In addition to monitoring the third-party vendor’s policies, the Company is also responsible for monitoring the valuation results. Controls are in place to monitor the reasonableness of the valuations received. These controls include price-analytic reports that monitor significant fluctuations in price as well as an IPV process by which the Company obtains prices from vendors other than the primary source and compares them for reasonableness. Results of the independent price verification are also reviewed by the Pricing Committee. There are limited instances in which the primary third-party vendor is not used to obtain prices for fixed-maturity securities. These instances include private placement securities and certain other immaterial portfolios priced by a secondary external vendor or internal models. At December 31, 2016 and 2015, private placement securities of $1,042 and $1,047, respectively, were included in Level 3. Internal pricing models based on market proxy spreads and U.S. Treasury rates, which are monitored by the investment manager for reasonableness, are used to value these holdings. This includes ensuring the spreads used are still reasonable based on issuer specific credit development. (b) Valuation of Derivatives Active markets for OTC option assets and liabilities do not exist. The fair value of OTC option assets and liabilities is derived internally, by calculating their expected discounted cash flows, using a set of calibrated, risk-neutral stochastic scenarios, including a market data monitor, a market data model generator, a stochastic scenario calibrator, and the actual asset pricing calculator. The valuation results are reviewed by Management via the Pricing Committee. The fair value of the IRS are derived using a third-party vendor software program and deemed by management to be reasonable. OTC options and IRS are included in Level 2, because they use market observable inputs. TRS are included in Level 3 because they use valuation techniques in which significant inputs are unobservable. The fair value of futures are based on quoted market prices and are generally included in Level 1. (c) Valuation of Separate Account Assets and Liabilities Separate account assets are carried at fair value, which is based on the fair value of the underlying assets. Separate accounts assets consist primarily of variable investment option funds with the following investment types: bond, domestic equity, international equity, or specialty. Variable investment option funds are included in Level 1 because their fair value is based on net asset values that are quoted as prices (unadjusted) in an active, observable market. Additionally, the separate account assets hold certain money market funds which are also included in Level 1 because their fair value is based on quoted prices (unadjusted) in an active, observable market. In accordance with the Financial Services – Insurance Topic of the Codification, the fair value of separate account liabilities is set to equal the fair value of separate account assets. (d) Valuation of Reserves at Fair Value Reserves at fair value principally include the equity-indexed features contained in fixed-indexed annuity and life products, certain variable annuity riders and variable-indexed annuity products. Fair values of the embedded derivative liabilities are calculated based on internally developed models, because active, observable markets do not exist for these liabilities. The fair value is derived from techniques in which one or more significant inputs are unobservable and are included in Level 3. These fair values represent the Company’s best estimate of an amount that could be realized in a current market exchange absent actual market exchanges. The fair value of the embedded derivative contained in the fixed-indexed annuity products is the sum of the current year’s option value projected stochastically, the projection of future index growth at the option budget, and the historical interest/equity-indexed credits. The valuation of the embedded derivative includes an adjustment for the Company’s own credit standing and a risk margin for noncapital market inputs. The Company’s own credit adjustment is determined by taking into consideration publicly available information on industry default risk with considerations for the Company’s own credit profile. Risk margin is incorporated into the valuation model to capture the noncapital market risks of the instrument, which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of certain actuarial assumptions including surrenders, annuitization, and future equity index caps or participation rates. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility, changes in the Company’s own credit standing, and variations in actuarial assumptions regarding policyholder behavior and risk margin related to noncapital market inputs may result in significant fluctuations in the fair value of these embedded derivatives that could materially affect net income. The Company issues certain variable annuity products with guaranteed minimum benefit riders, including GMWB and GMAB riders. The fair value for these riders is estimated using the present value of future benefits minus the present value of future fees using actuarial and capital market assumptions related to the projected cash flows over the expected lives of the contracts. A risk neutral valuation methodology is used under which the cash flows from the riders are projected under multiple capital market scenarios using observable overnight index swap rates (OIS) plus funding valuation adjustments, as approximated by LIBOR. These cash flows are then discounted using the current month’s LIBOR plus a company-specific spread. The expected life-contingent GMWB payments are discounted using a blend of short and long term rates to the date the account value is expected to be exhausted. These obligations are then discounted to the current date using LIBOR plus a spread for the Company’s own nonperformance risk. The valuation of these riders includes an adjustment for the Company’s own credit standing and a risk margin for noncapital market inputs. The Company’s own credit adjustment is determined taking into consideration publicly available information relating to the Company’s claims paying ability. Risk margin is established to capture the noncapital market risks of the instrument, which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of certain actuarial assumptions including surrenders, annuitization, and premium persistency. The establishment of the risk margin requires the use of significant management judgment. These riders may be more costly than expected in volatile or declining equity markets. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility, changes in the Company’s own credit standing and variations in actuarial assumptions regarding policyholder behavior, and risk margins related to noncapital market inputs may result in significant fluctuations in the fair value of the riders that could materially affect net income. The Company elected the fair value option for certain insurance contracts related to a variable-indexed annuity product. The fair value is calculated internally using the present value of future expected cash flows, floored at the current contract value. Future expected cash flows are generated using contractual features, actuarial assumptions, and market emergence over a complete set of market consistent scenarios. Cash flows are then averaged over the scenario set and discounted back to the valuation date using appropriate discount factors adjusted for nonperformance risk on the noncollateralized portions of the contract. (e) Level 3 Rollforward The following table provides a reconciliation of the beginning and ending balances for the Company’s Level 3 assets and liabilities measured at fair value on a recurring basis: December 31, 2016 December 31, 2015 Fixed- Derivative Derivative Reserves Fixed- Reserves Balance, beginning of year $ 1,047 — — (265,884 ) 1,072 (150,251 ) Total realized/unrealized gains (losses) included in: Net income (loss) — 7,774 (7,189 ) (8,708 ) — 15,670 Other comprehensive income (loss) (5 ) — — — (25 ) — Purchases and issuances — — — (140,054 ) — (138,736 ) Sales and settlements — (7,774 ) 7,189 15,386 — 7,433 Balance, end of year $ 1,042 — — (399,260 ) 1,047 (265,884 ) Losses included in net income (loss) related to financial instruments still held at the end of the year (1) (2) $ — — — (8,708 ) — 15,670 (1) The Company classifies realized and unrealized gains (losses) on Reserves at fair value as unrealized gains (losses) for purposes of disclosure in this table because it is impracticable to track the realized gains (losses) on a contract-by-contract basis. (2) The previously issued 2015 financial statements improperly disclosed losses included in net income (loss) related to Reserves at fair value still held at December 31, 2015 by including issuances of $138,736. The December 31, 2015 amount has been corrected to conform with current year presentation. (f) Transfers The Company reviews its fair value hierarchy classifications annually. This review could reveal that previously observable inputs for specific assets or liabilities are no longer available or reliable. For example, the market for a Level 1 asset becomes inactive. In this case, the Company may need to adopt a valuation technique that relies on observable or unobservable components causing the asset to be transferred to Level 2 or Level 3. Alternatively, if the market for a Level 3 asset or liability becomes active, the Company will report a transfer out of Level 3. Transfers in and/or out of Level 1, 2, and 3 are reported as of the end of the period in which the change occurs. There were no transfers of securities into or out of Level 3 for the years ended December 31, 2016 and 2015. In addition, there were no transfers of securities between Level 1 and Level 2 for the years ended December 31, 2016 and 2015. (g) Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs The following table provides a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities on a recurring basis at December 31, 2016: Valuation Unobservable Range (weighted Fair value technique input average) Fixed-maturity securities: Available-for-sale: Corporate securities $ 1,042 Discounted cash flow Option adjusted spread * 72 (72) Reserves at fair value: MVLO (15,896 ) Discounted cash flow Annuitizations 0–25% Surrenders 0–25% Mortality 0–100% Withdrawal Benefit Election 0–50% GMWB and GMAB (161,225) Discounted cash flow Surrenders 0.5–35% Mortality 0–100% Variable-indexed annuity (222,139) Contract value N/A * N/A * * No range is applicable due to only one security within classification. Mortality assumptions are derived by applying management determined factors to the Annuity 2000 Mortality Table. * Unobservable inputs are not applicable as the fair value of the variable-indexed annuity reserve is held at contract value. (h) Sensitivity of Fair Value Measurements to Changes in Unobservable Inputs Fixed-maturity securities: Reserves at fair value: (i) Nonrecurring Fair Value Measurements Occasionally, certain assets and liabilities are measured at fair value on a nonrecurring basis. There were no nonrecurring fair value adjustments recorded in 2016, 2015, or 2014. (j) Fair Value of Financial Assets and Liabilities The following table presents the carrying amounts and fair values of financial assets and liabilities carried at book value at December 31: 2016 Carrying Fair value amount Level 1 Level 2 Level 3 Total Financial assets: Policy loans $ 338 — 338 — 338 Financial liabilities: Investment contracts $ 448,009 — — 448,876 448,876 2015 Carrying Fair value amount Level 1 Level 2 Level 3 Total Financial assets: Policy loans $ 275 — 275 — 275 Financial liabilities: Investment contracts $ 465,891 — — 466,527 466,527 Policy loans, which are supported by the underlying cash value of the policies, are carried at unpaid principal balances, which approximate fair value. Therefore, fair value is classified as Level 2. Investment contracts include certain reserves related to annuity products. These reserves are included in Account balances and future policy benefit reserves on the Balance Sheets. The fair values of investment contracts are determined by testing amounts payable on demand against discounted cash flows using market interest rates commensurate with the risks involved, including consideration of the Company’s own credit standing and a risk margin for noncapital market inputs. Therefore, fair value is classified as Level 3. The previously issued 2015 financial statements improperly disclosed the carrying amount and fair value of investment contracts as $729,819 and $730,455, respectively. Investment contracts previously included reserves that are held at fair value on a recurring basis and reserves that do not meet the definition of a financial liability with a total carrying amount and fair value of $263,928. The December 31, 2015 amounts have been corrected to conform with current year presentation. Changes in market conditions subsequent to year-end may cause fair values calculated subsequent to year-end to differ from the amounts presented herein.

Financing Receivables

Financing Receivables	12 Months Ended
Financing Receivables	Dec. 31, 2016
Financing Receivables	(7) Financing Receivables The Company’s financing receivables are comprised of nontrade receivables. Nontrade receivables are amounts for policy or contract premiums due from the agents and broker-dealers, or amounts due from reinsurers. The nontrade receivables are evaluated on a collective basis for impairment unless circumstances arise that warrant individual evaluation. For additional information, see receivables section of note 2. Credit Quality Indicators The Company analyzes certain financing receivables for credit risk by using specific credit quality indicators. The Company’s nontrade receivables are analyzed for credit risk based upon the customer classification of agent or reinsurer. The nontrade receivable and allowance for credit losses by customer classification as of December 31 are shown below: 2016 2015 Agent Reinsurer Total Agent Reinsurer Total Nontrade receivables $ 43 54 97 41 50 91 Allowance for credit losses (43 ) — (43 ) (33 ) — (33 ) Net nontrade receivable $ — 54 54 8 50 58 Allowance for Credit Losses In 2016 and 2015, the Company reevaluated the allowance related to the financing receivable and increased the provision by $10 and $13, respectively. Past-due Aging Analysis Aging analysis of past-due nontrade financing receivables as of December 31 is shown below: 31–60 61–90 Greater than Total Current Total 2016 $ 22 1 43 66 31 97 2015 $ 29 — 33 62 29 91 As of December 31, 2016 and 2015, the Company’s financing receivables do not include any balances which are on a nonaccrual status, classified as a troubled debt restructuring, or impaired without a corresponding allowance for credit loss.

Reinsurance

Reinsurance	12 Months Ended
Reinsurance	Dec. 31, 2016
Reinsurance	(8) Reinsurance The Company primarily enters into reinsurance agreements to manage risk resulting from its life, annuity and accident and health businesses, as well as businesses the Company has chosen to exit. In the normal course of business, the Company seeks to limit its exposure to loss on any single insured and to recover a portion of benefits paid by ceding risks under excess yearly renewal term (YRT) coverage. The Company generally retained between $50 and $1,500 coverage per individual life depending on the type of policy for the years ended December 31, 2016 and 2015. The Company monitors the financial exposure to the reinsurers, as well as evaluates the financial strength of the reinsurers on an ongoing basis. The effect of reinsurance on premiums is disclosed in Schedule IV in the Financial Statements.

Deferred Acquisition Costs

Deferred Acquisition Costs	12 Months Ended
Deferred Acquisition Costs	Dec. 31, 2016
Deferred Acquisition Costs	(9) Deferred Acquisition Costs DAC at December 31 and the changes in the balance for the years then ended are as follows: 2016 2015 2014 Balance, beginning of year $ 134,374 118,319 104,002 Capitalization 6,406 13,531 16,906 Interest 6,471 6,197 5,541 Amortization (17,691 ) (11,563 ) (7,383 ) Change in shadow DAC 308 7,890 (747 ) Balance, end of year $ 129,868 134,374 118,319 The Company reviews its best-estimate assumptions each year and records “unlocking” as appropriate. These reviews are based on recent changes in the organization and businesses of the Company and actual and expected performance of in-force policies. The reviews include all assumptions, including mortality, lapses, expenses, and separate account returns. The revised best estimate assumptions were applied to the current in-force policies to project future gross profits. The pretax impact on the Company’s assets and liabilities as a result of the unlocking during the years ended December 31 is as follows: 2016 2015 2014 Assets: DAC $ (1,030 ) 2,641 856 DSI (212 ) 337 356 Total (decrease) increase in assets (1,242 ) 2,978 1,212 Liabilities: Account balances and future policy benefit reserves (1,954 ) 5,867 (1,259 ) Unearned premiums 4 40 (2 ) Total (decrease) increase in liabilities (1,950 ) 5,907 (1,261 ) Net increase (decrease) before tax 708 (2,929 ) 2,473 Deferred income tax expense (benefit) 248 (1,025 ) 866 Net increase (decrease) after tax $ 460 (1,904 ) 1,607

Deferred Sales Inducements

Deferred Sales Inducements	12 Months Ended
Deferred Sales Inducements	Dec. 31, 2016
Deferred Sales Inducements	(10) Deferred Sales Inducements DSI at December 31, and the changes in the balance for years then ended, are as follows: 2016 2015 2014 Balance, beginning of year $ 21,148 19,510 18,345 Capitalization 566 1,492 2,370 Interest 1,004 1,020 971 Amortization (2,939 ) (2,924 ) (1,762 ) Change in shadow DSI 101 2,050 (414 ) Balance, end of year $ 19,880 21,148 19,510 The change in shadow DSI balances are impacted by movements in unrealized gains and losses as a result of market conditions. See note 9 for impacts of unlocking relating to DSI.

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2016
Income Taxes	(11) Income Taxes (a) Income Tax Expense (Benefit) Total income tax expense (benefit) for the years ended December 31 is as follows: 2016 2015 2014 Income tax expense (benefit) attributable to operations: Current tax expense $ 21 9,567 4,774 Deferred tax expense (benefit) 2,922 (14,008 ) (7,907 ) Total income tax expense (benefit) attributableto operations 2,943 (4,441 ) (3,133 ) Income tax effect on equity: Attributable to unrealized gains (losses) for the year 1,184 (6,277 ) 3,397 Total income tax effect on equity $ 4,127 (10,718 ) 264 (b) Components of Income Tax Expense (Benefit) Income tax expense (benefit) computed at the statutory rate of 35% varies from income tax (benefit) expense reported in the Statements of Operations for the respective years ended December 31 as follows: 2016 2015 2014 Income tax expense (benefit) computed at the statutory rate $ 5,734 (1,996 ) (1,504 ) Dividends-received deductions and tax-exempt interest (2,803 ) (2,455 ) (1,447 ) Other 12 10 (182 ) Income tax expense (benefit) as reported $ 2,943 (4,441) (3,133 ) (c) Components of Deferred Tax Assets and Liabilities on the Balance Sheet Tax effects of temporary differences giving rise to the significant components of the net deferred tax asset (liability). Net deferred tax asset on the Balance Sheets at December 31 are as follows: 2016 2015 Deferred tax assets: Policy reserves $ 151,608 113,361 Expense accruals 711 241 Total deferred tax assets 152,319 113,602 Deferred tax liabilities: Deferred acquisition costs (41,247 ) (42,684 ) Due and deferred premium (13 ) (14 ) Net unrealized gains on investments (5,801 ) (4,763 ) Investment income (75,704 ) (32,481 ) Total deferred tax liabilities (122,765 ) (79,942 ) Net deferred tax asset $ 29,554 33,660 Although realization is not assured, the Company believes it is not necessary to establish a valuation allowance for ordinary deferred tax assets, as it is more likely than not the deferred tax assets will be realized principally through future reversals of existing ordinary taxable temporary differences and future ordinary taxable income. For deferred tax assets that are capital in nature, considering all objective evidence and the available tax planning strategy, it is more likely than not the deferred tax assets that are capital in nature will be realized and no valuation allowance is required. The amount of the ordinary and capital deferred tax assets considered realizable could be reduced in the near term if estimates of future reversals of existing taxable temporary differences and future ordinary and capital taxable income are reduced. Income taxes paid by the Company were $9,714, $4,405, and $2,271, in 2016, 2015, and 2014, respectively. The Company had a tax payable to AZOA of $180 and $9,874 at December 31, 2016 and 2015, respectively reported in Other liabilities on the Balance Sheets. The Company is included in the consolidated group for which AZOA files a federal income tax return on behalf of all group members. As a member of the AZOA consolidated group, the Company is no longer subject to U.S. federal and non-U.S. income tax examinations for years prior to 2013, though examinations of combined returns filed by AZOA which include the Company by certain U.S. state and local tax authorities may still be conducted for 2008 and subsequent years. The last Internal Revenue Service examination of AZOA involved amended returns filed by AZOA for the 2008 and 2009 tax years. These amended returns were accepted by the Internal Revenue Service as filed. The Internal Revenue Service has initiated an examination of AZOA’s 2011 tax return. While 2011 is closed to assessment, AZOA did file an amended tax return on which it claimed income tax refunds. Under federal tax law, the amount claimed is subject to offsetting assessments even though the statute of limitations for the year is closed. In accordance with the Income Taxes Topic of the Codification, the Company recognizes liabilities for certain unrecognized tax benefits. The Company had no unrecognized tax benefits as of December 31, 2016 and 2015. The Company does not expect any significant changes related to unrecognized tax benefits during the next 12 months. The Company recognizes interest and penalties accrued related to unrecognized tax benefits in federal income tax expense. During the years ended December 31, 2016, 2015, and 2014, the Company did not recognize any expense related to interest and penalties. The Company accrued $0 for the payment of interest and penalties at December 31, 2016 and 2015.

Separate Accounts and Annuity P

Separate Accounts and Annuity Product Guarantees	12 Months Ended
Separate Accounts and Annuity Product Guarantees	Dec. 31, 2016
Separate Accounts and Annuity Product Guarantees	(12) Separate Accounts and Annuity Product Guarantees The following assumptions were used to determine the GMDB and GMIB liabilities as of December 31, 2016 and 2015: • 100 stochastically generated investment performance scenarios. • Mean investment performance assumption was 6.5% for 2016 and 2015. • Volatility assumption was 13.4% for 2016 and 2015. • For 2016 and 2015, the mortality assumption is based on the Annuity 2000 mortality table for all variable products. The 2016 past mortality improvement is based on gender distinct mortality loads varying by attained age, and future mortality improvement factors are based on gender distinct projection scales varying by attained age and subject to grading factors. The 2015 mortality assumption was 87% of the Annuity 2000 mortality table with a constant mortality improvement. • Lapse rates vary by contract type and duration. Spike rates could approach 40%, with an ultimate rate around 15%. • Discount rates vary by contract type and equal an assumed long-term investment return (6.5%), less the applicable mortality and expense rate. • GMIB contracts contain a dynamic lapse assumption. For example, if the contract is projected to have a large additional benefit, then it becomes less likely to lapse. The following assumptions were used to determine the GMAB and GMWB liabilities as of December 31, 2016 and 2015: • 1000 stochastically generated investment performance scenarios. • Market volatility assumption varies by fund type and grades from a current volatility number to a long-term assumption over four years as shown below: 2016 Fund index type Current Long-term Large cap 16.3 % 18.1 % Bond 3.4 3.9 International 16.8 21.4 Small cap 20.3 21.5 2015 Fund index type Current Long-term Large cap 17.6 % 18.1 % Bond 3.4 3.9 International 17.9 23.1 Small cap 20.8 21.3 • For 2016 and 2015, the mortality assumption is based on the Annuity 2000 mortality table for all variable products. The 2016 past mortality improvement is based on gender distinct mortality loads varying by attained age, and future mortality improvement factors are based on gender distinct projection scales varying by attained age and subject to grading factors. The 2015 mortality assumption was 87% of the Annuity 2000 mortality table with a constant mortality improvement. • Lapse rates vary by contract type and duration. Spike rates could approach 40%, with an ultimate rate around 15%. Guaranteed minimums for the respective years ended December 31 are summarized as follows (note that the amounts listed are not mutually exclusive, as many products contain multiple guarantees): 2016 2015 Account Net amount Weighted Account Net amount Weighted value at risk age (years) value at risk age (years) GMDB: Return of premium $ 1,816,268 7,444 63.1 1,609,269 17,498 62.6 Ratchet and return of premium 620,999 20,606 65.7 625,964 38,380 65.0 Reset 84,191 692 76.1 88,037 1,422 75.7 Total $ 2,521,458 28,742 2,323,270 57,300 GMIB: Return of premium $ 7,717 133 67.8 8,756 143 66.7 Ratchet and rollup 128,150 25,900 65.1 140,274 32,123 64.2 Total $ 135,867 26,033 149,030 32,266 GMAB: Five years $ 17,899 61 69.8 19,420 549 68.9 Target date retirement – 7 year 44,589 69 64.1 48,571 1,636 63.3 Target date retirement – 10 year 19,140 331 64.3 20,690 1,307 63.2 Target date with management levers 385,249 8,501 63.6 377,123 21,100 63.0 Total $ 466,877 8,962 465,804 24,592 GMWB: No living benefit $ 61,926 — 67.8 62,096 — 67.1 Life benefit with optional reset 72,366 6,887 71.7 78,108 8,170 70.7 Life benefit with 8% rollup 28,562 6,286 70.2 30,070 6,520 69.1 Life benefit with management levers 1,386,689 265,514 61.2 1,310,233 232,424 60.7 Total $ 1,549,543 278,687 1,480,507 247,114 The growth in account values has outpaced the growth in the net amount at risk in 2016 due to the increased market performance of the separate accounts. At December 31, variable annuity account balances were invested in separate account funds with the following investment objectives. Balances are presented at fair value: Investment type 2016 2015 Bond $ 310,976 291,103 Domestic equity 1,179,744 1,164,383 International equity 61,096 71,227 Specialty 665,294 646,452 Money market 37,065 31,191 Other 1,401 1,192 Total $ 2,255,576 2,205,548 The following table summarizes the liabilities for variable contract guarantees that are reflected in the general account and shown in Account balances and future policy benefit reserves on the Balance Sheets: GMDB GMIB GMAB GMWB Totals Balance as of December 31, 2014 $ 1,658 3,158 16,870 92,877 114,563 Incurred guaranteed benefits 1,111 907 11,755 54,413 68,186 Paid guaranteed benefits (530 ) (42 ) (1,046 ) — (1,618 ) Balance as of December 31, 2015 2,239 4,023 27,579 147,290 181,131 Incurred guaranteed benefits 528 (246 ) (8,845 ) (2,659 ) (11,222 ) Paid guaranteed benefits (782 ) (560 ) (2,140 ) — (3,482 ) Balance as of December 31, 2016 $ 1,985 3,217 16,594 144,631 166,427

Accident and Health Claim Reser

Accident and Health Claim Reserves	12 Months Ended
Accident and Health Claim Reserves	Dec. 31, 2016
Accident and Health Claim Reserves	(13) Accident and Health Claim Reserves Accident and health claim reserves are based on estimates that are subject to uncertainty. Uncertainty regarding reserves of a given accident year is gradually reduced as new information emerges each succeeding year, thereby allowing more reliable reevaluations of such reserves. While management believes that reserves as of December 31, 2016, are appropriate, uncertainties in the reserving process could cause such reserves to develop favorably or unfavorably in the near term as new or additional information emerges. Any adjustments to reserves are reflected in the operating results of the periods in which they are made. Movements in reserves could significantly impact the Company’s future reported earnings. Activity in the accident and health claim reserves is summarized as follows: 2016 2015 2014 Balance at January 1, net of reinsurance recoverables of $497, $360, and $264, respectively $ 3,504 2,136 1,032 Incurred related to: Current year 1,504 2,173 1,251 Prior years (361 ) (154 ) 283 Total incurred 1,143 2,019 1,534 Paid related to: Current year 85 42 49 Prior years 685 609 381 Total paid 770 651 430 Balance at December 31, net of reinsurance recoverables of $544, $497, and $360, respectively $ 3,877 3,504 2,136 Prior year incurred claim reserves for 2016 reflect unfavorable development as a result of re-estimation of unpaid claims and claim adjustment expenses, principally on LTC and group health lines of business. Prior years incurred claim reserves incurred for 2015 and 2014 reflect favorable/(unfavorable) claim development with the group marketing and individual long term care lines of business.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2016
Commitments and Contingencies	(14) Commitments and Contingencies The Company is or may become subject to claims and lawsuits that arise in the ordinary course of business. In the opinion of management, the ultimate resolution of any such known litigation will not have a material adverse effect on the Company’s financial position. The Company is contingently liable for possible future assessments under regulatory requirements pertaining to insolvencies and impairments of unaffiliated insurance companies. Provision has been made for assessments currently received and assessments anticipated for known insolvencies. The financial services industry, including mutual funds, variable and fixed annuities, life insurance, distribution companies, and broker-dealers, is subject to close scrutiny by regulators, legislators, and the media. Federal and state regulators, such as state insurance departments, state securities departments, the SEC, the Financial Industry Regulatory Authority, and other regulatory bodies regularly make inquiries and conduct examinations or investigations concerning various selling practices, including suitability reviews, product exchanges, sales to seniors, and compliance with, among other things, insurance laws and securities laws. The Company is subject to ongoing market conduct examinations and investigations by regulators, which may have a material adverse effect on the Company. These matters could result in legal precedents and new industry-wide legislation, rules, and regulations that could significantly affect the financial services industry, including life insurance and annuity companies. It is unclear at this time whether any such litigation or regulatory actions will have a material adverse effect on the Company in the future. When evaluating litigation, claims, and assessments, management considers the nature of the litigation, progress of the case, opinions or views of legal counsel, as well as prior experience in similar cases. Management uses this information to assess whether a loss is probable and if the amount of loss can be reasonably estimated prior to making any accruals. The Company leases office space and equipment from an affiliate (see further information in note 16). The future minimum lease payments required under operating leases are as follows: 2017 $ 24 2018 24 2019 24 2020 13 2021 and beyond — Total $ 85

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
Employee Benefit Plans	Dec. 31, 2016
Employee Benefit Plans	(15) Employee Benefit Plans The Company participates in the Allianz Asset Accumulation Plan (AAAP), a defined contribution plan sponsored by Allianz of America Corporation. Eligible employees are immediately enrolled in the AAAP on their first day of employment. The AAAP will accept participants’ pretax, Roth 401(k) and/or after-tax contributions up to 80% of the participants’ eligible compensation, although contributions remain subject to annual limitations set by the Internal Revenue Service. The Company matches up to a maximum of 7.5% of the employees’ eligible compensation. Participants are 100% vested in the Company’s matching contribution after three years of service. The AAAP administration expenses and the trust fund, including trustee fees, investment manager fees, and audit fees, are payable from the trust fund but may, at the Company’s discretion, be paid by the Company. Any legal fees are not paid from the trust fund, but are instead paid by the Company. It is the Company’s policy to fund the AAAP costs as incurred. The Company has expensed $228, $205, and $214 in 2016, 2015, and 2014, respectively, toward the AAAP matching contributions and administration expenses. In addition to the AAAP, the Company offers certain benefits to eligible employees, including a comprehensive medical, dental, and vision plan and a flexible spending plan.

Related-Party Transactions

Related-Party Transactions	12 Months Ended
Related-Party Transactions	Dec. 31, 2016
Related-Party Transactions	(16) Related-Party Transactions (a) Real Estate The Company subleases office space from Allianz Global Corporate and Specialty. In connection with this agreement, the Company incurred rent expense of $27, $27, and $32 in 2016, 2015, and 2014, respectively, which is included in General and administrative expenses in the Statements of Operations. (b) Service Fees The Company incurred fees for services provided by Allianz Life of $10,135, $9,437, and $8,368 in 2016, 2015, and 2014, respectively. The Company’s liability for these fees was $1,086 and $839 as of December 31, 2016 and 2015, respectively, and is included in Other liabilities on the Balance Sheets. The Company incurred fees for services provided by affiliated companies of $491, $272, and $212 in 2016, 2015, and 2014, respectively. The Company’s liability for these charges was $40 and $22 as of December 31, 2016 and 2015, respectively, and is included in Other liabilities on the Balance Sheets. The Company has an agreement with Allianz Investment Management LLC which has subsequent agreements with its affiliates Pacific Investment Management Company (PIMCO), Oppenheimer Capital LLC (OpCap), and with certain other related parties whereby (1) specific investment options managed by PIMCO and OpCap are made available through the Company’s separate accounts to holders of the Company’s variable annuity products, (2) the Company receives compensation for providing administrative and recordkeeping services relating to the investment options managed by PIMCO and OpCap. Income recognized by the Company from these affiliates for distribution and in-force related costs as a result of providing investment options to the contractholders was $1,097, $1,115, and $1,182 during 2016, 2015, and 2014, respectively, which is included in Fee, commission and other revenue in the Statements of Operations. At December 31, 2016 and 2015, $176 and $181, respectively, was included for these fees in Receivables on the Balance Sheets. The Company has incurred commission expense related to the distribution of variable annuity products from Allianz Life Financial Services, LLC, (ALFS) an affiliated company, in the amount of $21,607, $23,410, and $24,771 for the years ended December 31, 2016, 2015, and 2014, respectively. At December 31, 2016 and 2015, $1,747 and $1,771, respectively, was included for the expense in Other liabilities on the Balance Sheets. The Company has an agreement with ALFS, whereby 12b-1 fees are assigned to the Company and Allianz Life. The Company has also agreed with Allianz Life to share in reimbursing ALFS for the excess of ALFS expenses over revenues, exclusive of trading gains (losses). In the event that revenues exceed expenses, ALFS records a reimbursement to the Company and Allianz Life. The Company recorded revenue from this agreement of $4,264, $4,332, and $3,860 for the years ended December 31, 2016, 2015, and 2014, respectively. The Company recorded expenses related to this agreement of $4,348, $4,198, and $1,454, for the years ended December 31, 2016, 2015, and 2014, respectively. (c) Line of Credit Agreement The Company has a line of credit agreement with its parent, Allianz Life, to provide liquidity, as needed. As of December 31, 2016 and 2015, there are no amounts outstanding under the line of credit agreement and no amounts have been borrowed during the years ended December 31, 2016 and 2015.

Statutory Financial Data and Di

Statutory Financial Data and Dividend Restrictions	12 Months Ended
Statutory Financial Data and Dividend Restrictions	Dec. 31, 2016
Statutory Financial Data and Dividend Restrictions	(17) Statutory Financial Data and Dividend Restrictions Statutory accounting practices prescribed or permitted by the Company’s state of domicile are directed toward insurer solvency and protection of policyholders. Accordingly, certain items recorded in financial statements prepared under GAAP are excluded or vary in calculation in determining statutory policyholders’ surplus and gain from operations. Currently, these items include, among others, DAC, deferred taxes, receivables (which are more than 90 days past due), reinsurance, and certain investments. Additionally, account balances and future policy benefit reserves calculated for statutory reporting do not include provisions for withdrawals. The Company’s statutory capital and surplus reported in the statutory annual statements filed with the State of New York as of December 31, 2016 and 2015 was $202,130 and $198,759, respectively. The Company is required to meet minimum statutory capital and surplus requirements. The Company’s statutory capital and surplus as of December 31, 2016 and 2015 were significantly in excess of these requirements. The maximum amount of dividends that can be paid by New York insurance companies to stockholders without prior approval of the Department is subject to restrictions relating to statutory earned surplus, also known as unassigned funds. Unassigned funds are determined in accordance with the accounting procedures and practices governing preparation of the statutory annual statements. In accordance with New York statutes, the maximum amount of ordinary dividends that can be paid by the Company is the greater of 10% of prior year-end capital and surplus, or the prior year net gain from operations, but is limited by the amount in unassigned surplus. Based on these limitations, ordinary dividends of $20,213 can be paid in 2017 without the approval of the Department. The Company paid no dividends in 2016, 2015 or 2014. Regulatory Risk-Based Capital An insurance enterprise’s state of domicile imposes minimum risk-based capital requirements that were developed by the NAIC. The formulas for determining the amount of risk-based capital specify various weighting factors that are applied to financial balances or various levels of activity based on the perceived degree of risk. Regulatory compliance is determined by a ratio of an enterprise’s regulatory total adjusted capital to its authorized control level risk-based capital, as defined by the NAIC. Companies below specific trigger points or ratios are classified within certain levels, each of which requires specified corrective action. This ratio for the Company significantly exceeds required minimum thresholds, as of December 31, 2016 and 2015.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	12 Months Ended
Accumulated Other Comprehensive Income	Dec. 31, 2016
Accumulated Other Comprehensive Income	(18) Accumulated Other Comprehensive Income Changes in AOCI, net of tax, by component consist of the following: Year ended Year ended Net unrealized Net unrealized Beginning balance $ 5,000 16,656 OCI before reclassifications 2,216 (11,280 ) Amounts reclassified from AOCI (19 ) (376 ) Net OCI 2,197 (11,656 ) Ending balance $ 7,197 5,000 Reclassifications from AOCI, net of tax, consist of the following: Amount reclassified from AOCI Affected line item December 31, in the AOCI 2016 2015 Statements of Operations Net unrealized gain on securities: Available-for-sale securities $ 30 578 Realized investment (loss) gains, net Income tax expense 11 202 Income tax expense (benefit) Total amounts reclassified from AOCI $ 19 376 Net income (loss)

Segment Information

Segment Information	12 Months Ended
Segment Information	Dec. 31, 2016
Segment Information	(19) Segment Information The Company has organized its principal operations into the following segments: Individual Annuities and Other products. The Individual Annuities segment consists of variable, variable-indexed, fixed-indexed and fixed annuities, which are provided through independent distribution channels made up of independent and wholly owned broker dealers, agents, and registered representatives. Revenues for the Company’s variable annuity products are primarily earned as management and expense fees charged on underlying account balances. Revenues for the Company’s fixed annuity products are primarily earned as net investment income on invested assets supporting fixed account balances, with profitability driven by the spread between net investment income earned and interest credited to account balances. The Company discontinued selling fixed-indexed and fixed annuity products and the block of business is in run off, however, in-force volumes are material and included within the Individual Annuities segment. The Other products segment consists of closed blocks of Life, LTC, and Special Markets products. The Special Markets products include individual and group annuity and life products, including whole and term life insurance. Although other products are part of the combined results, the Company does not allocate additional resources to these areas other than to maintain the operational support to its current customers. The Company does not maintain segregated investment portfolios for each segment. All Interest and similar income, net and Realized investment (losses) gains, net are allocated to the segments. Assets are only monitored at the individual company level, and as such, asset disclosures by segment are not included herein. Segment results are reconciled to the Statements of Operations in the tables below: Year ended December 31, 2016 Individual Other Total Revenue: Net premiums and policy fees $ 68,752 3,155 71,907 Interest and similar income, net 27,462 2,096 29,558 Change in fair value of assets and liabilities (41,554 ) — (41,554 ) Realized investment (losses), net (192 ) (13 ) (205 ) Fee, commission, and other revenue 7,051 — 7,051 Total revenue 61,519 5,238 66,757 Benefits and expenses: Net benefits and expenses 2,441 3,171 5,612 General and administrative expenses and commissions 39,355 593 39,948 Change in deferred acquisition costs, net 3,933 881 4,814 Total benefits and expenses 45,729 4,645 50,374 Pretax income $ 15,790 593 16,383 Year ended December 31, 2015 Individual Other Total Revenue: Net premiums and policy fees $ 65,603 3,267 68,870 Interest and similar income, net 25,378 2,009 27,387 Change in fair value of assets and liabilities 11,374 (1 ) 11,373 Realized investment gains, net 549 34 583 Fee, commission, and other revenue 7,221 — 7,221 Total revenue 110,125 5,309 115,434 Benefits and expenses: Net benefits and expenses 81,697 5,814 87,511 General and administrative expenses and commissions 41,145 647 41,792 Change in deferred acquisition costs, net (8,687 ) 522 (8,165 ) Total benefits and expenses 114,155 6,983 121,138 Pretax loss $ (4,030 ) (1,674 ) (5,704 ) Year ended December 31, 2014 Individual Other Total Revenue: Net premiums and policy fees $ 58,728 2,988 61,716 Interest and similar income, net 27,293 1,566 28,859 Change in fair value of assets and liabilities 66,806 — 66,806 Realized investment gains, net 73 4 77 Fee, commission, and other revenue 6,869 (5 ) 6,864 Total revenue 159,769 4,553 164,322 Benefits and expenses: Net benefits and expenses 138,957 4,936 143,893 General and administrative expenses and commissions 38,886 903 39,789 Change in deferred acquisition costs, net (15,088 ) 24 (15,064 ) Total benefits and expenses 162,755 5,863 168,618 Pretax loss $ (2,986 ) (1,310 ) (4,296 )

Subsequent Events

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2016
Subsequent Events	(20) Subsequent Events No material subsequent events have occurred since December 31, 2016 through March 29, 2017, the date at which the financial statements were issued, that would require adjustment to the financial statements.

Summary of Investments - Other

Summary of Investments - Other than Investments in Related Parties	12 Months Ended
	Dec. 31, 2016
Summary of Investments - Other than Investments in Related Parties	Schedule I ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK Summary of Investments – Other than Investments in Related Parties December 31, 2016 (In thousands) Type of investment Amortized (1) Fair value Amount at Fixed-maturity securities: U.S. government $ 48,676 49,217 49,217 States and political subdivisions 10,546 10,644 10,644 Corporate securities 491,518 509,279 509,279 Mortgage-backed securities 184,217 182,391 182,391 Total fixed-maturity securities 734,957 751,531 751,531 Equity securities, trading 7,464 7,539 7,539 Other investments: Policy loans 338 338 338 Derivative assets 32,993 32,993 32,993 Total other investments 33,331 33,331 33,331 Total investments $ 775,752 792,401 792,401 (1) Original cost of fixed-maturity securities reduced by repayments and adjusted for amortization of premiums or accrual discounts. See accompanying report of independent registered public accounting firm.

Supplementary Insurance Informa

Supplementary Insurance Information	12 Months Ended
Supplementary Insurance Information	Dec. 31, 2016
Supplementary Insurance Information	Schedule III ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK Supplementary Insurance Information Years ended December 31, 2016, 2015, and 2014 (In thousands) As of December 31 Year ended December 31 Deferred Deferred Account Unearned Policy and Net premium Interest and Net Net change Net Other 2016: Annuities $ 128,128 19,880 852,430 — — 68,752 27,462 1,072 1,369 3,933 39,355 Other 1,740 — 26,821 1,652 4,771 3,155 2,096 3,171 — 881 593 $ 129,868 19,880 879,251 1,652 4,771 71,907 29,558 4,243 1,369 4,814 39,948 2015: Annuities $ 131,754 21,148 738,333 — — 65,603 25,378 81,285 412 (8,687 ) 41,145 Other 2,620 — 24,653 1,571 4,157 3,267 2,009 5,814 — 522 647 $ 134,374 21,148 762,986 1,571 4,157 68,870 27,387 87,099 412 (8,165 ) 41,792 2014: Annuities $ 115,271 19,510 670,265 — — 58,728 27,293 140,536 (1,579 ) (15,088 ) 38,886 Other 3,048 — 20,746 1,518 2,787 2,988 1,566 4,936 — 24 903 $ 118,319 19,510 691,011 1,518 2,787 61,716 28,859 145,472 (1,579 ) (15,064 ) 39,789 (1) Deferred sales inducements is located in Other assets on the Balance Sheets. (2) Excludes net change in deferred sales inducements. * See note 10 for aggregate gross amortization of deferred sales inducements. ** See note 9 for aggregate gross amortization of deferred acquisition costs. See accompanying report of independent registered public accounting firm.

Reinsurance30

Reinsurance	12 Months Ended
Reinsurance	Dec. 31, 2016
Reinsurance	Schedule IV ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK Reinsurance Years ended December 31, 2016, 2015, and 2014 (In thousands) Year ended Direct Ceded to other Assumed Net Percentage December 31, 2016: Life insurance in force $ 66,299 57,082 — 9,217 — % Premiums and policy fees: Life $ 1,025 836 — 189 — Annuities 68,752 — — 68,752 — Accident and health 3,459 493 — 2,966 — Total premiums and policy fees $ 73,236 1,329 — 71,907 — % December 31, 2015: Life insurance in force $ 71,620 61,791 — 9,829 — % Premiums and policy fees: Life $ 1,144 842 — 302 — Annuities 65,603 — — 65,603 — Accident and health 3,470 505 — 2,965 — Total premiums and policy fees $ 70,217 1,347 — 68,870 — % December 31, 2014: Life insurance in force $ 77,593 67,376 — 10,217 — % Premiums and policy fees: Life $ 902 916 — (14 ) — Annuities 58,727 — — 58,727 — Accident and health 3,529 526 — 3,003 — Total premiums and policy fees $ 63,158 1,442 — 61,716 — % See accompanying report of independent registered public accounting firm.

Summary of Significant Accoun31

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2016
Basis of Presentation	(a) Basis of Presentation The Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which vary in certain respects from accounting practices permitted or prescribed by the New York State Department of Financial Services (the Department).
Use of Estimates	(b) Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect reported amounts of assets and liabilities, including reporting or disclosure of contingent assets and liabilities as of the balance sheet date, and the reported amounts of revenues and expenses during the reporting period. Future events, including changes in mortality, morbidity, interest rates, capital markets, and asset valuations could cause actual results to differ from the estimates used in the Financial Statements. Such changes in estimates are recorded in the period they are determined.
Investment Products and Universal Life Business	(c) Investment Products and Universal Life Business Investment products consist primarily of fixed and variable annuity products. Premium receipts are reported as deposits to the contractholders’ accounts. Policy fees in the Statements of Operations represent asset fees, cost of insurance charges, administrative fees, charges for guarantees on investment products, and surrender charges for investment products and universal life insurance. These fees have been earned and assessed against contractholders on a daily or monthly basis throughout the contract period and are recognized as revenue when assessed and earned. Amounts assessed that represent compensation to the Company for services to be provided in future periods are not earned in the period assessed. Such amounts are reported as unearned premiums and recognized in operations over the period benefited using the same assumptions and factors used to amortize capitalized acquisition costs. Surrender charges are recognized upon surrender of a contract in accordance with contractual terms. Derivatives embedded in fixed-indexed and variable products are recorded at fair value and changes in value are included in Change in fair value of annuity and life embedded derivatives in the Statements of Operations. Benefits consist of interest credited to contractholders’ accounts and claims incurred in excess of the contractholders’ account balance and are included in Net interest credited to account values and Policyholder benefits, respectively, within the Statements of Operations. The Company offers a variable-indexed annuity product that combines a separate account option with a general account option that is similar to a fixed-indexed annuity. The Company has elected the fair value option to account for the entire insurance contract liability and the variable investment option assets backing the separate account. The insurance contracts’ reserves are reported in Account balances and future policy benefit reserves and the variable investment option assets within the separate account are reported in Equity securities, trading on the Balance Sheets. Electing the fair value option for an insurance contract liability requires that the Company account for that liability as a financial instrument and also requires that acquisition costs be recognized immediately in expense.
Life and Accident and Health Insurance	(d) Life and Accident and Health Insurance Premiums on traditional life products are recognized as revenue over the premium-paying periods of the contracts when due from contractholders. Premium revenue generally exceeds expected policy benefits in the early years of the contracts and it is necessary to accrue, as premium is recognized, a liability for costs that are expected to be paid in the later years of the contracts. Accident and health premiums are recognized as earned on a pro rata basis over the risk coverage periods. Benefits and expenses are recognized as incurred.
Investments	(e) Investments Fixed-maturity Securities and Equity Securities The Company has portfolios of fixed-maturity securities classified as “available-for-sale.” Accordingly, these securities are carried at fair value, and related unrealized gains and losses are credited or charged directly to accumulated other comprehensive income (AOCI) in stockholder’s equity, net of tax and related shadow adjustments. The adjustments to deferred acquisition costs (DAC) and deferred sales inducements (DSI) represent the change in amortization that would have been required as a charge or credit to operations had such unrealized amounts been realized. The adjustment to reserves represents the increase or decrease in the reserve balance that would have been required as a charge or credit to operations had such unrealized amounts been realized. The Company has a portfolio of equity securities classified as “trading”. These securities are carried at fair value, and their respective related unrealized gains and losses are reflected in Change in fair value of assets and liabilities within the Statements of Operations. Dividends are accrued on the date they are declared, and interest is accrued as earned. Premiums or discounts on fixed-maturity securities are amortized using the constant yield method. Realized gains and losses are computed based on the average cost basis of all lots owned of each security. Mortgage-backed securities and structured securities are amortized using, among other assumptions, anticipated prepayments. Prepayment assumptions for loan-backed securities are obtained from various external sources or internal estimates. The Company believes these assumptions are consistent with those a market participant would use. The Company recognizes income using a constant effective yield method based on prepayment assumptions and the estimated economic life of the securities. For all structured securities without expected credit deterioration, when actual prepayments differ significantly from anticipated prepayments, the effective yield is recalculated to reflect actual payments to date and anticipated future payments using the retrospective method. Any resulting adjustment is included in Interest and similar income, net in the Statements of Operations. For structured securities with expected credit deterioration, when adjustments are anticipated for prepayments and other expected changes in future cash flows, the effective yield is recalculated using the prospective method. The fair value of fixed-maturity securities and equity securities is obtained from third-party pricing sources whenever possible. Management completes its own Independent Price Verification (IPV) process, which ensures security pricing is obtained from a third-party source other than the sources used by the internal and external investment managers managing the investments held by the Company. The IPV process supports the reasonableness of price overrides and challenges by the internal and external investment managers and reviews pricing for appropriateness. Results of the IPV are reviewed by the Company’s Pricing Committee. The Company reviews the available-for-sale investment portfolio to determine whether or not declines in fair value are other than temporary. The Company continues to evaluate factors in addition to average cost and fair value, including credit quality, the extent and duration of the decline, market analysis, current events, recent price declines, changes in risk-free interest rates, likelihood of recovery in a reasonable period of time, and management’s judgment, to determine whether fixed-income securities are considered other-than-temporarily impaired. When the fair value of a fixed-maturity security is less than its amortized cost, the Company assesses whether or not (i) it has the intent to sell the security or (ii) it is more likely than not that the Company will be required to sell the security before its anticipated recovery. The Company evaluates these factors to determine whether the Company or any of its internal and external investment managers have the intent to sell a security or a group of securities. Additionally, the Company performs a cash flow projection for several years into the future to determine whether cash needs would require the sale of any securities in an unrealized loss position. If either of these conditions is met, the Company must recognize an other-than-temporary-impairment (OTTI) for the difference between the investment’s amortized cost basis and its fair value through earnings. For securities that do not meet the above criteria, and the Company does not expect to recover a security’s amortized cost basis, the security is considered other-than-temporarily impaired. For these securities, the Company separates the total impairment into the credit loss component and the amount of the loss related to other factors. The amount of the total impairment related to credit loss is considered an OTTI and is recognized in Realized investment (losses) gains, net in the Statements of Operations. The amount of the total impairment related to other factors is recognized in other comprehensive income (OCI), net of impacts to DAC, DSI, reserves, and deferred income taxes. For available-for-sale securities that have recognized an OTTI through earnings, if through subsequent evaluation there is a significant increase in the cash flow expected, the difference between the amortized cost basis and the discounted cash flows expected to be collected is accreted as interest income. Subsequent increases and decreases not related to additional credit losses in the fair value of available-for-sale securities are included in the Statements of Comprehensive Income (Loss). The Company evaluates whether a credit loss exists by considering primarily the following factors: (a) the length of time and extent to which the fair value has been less than the amortized cost of the security; (b) changes in the financial condition, credit rating, and near-term prospects of the issuer; (c) whether the issuer is current on contractually obligated interest and principal payments; (d) changes in the financial condition of the security’s underlying collateral, if any; and (e) the payment structure of the security. The Company uses a probability-weighted cash flow model for corporate bonds to determine the credit loss amount. This measurement is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions and significant judgments regarding the future performance of the security. The Company’s probability-weighted cash flow model involves assumptions including, but not limited to, various performance indicators, such as historical and projected default and recovery rates, credit ratings, and current delinquency rates. For structured securities, the Company selects a probability-weighted or best estimate cash flow model depending on the specifics of the individual security and the information available to measure the expected cash flows of the underlying collateral. In the event that sufficient information is not available to measure the expected cash flows of a structured security in a timely manner due to a lack of available information on the valuation date, the entire decline in fair value is considered to be related to credit loss. The Company provides a supplemental disclosure within the Statements of Operations that presents the total OTTI losses recognized during the period less the portion of OTTI losses recognized in OCI to equal the credit-related portion of OTTI that was recognized in earnings during the period. The portion of OTTI losses recognized in OCI includes the portion of OTTI losses related to factors other than credit recognized during the period, offset by reclassifications of OTTI losses previously determined to be related to factors other than credit that are determined to be credit-related in the current period. The amount presented in the supplemental disclosure within the Statements of Operations represents the portion of OTTI losses recognized in OCI and excludes subsequent increases and decreases in the fair value of these securities. The Company evaluates whether equity securities are other-than-temporarily impaired through a review process which includes, but is not limited to, market analysis, analyzing current events, assessing recent price declines, and management’s judgment related to the likelihood of recovery within a reasonable period of time. All previously impaired equity securities will incur additional OTTI should the fair value fall below the book value. Impairments in the value of securities held by the Company, considered to be other than temporary, are recorded as a reduction of the cost of the security, and a corresponding realized loss is recognized in the Statements of Operations. The Company adjusts DAC and DSI for impairments on securities, as discussed in their respective sections of this note. Variable Interest Entities In the normal course of business, the Company enters into relationships with various entities that are deemed to be a variable interest entity (VIE). A VIE is an entity that either (1) has equity investors that lack certain essential characteristics of a controlling financial interest (including the ability to control activities of the entity, the obligation to absorb the entity’s expected losses, and the right to receive the entity’s expected residual returns) or (2) lacks sufficient equity to finance its own activities without financial support provided by other entities, which in turn would be expected to absorb at least some of the expected losses of the VIE. The Company consolidates a VIE if it is determined to be the primary beneficiary. Those entities which do not meet the requirements to be a VIE are voting interest entities (VOEs). The Company consolidates a VOE if it holds a voting interest that is greater than 50%. Policy Loans Policy loans, which are supported by the underlying cash value of the policies, are carried at unpaid principal balances, which approximate fair value.
Derivatives	(f) Derivatives The Company utilizes derivatives within certain actively managed investment portfolios. Within these portfolios, derivatives can be used for hedging, replication, and income generation only. The financial instruments are valued and carried at fair value and the unrealized gains and losses on the derivatives are reflected in Change in fair value of assets and liabilities in the Statements of Operations. Options and Futures Contracts The Company provides additional benefits through certain life and annuity products, which are linked to the fluctuation of various United States and international stock and bond market indices. In addition, certain variable annuity contracts provide minimum guaranteed benefits. The Company has analyzed the characteristics of these benefits and has entered into over-the-counter (OTC) option contracts and exchange-traded futures contracts tied to an appropriate underlying index with similar characteristics with the objective to economically hedge these risks. The Company uses exchange-traded futures contracts with the objective to increase the effectiveness of the economic hedge. Management monitors in-force amounts and option and futures contract values to ensure satisfactory matching and to identify unsatisfactory mismatches. If persistency assumptions were to deviate significantly from anticipated rates, management would purchase or sell option and futures contracts as deemed appropriate or take other actions. The OTC option contracts are reported at fair value as Derivative assets and Derivative liabilities on the Balance Sheets. The fair value of the OTC options is derived internally and deemed by management to be reasonable via performing an IPV process. The process of deriving internal derivative prices requires the Company to calibrate Monte Carlo scenarios to actual market information. The calibrated scenarios are applied to derivative cash flow models to calculate fair value prices for the derivatives. Changes in unrealized gains and losses on the OTC option contracts and incremental gains and losses from expiring contracts are recorded within Change in fair value of assets and liabilities in the Statements of Operations. Futures contracts do not require an initial cash outlay, and the Company has agreed to daily net settlement based on movements of the representative index. Therefore, no asset or liability is recorded on the Balance Sheets. Gains and/or losses on futures contracts are included in Change in fair value of assets and liabilities in the Statements of Operations. Interest Rate Swaps and Total Return Swaps The Company utilizes interest rate swaps (IRS) to hedge market risks embedded in certain annuities. Beginning in 2016, the Company began transacting in total return swaps (TRS) also to hedge market risks in certain annuities. The IRS and TRS are reported at fair value in Derivative assets and Derivative liabilities on the Balance Sheets. The fair value of the IRS are derived using a third-party vendor software program and deemed by management to be reasonable. The fair value of the TRS is based on counterparty pricing and deemed by management to be reasonable. The unrealized gains and losses on the swaps are recorded in Change in fair value of assets and liabilities in the Statements of Operations.
Cash and cash equivalents	(g) Cash and cash equivalents Cash and cash equivalents includes cash on hand, demand deposits, overnight commercial paper, and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the recorded value is deemed to approximate fair value.
Receivables	(h) Receivables Receivable balances (contractual amount less allowance for doubtful accounts) are based on pertinent information available to management as of year-end, including the financial condition and creditworthiness of the parties underlying the receivables. Receivable balances are monitored and allowances for doubtful accounts are maintained based on the nature of the receivable, and the Company’s assessment of the ability to collect. The allowance is estimated by aging the balances due from individual parties and generally setting up an allowance for any balances that are more than 90 days old.
Reinsurance	(i) Reinsurance The Company cedes business with other insurers. Reinsurance premium and benefits paid or provided are accounted for in a manner consistent with the basis used in accounting for original policies issued and the terms of the reinsurance contracts and are included in Premiums and policy fees, ceded, and Benefit recoveries, respectively, in the Statements of Operations. Insurance liabilities are reported before the effects of reinsurance. Account balances and future policy benefit reserves and policy and contract claims covered under reinsurance contracts are recorded in Reinsurance recoverable on the Balance Sheets. Amounts paid or deemed to have been paid for claims covered by reinsurance contracts are recorded as Receivables on the Balance Sheets. Reinsurance recoverables are recognized in a manner consistent with the liabilities related to the underlying reinsured contracts. Amounts due to other insurers on assumed business are recorded as a reinsurance payable, and are included in Other liabilities on the Balance Sheets. A gain recognized when the Company enters into a coinsurance agreement with a third-party reinsurer is deferred and recorded in Other liabilities on the Balance Sheets. Such gains are amortized into operations over the revenue-producing period or the claims run-off period, of the related reinsured policies. These amortized gains are recorded in Fee, commission and other revenue in the Statements of Operations.
Deferred Acquisition Costs	(j) Deferred Acquisition Costs Acquisition costs consist of commissions and other incremental costs that are directly related to the successful acquisition of insurance contracts. Acquisition costs are deferred to the extent recoverable from future policy revenues and gross profits. However, acquisition costs associated with insurance contracts recorded under the fair value option are not deferred as guidance related to the fair value option requires that transaction costs are recorded immediately as an expense. For interest-sensitive products (all issue years) and variable annuity contracts (issued in 2010 and after), acquisition costs are amortized in relation to the present value of expected future gross profits from investment and mortality, morbidity, and expense charges. For variable annuity contracts issued prior to 2010, acquisition costs are amortized in relation to the present value of estimated gross revenues from investment and mortality, morbidity, and expense charges. Acquisition costs for accident and health insurance policies are deferred and amortized over the lives of the policies in the same manner as premiums are earned. For traditional life and group life products, such costs are amortized over the projected earnings pattern of the related policies using the same actuarial assumptions used in computing future policy benefit reserves. DAC are reviewed for recoverability and loss recognition, at least annually, and adjusted when necessary. The evaluation is a two-step process where current policy year issues are evaluated for recoverability, and then in-force policies are evaluated for loss recognition. Before assessing recoverability and loss recognition, DAC are capped, if necessary, such that the balance cannot exceed the original capitalized costs plus interest. Changes in assumptions can have an impact on the amount of DAC reported for annuity and life insurance products and their related amortization patterns. In the event experience differs from assumptions or assumptions are revised, the Company is required to record an increase or decrease in DAC amortization expense, which is referred to as DAC unlocking. In general, increases in the estimated investment spreads and fees result in increased expected future profitability and may decrease the rate of DAC amortization, while increases in costs of product guarantees, and lapse/surrender and mortality assumptions reduce the expected future profitability of the underlying business and may increase the rate of DAC amortization. The Company formally evaluates the appropriateness of the best-estimate assumptions on an annual basis. If the economic environment or policyholder behavior changes quickly and substantially, assumptions will be reviewed more frequently to affirm best estimates. Any resulting DAC unlocking is reflected prospectively as a Change in deferred acquisition costs, net in the Statements of Operations. Adjustments to DAC are made to reflect the corresponding impact on the present value of expected future gross profits and revenue from unrealized gains and losses on available-for-sale investments used to support policyholder liabilities (commonly known as shadow DAC). These adjustments are included in AOCI and are explained further in the Investments section of this note. Adjustments may also be made to the estimated gross profits (EGP) or estimated gross revenues related to DAC that correspond with deferred annuities and universal life products for investment activity, such as write-downs on other-than-temporarily impaired fixed-maturity securities, and realized gains and losses. Management action may include assumption changes in the DAC models, such as adjustments to expected future gross profits or revenues used, as well as in-force management action such as crediting rate changes or index rate cap adjustments. This approach applies to fixed-maturity securities purchased as investment-grade only and not noninvestment-grade items that were purchased with other yield considerations. See further discussion of DAC unlocking in note 9. The Company assesses internal replacements on insurance contracts to determine whether such modifications significantly change the contract terms. An internal replacement represents a modification in product benefits, features, rights, or coverage that occurs by the exchange of an in-force insurance contract for a new insurance contract, or by amendment, endorsement, or rider to a contract. If the modification substantially changes the contract, the remaining DAC on the original contract are immediately expensed and any new DAC on the replacement contract are deferred. If the contract modification does not substantially change the contract, DAC amortization on the original contract continues and any new acquisition costs associated with the modification are immediately expensed.
Deferred Sales Inducements	(k) Deferred Sales Inducements Sales inducements are product features that enhance the investment yield to the contractholder on the contract. The Company offers two types of sales inducements on certain universal life and annuity contracts. The first type, an immediate bonus, increases the account value at inception, and the second type, a persistency bonus, increases the account value at the end of a specified period. Annuity sales inducements are deferred when credited to contractholders, and life sales inducements are deferred and recognized as part of the liability for policy benefits. DSI are reported in Other assets on the Balance Sheets. They are amortized over the expected life of the contract in a manner similar to DAC and are reviewed annually for recoverability. DSI capitalization and amortization is recorded in Policyholder benefits within the Statements of Operations. Adjustments to DSI are made to reflect the estimated corresponding impact on the present value of expected future gross profits and revenues from unrealized gains and losses on available-for-sale investments used to support policyholder liabilities (commonly known as shadow DSI). These adjustments are included in AOCI and are explained further in the Investments section of this note. Adjustments may also be made to DSI related to deferred annuities for investment activity, such as write-downs on other-than-temporarily impaired fixed-maturity securities, and realized gains and losses. Management action may include assumption changes in the DSI models, such as adjustments to expected future gross profits used, as well as policyholder changes, such as credited rate changes. This approach applies to fixed-maturity securities purchased at investment grade only and not noninvestment grade items that were purchased with other yield considerations.
Income Taxes	(l) Income Taxes The Company and the Company’s parent, Allianz Life, file a consolidated federal income tax return with AZOA and many of its wholly owned subsidiaries. The consolidated tax allocation agreement stipulates that each company participating in the return will bear its share of the tax liability pursuant to certain tax allocation elections under the Internal Revenue Code and its related regulations, and that reimbursement will be in accordance with an intercompany tax reimbursement arrangement. The Company generally will be paid for the tax benefit on its losses and any other tax attributes to the extent it could have obtained a benefit against the Company’s post-1990 separate return tax liability. The Company provides for federal income taxes based on amounts the Company believes it ultimately will owe. Inherent in the provision for federal income taxes are estimates regarding the deductibility of certain items and the realization of certain tax credits. In the event the ultimate deductibility of certain items or the realization of certain tax credits differs from estimates, the Company may be required to significantly change the provision for federal income taxes recorded on the Balance Sheets. Any such change could significantly affect the amounts reported in the Statements of Operations. Management uses best estimates to establish reserves based on current facts and circumstances regarding tax exposure items where the ultimate deductibility is open to interpretation. Quarterly, management evaluates the appropriateness of such reserves based on any developments specific to their fact patterns. Information considered includes results of completed tax examinations, Technical Advice Memorandums, and other rulings issued by the Internal Revenue Service or the tax courts. The Company utilizes the asset and liability method of accounting for income tax. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. Valuation allowances are established when it is determined that it is more likely than not that the deferred tax asset will not be fully realized or that the related temporary differences, such as OTTI, will not reverse over time (see further discussion in note 11).
Separate Accounts and Annuity Product Guarantees	(m) Separate Accounts and Annuity Product Guarantees The Company issues variable annuity contracts through its separate accounts for which investment income and investment gains and losses accrue directly to, and investment risk is borne by, the contractholder. The Company also issues variable-indexed annuity contracts to its customers. These products have investment options similar to fixed-indexed annuities, but allow contractholders to invest in a variety of variable separate account investment options. The Company recognizes gains or losses on transfers from the general account to the separate accounts at fair value to the extent of contractholder interests in separate accounts, which are offset by changes in contractholder liabilities. The Company also issues variable annuity contracts through its separate accounts, where the Company provides certain contractual guarantees to the contractholder. These guarantees are in the form of a guaranteed minimum death benefit (GMDB), a guaranteed minimum income benefit (GMIB), a guaranteed minimum accumulation benefit (GMAB), and a guaranteed minimum withdrawal benefit (GMWB). The investments backing the guarantees are held in the general account. These guarantees provide for benefits that are payable to the contractholder in the event of death, annuitization, exercise of the living withdrawal benefit, or at specified dates during the accumulation period. Separate account assets supporting variable annuity contracts represent funds for which investment income and investment gains and losses accrue directly to contractholders. Each fund has specific investment objectives, and the assets are carried at fair value. The assets of each account are legally segregated and are not subject to claims that arise out of any of the other business of the Company. Separate account assets and liabilities are reported as summary totals on the Balance Sheets. Amounts charged to the contractholders for mortality and contract maintenance are included in Policy fees in the Statements of Operations. These fees have been earned and assessed against contractholders on a daily or monthly basis throughout the contract period and are recognized as revenue when assessed and earned. Changes in GMDB and GMIB are calculated in accordance with the Financial Services – Insurance Topic of the Accounting Standards Codification (Codification), and are included in Policyholder benefits in the Statements of Operations. GMAB and GMWB are considered to be embedded derivatives under the Derivatives and Hedging Topic of the Codification, and the changes in these embedded derivatives are included in Change in fair value of annuity and life embedded derivatives in the Statements of Operations. The GMDB net amount at risk is defined as the guaranteed amount that would be paid upon death, less the current accumulated contractholder account value. The GMIB net amount at risk is defined as the current amount that would be needed to fund expected future guaranteed payments less the current contractholder account value, assuming that all benefit selections occur as of the valuation date. The GMAB net amount at risk is defined as the current guaranteed value amount that would be added to the contracts less the current contractholder account value. The GMWB net amount at risk is defined as the current accumulated benefit base amount less the current contractholder account value. The GMDB provides a specified minimum return upon death. The survivor has the option to terminate the contract or continue it and have the death benefit paid into the contract. The Company’s GMDB options have the following features: • Return of Premium • Reset • Ratchet The GMIB is a living benefit that provides the contractholder with a guaranteed annuitization value. The GMIB features are: • Return of Premium • Rollup The GMDB and GMIB liabilities are determined each period by estimating the expected future claims in excess of the associated account balances. The Company regularly evaluates estimates and adjusts the additional liability balance, with a related charge or credit to Policyholder benefits in the Statements of Operations, if actual experience or other evidence suggests that earlier assumptions should be revised. The GMAB is a living benefit that provides the contractholder with a guaranteed value that was established at least five years prior at each contract anniversary. This benefit is first available at the fifth contract anniversary, seventh contract anniversary, or tenth contract anniversary depending on the type of contract. Depending on the contractholder’s selection at issue, this value either may be a return of premium or may reflect market gains, adjusted at least proportionately for withdrawals. The contractholder also has the option to reset this benefit. The GMWB is a living benefit that provides the contractholder with a guaranteed amount of income in the form of partial withdrawals. The benefit is payable provided the covered person is between the specified ages in the contract. The benefit is a fixed rate (depending on the age of the covered person) multiplied by the benefit base in the first year the benefit is taken and contract value in following years. The benefit does not decrease if the contract value decreases due to market losses. The benefit can decrease if the contract value is reduced by withdrawals. The benefit base used to calculate the initial benefit is the maximum of the contract value, the quarterly anniversary value, or the guaranteed annual increase of purchase payments (either simple or compound interest, depending on the contract). Additionally, there is a GMWB living benefit where the benefit is an initial payment percentage established at issue, based on issue age. For each year there is a year over year contract value increase, the payment percentage will increase by 1.0% (up to age 91). This payment percentage is applied against total purchase payments instead of a benefit base value. The GMAB and GMWB liabilities are determined each period as the difference between expected future claims and the expected future profits. One result of this calculation is that these liabilities can be negative (contra liability). If the sum of the total embedded derivative balance is negative, the Company will reclassify the balance as an asset on the Balance Sheets. This methodology will also be applied to the fixed-indexed benefit. The Company regularly evaluates estimates used and adjusts the additional liability balance, with a related charge or credit to Change in fair value of annuity and life embedded derivatives in the Statements of Operations, if experience or other evidence suggests that earlier assumptions should be revised. Products featuring these benefits were first issued in 2007. In the calendar year that a product with GMAB or GMWB liabilities launches, the reserves are set to zero, until the policy’s first anniversary date. GMAB cash flows are discounted using a rate equal to the current month’s London Interbank Offered Rate (LIBOR) plus a Company specific spread. The expected life-contingent GMWB payments are discounted using a blend of short and long term rates to the date the account value is expected to be exhausted. These obligations and all cash flows are then discounted to the current date using LIBOR plus a spread for the Company’s own nonperformance risk. The Company has in-force fixed-indexed annuities with a GMWB as an optional rider. The GMWB has a roll up feature. The net amount at risk is partially limited because the contractholder account value has an annual credit that is floored at zero. Since the account value cannot decrease, in contrast to a variable annuity, the difference between the withdrawal value and the account value will not diverge to the degree that is possible in a variable annuity.
Account Balances and Future Policy Benefit Reserves	(n) Account Balances and Future Policy Benefit Reserves The Company establishes liabilities for amounts payable to policyholders associated with annuity and life insurance policies sold. Policy and contract account balances for interest-sensitive products, which include universal life and fixed deferred annuities, are generally carried at accumulated contract values. For fixed-indexed annuity products, the policyholder obligation is divided into two parts: the first part representing the value of the underlying base contract (host contract); and the second part representing the fair value of the expected index benefit over the life of the contract. The value of the host contract accrues to guaranteed minimum amounts of the base policy. The index benefit is valued at fair value using current capital market assumptions, such as index and volatility, to estimate future index levels. The index benefit valuation is also dependent upon estimates of future policyholder behavior. The Company must include provisions for the Company’s own credit risk and for risk that the Company’s assumptions about policyholder activity could differ from actual experience. The fair value determination of the index benefit is sensitive to the economic market and interest rate environment, as it is discounted at current market interest rates. There is volatility in this liability due to these external market sensitivities. Policy and contract account balances for variable annuity products are carried at accumulated contract values. Future policy benefit reserves for any death and income benefits that may exceed the accumulated contract values are established using a range of economic scenarios and are accrued for using assumptions consistent with those used in estimating gross profits or gross revenues for purposes of amortizing DAC. Future policy benefit reserves for accumulation and withdrawal benefits that may exceed account values are established using capital market assumptions, such as index and volatility, along with estimates of future policyholder behavior. Future policy benefit reserves on traditional life products are computed by the net level-premium method based upon estimated future investment yield, mortality, and withdrawal assumptions, commensurate with the Company’s experience, modified as necessary to reflect anticipated trends, including possible unfavorable deviations. Most life reserve interest assumptions range from 2.3% to 6.0%. An additional reserve has been established to provide for future expected losses that are anticipated to occur after a period of profits. The reserve accrual will be over the profit period and is based on best estimate assumptions as of the current accrual period without provisions for adverse deviation.
Policy and Contract Claims	(o) Policy and Contract Claims Policy and contract claims include the liability for claims reported but not yet paid, claims incurred but not yet reported (IBNR), and claim settlement expenses on the Company’s accident and health business. Actuarial reserve development methods are generally used in the determination of IBNR liabilities. In cases of limited experience or lack of credible claims data, loss ratios are used to determine an appropriate IBNR liability. Claim and IBNR liabilities of a short-term nature are not discounted, but those claim liabilities resulting from disability income or LTC benefits include interest and mortality discounting.
Permitted and Prescribed Statutory Accounting Practices	(p) Permitted and Prescribed Statutory Accounting Practices The Company is required to file annual statements with insurance regulatory authorities, which are prepared on an accounting basis prescribed or permitted by such authorities. Permitted statutory accounting practices encompass all accounting practices that are not prescribed; such practices differ from state to state, may differ from company to company within a state, and may change in the future. Prescribed statutory accounting practices include state laws, regulations, and general administrative rules, as well as a variety of publications of the National Association of Insurance Commissioners (NAIC). The Company does not have any permitted or prescribed practices in effect that had an impact on net income or statutory surplus as of December 31, 2016.
Recently Issued Accounting Pronouncements - Adopted	(q) Recently Issued Accounting Pronouncements – Adopted In December 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-19, Technical Corrections and Improvements, to make various minor changes and improvements to various sections of accounting guidance within the Codification. The FASB did not anticipate that these amendments would affect current accounting practice. The amendments are intended to simplify and improve the readability of select guidance and in particular result in clarification of glossary terms. The majority of the amendments in this update are effective immediately. The amendments in this update do not have an impact on the Financial Statements. In May 2015, the FASB released ASU 2015-09, Disclosures about Short-Duration Contracts, to add disclosure requirements for the liability for unpaid claims and claim adjustment expenses on short- duration insurance contracts. The update is effective for fiscal years beginning after December 15, 2015, and interim periods within fiscal years beginning after December 15, 2016. The amount of short-duration contracts is not material and therefore no disclosures were included in the Financial Statements. In May 2015, the FASB issued ASU 2015-07, Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent). The existing Topic 820, Fair Value Measurement, permits a practical expedient to measure the fair value of certain investments using the net asset value per share of the investment. The investments valued using the practical expedient are categorized within the hierarchy on the basis of whether the investment is redeemable with the investee at net asset value on the measurement date, never redeemable with the investee at net asset value, or redeemable with the investee at net asset value at a future date. The amendments in this update remove the requirement to categorize within the fair value hierarchy all investments for which fair values are measured using the net asset value per share practical expedient. The amendments are effective for fiscal years beginning after December 15, 2015 and interim periods within those years. This guidance does not have an impact on the Financial Statements as the Company does not currently value any investments using the net asset value per share practical expedient. In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis, to reduce the number of consolidation models and place more emphasis on risk of loss when determining a controlling financial interest. Specifically, the amendments: 1) modify the evaluation of whether limited partnerships and similar legal entities are VIEs or voting interest entities; 2) eliminate the presumption that a general partner should consolidate a limited partnership; 3) affect the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships; and 4) provide a scope exception from consolidation guidance for reporting entities with interests in legal entities that are required to comply with or operate in accordance with requirements that are similar to those in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds. The amendments are effective for fiscal years and interim periods beginning after December 15, 2015. The update does not have a material impact on the Financial Statements. In January 2015, the FASB issued ASU 2015-01, Extraordinary and Unusual Items, to simplify financial statements by eliminating the concept of extraordinary items. The amendments are effective for interim and fiscal years beginning after December 15, 2015. The Company does not currently report any extraordinary items; therefore, the amendment does not impact the Financial Statements. In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements—Going Concern, to provide guidance about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. The amendments in this update are intended to reduce diversity in the timing and content of footnote disclosures. Additional disclosures are required if the Company believes there is substantial doubt about the entity’s ability to continue as a going concern. The amendments in this update are effective for fiscal years ending after December 15, 2016 and for annual and interim periods, thereafter. The amendments in this update do not have an impact on the Financial Statements as management believes there is not substantial doubt the entity’s ability to continue as a going concern. In August 2014, the FASB issued ASU 2014-13, Measuring the Financial Liabilities of a Consolidated Collateralized Financing Entity, to release revised guidance related to consolidations of variable interest entities that are a collateralized financing entity, such as a collateralized debt obligation (CDO) or a collateralized loan obligation entity, when the reporting entity determines that it is the primary beneficiary. This revision will apply to reporting entities that are required to consolidate a collateralized financing entity under the variable interest entity guidance when: 1) the reporting entity measures the financial assets and liabilities of that collateralized financing entity at fair value based on other Topics; and 2) the changes in the fair value are reflected in earnings. The amendments are effective for fiscal years beginning after December 15, 2015. The guidance does not have an impact on the Financial Statements.
Recently Issued Accounting Pronouncements - To Be Adopted	(r) Recently Issued Accounting Pronouncements – To Be Adopted The FASB issued the following updates as part of their comprehensive new revenue recognition standard: • ASU 2014-09, Revenue from Contracts with Customers. This update defines the new standard for recognizing revenue from contracts when goods and services are transferred to a customer in exchange for payment. The model requires 1) identifying contracts with a customer; 2) identifying separate performance obligations; 3) determining the transaction price; 4) allocating the transaction price to the separate performance obligations; and 5) recognizing revenue when (or as) the entity satisfies a performance obligation. The revenue recognition standard does not apply to financial instruments or to insurance contracts. However, the standard will require significantly more disclosures about items that are recorded under the new revenue recognition model. The amendments in this update are effective for fiscal years beginning after December 15, 2017. • ASU 2016-08, Revenue Recognition—Principal versus Agent (reporting revenue gross versus net). This update adds clarifications to the principal versus agent guidance contained within ASU 2014-09 and provides guidance to aid in the assessment of control. Under the new guidance, an entity that controls the specified good or services before it is transferred to a customer is considered a principal and will recognize revenue on a gross basis. The amendments in this update are effective concurrently with ASU 2014-09. • ASU 2016-12, Revenue Recognition—Narrow-scope Improvements and Practical Expedients. This update provides clarifying guidance impacting several areas of the new standard, including noncash consideration and assessing collectability. The amendments in this update are effective concurrently with ASU 2014-09. • ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers. This update makes various minor clarifications to the guidance issued in ASU 2014-09. The amendments in this update are effective concurrently with ASU 2014-09. The Company does not have sources of revenue outside insurance contracts, which are specifically excluded from the scope of the new revenue recognition standard. Therefore, the Company does not anticipate the amendments in this update to have a material impact upon adoption. In October 2016, the FASB issued ASU 2016-17, Consolidation: Interests Held Through related Parties That Are under Common Control, to require a reporting entity to include all of its direct variable interests in a VIE, and on a proportionate basis, its indirect variable interests in a VIE held through related parties, including related parties that are under common control with the reporting entity when determining whether the reporting entity is the primary beneficiary of the VIE, and therefore required to consolidate the VIE. The amendments in this update are effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The amendments in this update do not have an impact on the Financial Statements. In October 2016, the FASB issued ASU 2016-16, Income Taxes: Intra-Entity Transfers of Assets Other than Inventory, to require entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs, rather than when it is sold externally. The amendments in this update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company is currently assessing the impact of the amendments in this update. In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments, to clarify or provide additional guidance regarding eight specific cash flow issues. These issues address the following topics: 1) debt prepayment or debt extinguishment costs; 2) settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; 3) contingent consideration payments made after a business combination; 4) proceeds from the settlement of insurance claims; 5) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned life insurance policies; 6) distributions received from equity method investees; 7) beneficial interests in securitization transactions; and 8) separately identifiable cash flows and application of the predominance principle. The update is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The Company is currently assessing the impact of this update. In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments, to replace the existing incurred loss impairment model with a new methodology that reflects expected credit losses and requires the entity to consider more information to develop credit loss estimates. The update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted after December 15, 2018. The Company is currently assessing the impact of this update. In March 2016, the FASB released ASU 2016-06, Contingent Put and Call Options in Debt Instruments, to provide clarifying guidance regarding the assessment of whether contingent call or put options on debt instruments are clearly related to their debt hosts. The amendments eliminate diversity in practice in assessing embedded contingent call and put options in debt instruments by requiring an entity to make the assessment solely with the four-step decision process. The amendments are effective for fiscal years beginning after December 15, 2016, and interim periods within those fiscal years. The Company is currently assessing the impact of this update. In March 2016, the FASB released ASU 2016-05, Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships, which adds guidance to clarify that in the event of a change in counterparty to the derivative instrument designated as a hedging instrument, the change will not require de-designation unless other criteria are also present. The amendments are effective for fiscal years beginning after December 15, 2016, and interim periods within those years. The Company is currently assessing the impact of this update. In February 2016, the FASB released ASU 2016-02, Leases, to require that the lessee recognize a right-of-use asset and a lease liability for all leases. There continues to be a distinction between finance leases and operating leases; however, operating leases will now require that the lease assets and liabilities be recognized in the statement of financial position. Lessor accounting remains largely unchanged. The amendments are effective for fiscal years beginning after December 15, 2018, and interim periods within those years. The Company is currently assessing the impact of the amendments in this update. The Company does not anticipate a material impact as it does not hold material leases as a lessee; however, it does anticipate that currently held leases would require recognition of a right-of-use asset and lease liability in accordance with the update. In January 2016, the FASB released ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities, to make various targeted improvements to the accounting for financial instruments, especially equity investments. In particular, the amendments provide improvements to recognition, measurement, presentation and disclosure guidance. The amendments are effective for fiscal years beginning after December 15, 2017 and interim periods thereafter. The Company is currently assessing the impact of this update.
Accounting Changes and Correction of Error	(s) Accounting Changes and Correction of Error A portfolio of equity securities related to investments backing variable annuity reserves is classified as trading on the Balance Sheets. For the year ended December 31, 2014, the presentation of purchases totaling ($4,780) and sales totaling $2,927 of these equity securities has been corrected in 2015 from Net cash (used in) provided by investing activities to Net cash provided by operating activities on the Statements of Cash Flows as a result of a correction of an error. On April 1, 2014, the Company applied a prospective change to its method of calculating DAC amortization for variable annuity policies issued prior to 2010. This was a change in estimate that is inseparable from the effect of a related change in accounting principle. For these annuities, acquisition costs are now amortized in relation to the present value of estimated gross revenues, whereas previously the amortization was based on estimated future gross profits. The implementation of the new DAC amortization will better reflect the revenue pattern of the pre-2010 variable block of business, which is currently in run-off. The implementation of this change resulted in a decrease in income from operations before income taxes of $8,820 for the year ended December 31, 2014. On December 1, 2014, the Company applied a prospective change to its method of calculating DAC amortization for variable annuity policies issued after 2010. The change in estimate will minimize accounting mismatches on interest and claim projections within the EGP calculation. The implementation of this change resulted in a decrease in income from operations before income taxes of approximately $669 for the year ended December 31, 2014.
Reclassification	(t) Reclassification Prior year balances related to investments classified as ‘Public utilities’ have been reclassified and are now presented within ‘Corporate securities’. The reclassification did not change total assets, stockholders equity, or net income as previously reported.

Investments (Tables)

Investments (Tables)	12 Months Ended
Investments (Tables)	Dec. 31, 2016
Fair Value of Available-for-Sale Securities	At December 31, 2016 and 2015, the amortized cost, gross unrealized gains, gross unrealized losses, and fair values of available-for-sale securities are as shown in the following tables: Amortized Gross Gross Fair 2016: Fixed-maturity securities: U.S. government $ 48,676 644 103 49,217 States and political subdivisions 10,546 285 187 10,644 Corporate securities 491,518 21,500 3,739 509,279 Mortgage-backed securities 184,217 1,732 3,558 182,391 Total $ 734,957 24,161 7,587 751,531 Amortized Gross Gross Fair 2015: Fixed-maturity securities: U.S. government $ 72,035 1,188 — 73,223 States and political subdivisions 11,112 214 282 11,044 Foreign government 505 5 — 510 Corporate securities 443,449 21,219 10,486 454,182 Mortgage-backed securities 133,853 2,909 1,159 135,603 Total $ 660,954 25,535 11,927 674,562
Net Unrealized Gains on Available-for-Sale Securities	The net unrealized gains on available-for-sale securities consist of the following at December 31: 2016 2015 2014 Available-for-sale: Fixed-maturity securities $ 16,574 13,608 41,419 Adjustments for: Shadow adjustments (5,501) (5,916 ) (15,794 ) Deferred taxes (3,876 ) (2,692 ) (8,969 ) Net unrealized gains $ 7,197 5,000 16,656
Amortized Cost and Fair Value of Fixed Maturity Securities, by Contractual Maturity	The amortized cost and fair value of available-for-sale fixed-maturity securities at December 31, 2016, by contractual maturity, are shown below: Amortized Fair value Available-for-sale fixed-maturity securities: Due in one year or less $ 23,313 23,685 Due after one year through five years 226,927 234,973 Due after five years through ten years 176,086 176,051 Due after ten years 119,112 128,731 Structured securities 189,519 188,091 Total available-for-sale fixed-maturity securities $ 734,957 751,531
Unrealized Losses on Available-For-Sale Securities and Related Fair Value	unrealized losses on available-for-sale securities that have been in a continuous loss position for the respective years ended December 31 are shown below: 12 months or less Greater than 12 months Total Fair value Unrealized Fair value Unrealized Fair value Unrealized 2016: Fixed-maturity securities: U.S. government $ 11,713 103 — — 11,713 103 States and political subdivisions 4,286 187 — — 4,286 187 Corporate securities 132,387 3,313 7,253 426 139,640 3,739 Mortgage-backed securities 102,435 3,483 1,622 75 104,057 3,558 Total temporarily impaired available-for-sale securities $ 250,821 7,086 8,875 501 259,696 7,587 12 months or less Greater than 12 months Total Fair value Unrealized Fair value Unrealized Fair value Unrealized 2015: Fixed-maturity securities: States and political subdivisions $ 4,206 282 — — 4,206 282 Corporate securities 118,027 5,912 12,707 4,574 130,734 10,486 Mortgage-backed securities 52,731 1,036 2,985 123 55,716 1,159 Total temporarily impaired available-for-sale securities $ 174,964 7,230 15,692 4,697 190,656 11,927
Cumulative Credit Impairments on Fixed-maturity Securities	The following table presents a rollforward of the Company’s cumulative credit impairments on fixed-maturity securities held at December 31: 2016 2015 Balance as of January 1 $ — — Additions for credit impairments recognized on: Securities not previously impaired 387 184 Reductions for credit impairments previously on: Securities that matured or were sold during the period (387) (184 ) Balance as of December 31 $ — —
Gross and Net Realized Investment Gains (Losses)	Gross and net realized investment (losses) gains for the respective years ended December 31 are summarized as follows: 2016 2015 2014 Fixed-maturity securities: Gross gains on sales $ 1,130 895 277 Gross losses on sales (949 ) (133 ) (206 ) OTTI (387 ) (184 ) — Other 1 5 6 Net realized investment (losses) gains $ (205 ) 583 77
Proceeds from Sale of Fixed-Maturity Securities	Proceeds from sales of available-for-sale investments for the years ended December 31 are presented in the following table: 2016 2015 2014 Available-for-sale: Fixed-maturity securities proceeds from sales $ 59,031 54,740 22,808
Interest and Similar Income, Net	Major categories of Interest and similar income, net, for the respective years ended December 31 are shown below: 2016 2015 2014 Interest and similar income: Fixed-maturity securities $ 30,189 27,699 29,131 Trading securities 16 24 24 Policy loans 22 18 17 Other invested assets, includes cash and cash equivalents 165 24 7 Total 30,392 27,765 29,179 Less: Investment expenses 834 378 320 Total interest and similar income, net $ 29,558 27,387 28,859
Carrying Amount and Maximum Exposure to Loss Relating to the VIEs	The carrying amount and maximum exposure to loss relating to the VIEs which the Company holds a variable interest but is not the primary beneficiary and which have not been consolidated were as follows: December 31, 2016 December 31, 2015 Carrying amount Maximum exposure to loss (1) Carrying amount Maximum exposure to loss (1) Fixed-maturity securities: Corporate securities $ 5,700 5,700 6,451 6,451 Mortgage-backed securities 182,391 182,391 135,603 135,603 Total fixed-maturity securities $ 188,091 188,091 142,054 142,054 (1) The maximum exposure to loss is equal to the carrying amount for fixed-maturity securities.

Derivative and Hedging Instru33

Derivative and Hedging Instruments (Tables)	12 Months Ended
Derivative and Hedging Instruments (Tables)	Dec. 31, 2016
Aggregate Notional Amounts and Fair Values Of Freestanding Derivative Instruments	The following table presents a summary of the aggregate notional amounts and fair values of the Company’s freestanding derivative instruments as of December 31: December 31, 2016 December 31, 2015 Gross Fair Value Gross Fair Value Notional (1) Assets Liabilities Notional (1) Assets Liabilities OTC Options $ 1,480,324 27,147 (14,073 ) 1,088,207 8,553 (7,112 ) IRS 502,000 5,846 (1,343 ) 508,000 6,511 (844 ) Futures 165,112 — — 494,534 — — TRS 23,000 — — — — — Total freestanding derivative instruments $ 32,993 (15,416 ) 15,064 (7,956 ) (1) Notional amounts are presented on a gross basis.
Fair Values of Embedded Derivative Instruments And Gains or Losses Recognized In Income	The following table presents a summary of the fair values of the Company’s embedded derivative instruments as of December 31: 2016 2015 GMWB $ (144,631 ) (147,290 ) GMAB (16,594 ) (27,579 ) MVLO (15,896 ) (18,525 ) Total embedded derivative instruments (177,121) (193,394 ) The following table presents the gains or losses recognized in income on the various freestanding derivative instruments and embedded derivatives: Location in statements of operations Amount of gains (losses) on years ended December 31 2016 2015 2014 GMWB Change in fair value of annuity and life embedded derivatives $ 2,659 (54,413 ) (101,961 ) GMAB Change in fair value of annuity and life embedded derivatives 8,844 (11,755 ) (14,372 ) MVLO Change in fair value of annuity and life embedded derivatives 1,688 5,292 3,969 Total change in fair value of annuity and life embedded derivatives 13,191 (60,876 ) (112,364 ) MVLO Policy fees 745 534 681 MVLO Policyholder benefits 196 127 98 IRS Change in fair value of assets and liabilities 5,690 23,296 93,758 Futures Change in fair value of assets and liabilities (32,111 ) (11,861 ) (26,878 ) TRS Change in fair value of assets and liabilities 1,105 — — OTC options Change in fair value of assets and liabilities (4,497 ) 692 232 Total derivative loss $ (15,681 ) (48,088 ) (44,473 )
Derivative Liabilities Subject to Master Netting Arrangement	The following tables present additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of the dates indicated: December 31, 2016 Gross amounts not offset in the Balance Sheet Gross Gross Net amounts Financial (1) Collateral Net amounts Derivative assets $ 32,993 — 32,993 (15,416 ) (10,674 ) 6,903 Derivative liabilities $ (15,416) — (15,416 ) 15,416 — — Net derivatives $ 17,577 — 17,577 — (10,674 ) 6,903 December 31, 2015 Gross amounts not offset in the Balance Sheet Gross Gross Net amounts in the Balance Sheet Financial (1) Collateral Net amounts Derivative assets $ 15,064 — 15,064 (7,907 ) (4,121 ) 3,036 Derivative liabilities $ (7,910 ) — (7,910 ) 7,907 — (3 ) Net derivatives $ 7,154 — 7,154 — (4,121 ) 3,033 (1) Represents the amount of assets or liabilities that could be offset by liabilities or assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Balance Sheets.
Derivative Assets Subject to Master Netting Arrangement	The following tables present additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of the dates indicated: December 31, 2016 Gross amounts not offset in the Balance Sheet Gross Gross Net amounts Financial (1) Collateral Net amounts Derivative assets $ 32,993 — 32,993 (15,416 ) (10,674 ) 6,903 Derivative liabilities $ (15,416) — (15,416 ) 15,416 — — Net derivatives $ 17,577 — 17,577 — (10,674 ) 6,903 December 31, 2015 Gross amounts not offset in the Balance Sheet Gross Gross Net amounts in the Balance Sheet Financial (1) Collateral Net amounts Derivative assets $ 15,064 — 15,064 (7,907 ) (4,121 ) 3,036 Derivative liabilities $ (7,910 ) — (7,910 ) 7,907 — (3 ) Net derivatives $ 7,154 — 7,154 — (4,121 ) 3,033 (1) Represents the amount of assets or liabilities that could be offset by liabilities or assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Balance Sheets.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Dec. 31, 2016
Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following tables present the assets and liabilities measured at fair value on a recurring basis and their corresponding level in the fair value hierarchy at December 31: Total Level 1 Level 2 Level 3 2016: Assets Fixed-maturity securities: U.S. government $ 49,217 49,217 — — States and political subdivisions 10,644 — 10,644 — Corporate securities 509,279 — 508,237 1,042 Mortgage-backed securities 182,391 — 182,391 — Derivative assets 32,993 — 32,993 — Equity securities, trading 7,539 7,539 — — Separate account assets 2,255,576 2,255,576 — — Total assets $ 3,047,639 2,312,332 734,265 1,042 Liabilities Derivative liabilities $ 15,416 — 15,416 — Separate account liabilities 2,255,576 2,255,576 — — Reserves at fair value (1) 399,260 — — 399,260 Total liabilities $ 2,670,252 2,255,576 15,416 399,260 Total Level 1 Level 2 Level 3 2015: Assets Fixed-maturity securities: U.S. government $ 73,223 73,223 — — States and political subdivisions 11,044 — 11,044 — Foreign government 510 — 510 — Corporate securities 454,182 — 453,135 1,047 Mortgage-backed securities 135,603 — 135,603 — Derivative assets 15,064 — 15,064 — Equity securities, trading 4,368 4,368 — — Separate account assets 2,205,548 2,205,548 — — Total assets $ 2,899,542 2,283,139 615,356 1,047 Liabilities Derivative liabilities $ 7,956 — 7,956 — Separate account liabilities 2,205,548 2,205,548 — — Reserves at fair value (1) 265,884 — — 265,884 Total liabilities $ 2,479,388 2,205,548 7,956 265,884 (1) Reserves at fair value are reported in Account balances and future policy benefit reserves on the Balance Sheets.
Reconciliation of the Beginning and Ending Balances for the Company's Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table provides a reconciliation of the beginning and ending balances for the Company’s Level 3 assets and liabilities measured at fair value on a recurring basis: December 31, 2016 December 31, 2015 Fixed- Derivative Derivative Reserves Fixed- Reserves Balance, beginning of year $ 1,047 — — (265,884 ) 1,072 (150,251 ) Total realized/unrealized gains (losses) included in: Net income (loss) — 7,774 (7,189 ) (8,708 ) — 15,670 Other comprehensive income (loss) (5 ) — — — (25 ) — Purchases and issuances — — — (140,054 ) — (138,736 ) Sales and settlements — (7,774 ) 7,189 15,386 — 7,433 Balance, end of year $ 1,042 — — (399,260 ) 1,047 (265,884 ) Losses included in net income (loss) related to financial instruments still held at the end of the year (1) (2) $ — — — (8,708 ) — 15,670 (1) The Company classifies realized and unrealized gains (losses) on Reserves at fair value as unrealized gains (losses) for purposes of disclosure in this table because it is impracticable to track the realized gains (losses) on a contract-by-contract basis. (2) The previously issued 2015 financial statements improperly disclosed losses included in net income (loss) related to Reserves at fair value still held at December 31, 2015 by including issuances of $138,736. The December 31, 2015 amount has been corrected to conform with current year presentation.
Significant Unobservable Inputs Used in Fair Value Measurements for Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table provides a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities on a recurring basis at December 31, 2016: Valuation Unobservable Range (weighted Fair value technique input average) Fixed-maturity securities: Available-for-sale: Corporate securities $ 1,042 Discounted cash flow Option adjusted spread * 72 (72) Reserves at fair value: MVLO (15,896 ) Discounted cash flow Annuitizations 0–25% Surrenders 0–25% Mortality 0–100% Withdrawal Benefit Election 0–50% GMWB and GMAB (161,225) Discounted cash flow Surrenders 0.5–35% Mortality 0–100% Variable-indexed annuity (222,139) Contract value N/A * N/A * * No range is applicable due to only one security within classification. Mortality assumptions are derived by applying management determined factors to the Annuity 2000 Mortality Table. * Unobservable inputs are not applicable as the fair value of the variable-indexed annuity reserve is held at contract value.
Fair Value of Financial Assets and Liabilities	The following table presents the carrying amounts and fair values of financial assets and liabilities carried at book value at December 31: 2016 Carrying Fair value amount Level 1 Level 2 Level 3 Total Financial assets: Policy loans $ 338 — 338 — 338 Financial liabilities: Investment contracts $ 448,009 — — 448,876 448,876 2015 Carrying Fair value amount Level 1 Level 2 Level 3 Total Financial assets: Policy loans $ 275 — 275 — 275 Financial liabilities: Investment contracts $ 465,891 — — 466,527 466,527

Financing Receivables (Tables)

Financing Receivables (Tables)	12 Months Ended
Financing Receivables (Tables)	Dec. 31, 2016
Nontrade Receivables and Allowance for Credit Losses	The Company analyzes certain financing receivables for credit risk by using specific credit quality indicators. The Company’s nontrade receivables are analyzed for credit risk based upon the customer classification of agent or reinsurer. The nontrade receivable and allowance for credit losses by customer classification as of December 31 are shown below: 2016 2015 Agent Reinsurer Total Agent Reinsurer Total Nontrade receivables $ 43 54 97 41 50 91 Allowance for credit losses (43 ) — (43 ) (33 ) — (33 ) Net nontrade receivable $ — 54 54 8 50 58
Aging Analysis of Past Due Financing Receivables	Aging analysis of past-due nontrade financing receivables as of December 31 is shown below: 31–60 61–90 Greater than Total Current Total 2016 $ 22 1 43 66 31 97 2015 $ 29 — 33 62 29 91

Deferred Acquisition Costs (Tab

Deferred Acquisition Costs (Tables)	12 Months Ended
Deferred Acquisition Costs (Tables)	Dec. 31, 2016
Deferred Acquisition Costs	DAC at December 31 and the changes in the balance for the years then ended are as follows: 2016 2015 2014 Balance, beginning of year $ 134,374 118,319 104,002 Capitalization 6,406 13,531 16,906 Interest 6,471 6,197 5,541 Amortization (17,691 ) (11,563 ) (7,383 ) Change in shadow DAC 308 7,890 (747 ) Balance, end of year $ 129,868 134,374 118,319
Pretax Impact on Assets and Liabilities as Result of Unlocking	The pretax impact on the Company’s assets and liabilities as a result of the unlocking during the years ended December 31 is as follows: 2016 2015 2014 Assets: DAC $ (1,030 ) 2,641 856 DSI (212 ) 337 356 Total (decrease) increase in assets (1,242 ) 2,978 1,212 Liabilities: Account balances and future policy benefit reserves (1,954 ) 5,867 (1,259 ) Unearned premiums 4 40 (2 ) Total (decrease) increase in liabilities (1,950 ) 5,907 (1,261 ) Net increase (decrease) before tax 708 (2,929 ) 2,473 Deferred income tax expense (benefit) 248 (1,025 ) 866 Net increase (decrease) after tax $ 460 (1,904 ) 1,607

Deferred Sales Inducements (Tab

Deferred Sales Inducements (Tables)	12 Months Ended
Deferred Sales Inducements (Tables)	Dec. 31, 2016
Schedule of Deferred Sales Inducement	DSI at December 31, and the changes in the balance for years then ended, are as follows: 2016 2015 2014 Balance, beginning of year $ 21,148 19,510 18,345 Capitalization 566 1,492 2,370 Interest 1,004 1,020 971 Amortization (2,939 ) (2,924 ) (1,762 ) Change in shadow DSI 101 2,050 (414 ) Balance, end of year $ 19,880 21,148 19,510

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2016
Significant Components of Net Deferred Tax Asset (Liability)	Tax effects of temporary differences giving rise to the significant components of the net deferred tax asset (liability). Net deferred tax asset on the Balance Sheets at December 31 are as follows: 2016 2015 Deferred tax assets: Policy reserves $ 151,608 113,361 Expense accruals 711 241 Total deferred tax assets 152,319 113,602 Deferred tax liabilities: Deferred acquisition costs (41,247 ) (42,684 ) Due and deferred premium (13 ) (14 ) Net unrealized gains on investments (5,801 ) (4,763 ) Investment income (75,704 ) (32,481 ) Total deferred tax liabilities (122,765 ) (79,942 ) Net deferred tax asset $ 29,554 33,660

Separate Accounts and Annuity39

Separate Accounts and Annuity Product Guarantees (Tables)	12 Months Ended
Separate Accounts and Annuity Product Guarantees (Tables)	Dec. 31, 2016
Market Volatility Assumptions	Market volatility assumption varies by fund type and grades from a current volatility number to a long-term assumption over four years as shown below: 2016 Fund index type Current Long-term Large cap 16.3 % 18.1 % Bond 3.4 3.9 International 16.8 21.4 Small cap 20.3 21.5 2015 Fund index type Current Long-term Large cap 17.6 % 18.1 % Bond 3.4 3.9 International 17.9 23.1 Small cap 20.8 21.3
Schedule of Guaranteed Minimums	Guaranteed minimums for the respective years ended December 31 are summarized as follows (note that the amounts listed are not mutually exclusive, as many products contain multiple guarantees): 2016 2015 Account Net amount Weighted Account Net amount Weighted value at risk age (years) value at risk age (years) GMDB: Return of premium $ 1,816,268 7,444 63.1 1,609,269 17,498 62.6 Ratchet and return of premium 620,999 20,606 65.7 625,964 38,380 65.0 Reset 84,191 692 76.1 88,037 1,422 75.7 Total $ 2,521,458 28,742 2,323,270 57,300 GMIB: Return of premium $ 7,717 133 67.8 8,756 143 66.7 Ratchet and rollup 128,150 25,900 65.1 140,274 32,123 64.2 Total $ 135,867 26,033 149,030 32,266 GMAB: Five years $ 17,899 61 69.8 19,420 549 68.9 Target date retirement – 7 year 44,589 69 64.1 48,571 1,636 63.3 Target date retirement – 10 year 19,140 331 64.3 20,690 1,307 63.2 Target date with management levers 385,249 8,501 63.6 377,123 21,100 63.0 Total $ 466,877 8,962 465,804 24,592 GMWB: No living benefit $ 61,926 — 67.8 62,096 — 67.1 Life benefit with optional reset 72,366 6,887 71.7 78,108 8,170 70.7 Life benefit with 8% rollup 28,562 6,286 70.2 30,070 6,520 69.1 Life benefit with management levers 1,386,689 265,514 61.2 1,310,233 232,424 60.7 Total $ 1,549,543 278,687 1,480,507 247,114
Variable Annuity Account Balances Invested In Separate Account	At December 31, variable annuity account balances were invested in separate account funds with the following investment objectives. Balances are presented at fair value: Investment type 2016 2015 Bond $ 310,976 291,103 Domestic equity 1,179,744 1,164,383 International equity 61,096 71,227 Specialty 665,294 646,452 Money market 37,065 31,191 Other 1,401 1,192 Total $ 2,255,576 2,205,548
Summary of Liabilities for Variable Contract Guarantees	The following table summarizes the liabilities for variable contract guarantees that are reflected in the general account and shown in Account balances and future policy benefit reserves on the Balance Sheets: GMDB GMIB GMAB GMWB Totals Balance as of December 31, 2014 $ 1,658 3,158 16,870 92,877 114,563 Incurred guaranteed benefits 1,111 907 11,755 54,413 68,186 Paid guaranteed benefits (530 ) (42 ) (1,046 ) — (1,618 ) Balance as of December 31, 2015 2,239 4,023 27,579 147,290 181,131 Incurred guaranteed benefits 528 (246 ) (8,845 ) (2,659 ) (11,222 ) Paid guaranteed benefits (782 ) (560 ) (2,140 ) — (3,482 ) Balance as of December 31, 2016 $ 1,985 3,217 16,594 144,631 166,427

Accident and Health Claim Res40

Accident and Health Claim Reserves (Tables)	12 Months Ended
Accident and Health Claim Reserves (Tables)	Dec. 31, 2016
Activity in Accident and Health Claim Reserves	Activity in the accident and health claim reserves is summarized as follows: 2016 2015 2014 Balance at January 1, net of reinsurance recoverables of $497, $360, and $264, respectively $ 3,504 2,136 1,032 Incurred related to: Current year 1,504 2,173 1,251 Prior years (361 ) (154 ) 283 Total incurred 1,143 2,019 1,534 Paid related to: Current year 85 42 49 Prior years 685 609 381 Total paid 770 651 430 Balance at December 31, net of reinsurance recoverables of $544, $497, and $360, respectively $ 3,877 3,504 2,136

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
Commitments and Contingencies (Tables)	Dec. 31, 2016
Future Minimum Lease Payments Required under Operating Leases	The Company leases office space and equipment from an affiliate (see further information in note 16). The future minimum lease payments required under operating leases are as follows: 2017 $ 24 2018 24 2019 24 2020 13 2021 and beyond — Total $ 85

Accumulated Other Comprehensi42

Accumulated Other Comprehensive Income (Tables)	12 Months Ended
Accumulated Other Comprehensive Income (Tables)	Dec. 31, 2016
Changes in AOCI by component	Changes in AOCI, net of tax, by component consist of the following: Year ended Year ended Net unrealized Net unrealized Beginning balance $ 5,000 16,656 OCI before reclassifications 2,216 (11,280 ) Amounts reclassified from AOCI (19 ) (376 ) Net OCI 2,197 (11,656 ) Ending balance $ 7,197 5,000
Reclassifications from AOCI	Reclassifications from AOCI, net of tax, consist of the following: Amount reclassified from AOCI Affected line item December 31, in the AOCI 2016 2015 Statements of Operations Net unrealized gain on securities: Available-for-sale securities $ 30 578 Realized investment (loss) gains, net Income tax expense 11 202 Income tax expense (benefit) Total amounts reclassified from AOCI $ 19 376 Net income (loss)

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
Segment Information (Tables)	Dec. 31, 2016
Reconciliation of Unconsolidated Segment Results to Consolidated Statement of Operations	Segment results are reconciled to the Statements of Operations in the tables below: Year ended December 31, 2016 Individual Other Total Revenue: Net premiums and policy fees $ 68,752 3,155 71,907 Interest and similar income, net 27,462 2,096 29,558 Change in fair value of assets and liabilities (41,554 ) — (41,554 ) Realized investment (losses), net (192 ) (13 ) (205 ) Fee, commission, and other revenue 7,051 — 7,051 Total revenue 61,519 5,238 66,757 Benefits and expenses: Net benefits and expenses 2,441 3,171 5,612 General and administrative expenses and commissions 39,355 593 39,948 Change in deferred acquisition costs, net 3,933 881 4,814 Total benefits and expenses 45,729 4,645 50,374 Pretax income $ 15,790 593 16,383 Year ended December 31, 2015 Individual Other Total Revenue: Net premiums and policy fees $ 65,603 3,267 68,870 Interest and similar income, net 25,378 2,009 27,387 Change in fair value of assets and liabilities 11,374 (1 ) 11,373 Realized investment gains, net 549 34 583 Fee, commission, and other revenue 7,221 — 7,221 Total revenue 110,125 5,309 115,434 Benefits and expenses: Net benefits and expenses 81,697 5,814 87,511 General and administrative expenses and commissions 41,145 647 41,792 Change in deferred acquisition costs, net (8,687 ) 522 (8,165 ) Total benefits and expenses 114,155 6,983 121,138 Pretax loss $ (4,030 ) (1,674 ) (5,704 ) Year ended December 31, 2014 Individual Other Total Revenue: Net premiums and policy fees $ 58,728 2,988 61,716 Interest and similar income, net 27,293 1,566 28,859 Change in fair value of assets and liabilities 66,806 — 66,806 Realized investment gains, net 73 4 77 Fee, commission, and other revenue 6,869 (5 ) 6,864 Total revenue 159,769 4,553 164,322 Benefits and expenses: Net benefits and expenses 138,957 4,936 143,893 General and administrative expenses and commissions 38,886 903 39,789 Change in deferred acquisition costs, net (15,088 ) 24 (15,064 ) Total benefits and expenses 162,755 5,863 168,618 Pretax loss $ (2,986 ) (1,310 ) (4,296 )

Organization - Additional Infor

Organization - Additional Information (Detail)	12 Months Ended
Organization - Additional Information (Detail)	Dec. 31, 2016
Annuity
Organization and Nature of Operations [Line Items]
Percentage of net premium written	99.00%
Accident, Health and Life Insurance Combined
Organization and Nature of Operations [Line Items]
Percentage of net premium written	1.00%
Variable Annuities
Organization and Nature of Operations [Line Items]
Percentage of net premium written	57.00%
variable-Indexed Annuities
Organization and Nature of Operations [Line Items]
Percentage of net premium written	43.00%

Summary Of Significant Accoun45

Summary Of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Significant Accounting Policies [Line Items]
Change in income from operation before income taxes	$ 16,383	$ (5,704)	$ (4,296)
Annuity Policies Issued Prior To 2010
Significant Accounting Policies [Line Items]
Change in income from operation before income taxes			(8,820)
Annuity Policies Issued After 2010
Significant Accounting Policies [Line Items]
Change in income from operation before income taxes			$ (669)
Minimum
Significant Accounting Policies [Line Items]
Traditional life products, life reserve interest assumptions range, maximum	2.30%
Maximum
Significant Accounting Policies [Line Items]
Traditional life products, life reserve interest assumptions range, maximum	6.00%

Amortized Cost or Cost, Gross U

Amortized Cost or Cost, Gross Unrealized Gains, Gross Unrealized Losses, and Fair Values of Available-For-Sale Securities (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Schedule of Available-for-sale Securities [Line Items]
Total available-for-sale fixed-maturity securities	$ 734,957	$ 660,954
Total fixed-maturity securities, available-for-sale, Gross unrealized gains	24,161	25,535
Total fixed-maturity securities, available-for-sale, Gross unrealized losses	7,587	11,927
Total fixed-maturity securities, available-for-sale, Fair value	751,531	674,562
U.S. government
Schedule of Available-for-sale Securities [Line Items]
Total available-for-sale fixed-maturity securities	48,676	72,035
Total fixed-maturity securities, available-for-sale, Gross unrealized gains	644	1,188
Total fixed-maturity securities, available-for-sale, Gross unrealized losses	103	0
Total fixed-maturity securities, available-for-sale, Fair value	49,217	73,223
States and political subdivisions
Schedule of Available-for-sale Securities [Line Items]
Total available-for-sale fixed-maturity securities	10,546	11,112
Total fixed-maturity securities, available-for-sale, Gross unrealized gains	285	214
Total fixed-maturity securities, available-for-sale, Gross unrealized losses	187	282
Total fixed-maturity securities, available-for-sale, Fair value	10,644	11,044
Corporate Securities
Schedule of Available-for-sale Securities [Line Items]
Total available-for-sale fixed-maturity securities	491,518	443,449
Total fixed-maturity securities, available-for-sale, Gross unrealized gains	21,500	21,219
Total fixed-maturity securities, available-for-sale, Gross unrealized losses	3,739	10,486
Total fixed-maturity securities, available-for-sale, Fair value	509,279	454,182
Mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Total available-for-sale fixed-maturity securities	184,217	133,853
Total fixed-maturity securities, available-for-sale, Gross unrealized gains	1,732	2,909
Total fixed-maturity securities, available-for-sale, Gross unrealized losses	3,558	1,159
Total fixed-maturity securities, available-for-sale, Fair value	$ 182,391	135,603
Foreign Government
Schedule of Available-for-sale Securities [Line Items]
Total available-for-sale fixed-maturity securities		505
Total fixed-maturity securities, available-for-sale, Gross unrealized gains		5
Total fixed-maturity securities, available-for-sale, Fair value		$ 510

Net Unrealized Gains On Availab

Net Unrealized Gains On Available -For-Sale Securities (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Net unrealized gains	$ 7,197	$ 5,000	$ 16,656
Fixed-maturity securities
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities	16,574	13,608	41,419
Shadow
Schedule of Available-for-sale Securities [Line Items]
Shadow adjustments	(5,501)	(5,916)	(15,794)
Deferred taxes
Schedule of Available-for-sale Securities [Line Items]
Deferred taxes	$ (3,876)	$ (2,692)	$ (8,969)

Amortized Cost and Fair Value A

Amortized Cost and Fair Value Available-For-Sale Fixed Maturity Securities (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Available-for-sale fixed-maturity securities:
Due in one year or less	$ 23,313
Due after one year through five years	226,927
Due after five years through ten years	176,086
Due after ten years	119,112
Structured securities	189,519
Total available-for-sale fixed-maturity securities	734,957	$ 660,954
Available-for-sale fixed-maturity securities:
Due in one year or less	23,685
Due after one year through five years	234,973
Due after five years through ten years	176,051
Due after ten years	128,731
Structured securities	188,091
Total available-for-sale fixed-maturity securities	$ 751,531	$ 674,562

Investments - Additional Inform

Investments - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)Investment	Dec. 31, 2015USD ($)Investment
Schedule of Investments [Line Items]
Fair value of investments held on deposit with various insurance departments and in other trusts	$ 1,699	$ 1,713
Available-for-sale investment holdings that were in an unrealized loss position for fixed-maturity securities \| Investment	149	104
External Credit Rating, Investment Grade
Schedule of Investments [Line Items]
Unrealized gain loss on investment grade securities	$ 7,250	$ 11,586
Percentage of unrealized loss	95.60%	97.10%

Unrealized Losses on Available-

Unrealized Losses on Available-For-Sale Securities and Related Fair Value (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Schedule of Available-for-sale Securities [Line Items]
Fair value,12 months or less	$ 250,821	$ 174,964
Unrealized losses, 12 months or less	7,086	7,230
Fair value, greater than 12 months	8,875	15,692
Unrealized losses, greater than 12 months	501	4,697
Fair value, total	259,696	190,656
Unrealized losses, total	7,587	11,927
U.S. government
Schedule of Available-for-sale Securities [Line Items]
Fair value,12 months or less	11,713
Unrealized losses, 12 months or less	103
Fair value, total	11,713
Unrealized losses, total	103
States and political subdivisions
Schedule of Available-for-sale Securities [Line Items]
Fair value,12 months or less	4,286	4,206
Unrealized losses, 12 months or less	187	282
Fair value, total	4,286	4,206
Unrealized losses, total	187	282
Corporate Securities
Schedule of Available-for-sale Securities [Line Items]
Fair value,12 months or less	132,387	118,027
Unrealized losses, 12 months or less	3,313	5,912
Fair value, greater than 12 months	7,253	12,707
Unrealized losses, greater than 12 months	426	4,574
Fair value, total	139,640	130,734
Unrealized losses, total	3,739	10,486
Mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Fair value,12 months or less	102,435	52,731
Unrealized losses, 12 months or less	3,483	1,036
Fair value, greater than 12 months	1,622	2,985
Unrealized losses, greater than 12 months	75	123
Fair value, total	104,057	55,716
Unrealized losses, total	$ 3,558	$ 1,159

Cumulative Credit Impairments o

Cumulative Credit Impairments on Fixed-Maturity Securities (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Other Than Temporary Impairment Losses Recognized [Line Items]
Beginning Balance	$ 0	$ 0
Additions for credit impairments recognized on:
Securities not previously impaired	387	184
Reductions for credit impairments previously on:
Securities that matured or were sold during the period	(387)	(184)
Ending Balance	$ 0	$ 0

Gross and Net Realized Investme

Gross and Net Realized Investment Gains (Losses) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Investment gains/losses [Line Items]
OTTI	$ (387)	$ (184)	$ 0
Net realized investment (losses) gains	(205)	583	77
Fixed-maturity securities
Investment gains/losses [Line Items]
Gross gains on sales	1,130	895	277
Gross losses on sales	(949)	(133)	(206)
OTTI	(387)	(184)	0
Other	1	5	6
Net realized investment (losses) gains	$ (205)	$ 583	$ 77

Proceeds from Sales of Availabl

Proceeds from Sales of Available-For-Sale Investments (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Fixed-maturity securities
Available-for-sale:
Proceeds from sales	$ 59,031	$ 54,740	$ 22,808

Major Categories of Interest an

Major Categories of Interest and Similar Income, Net (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Interest and Other Income [Line Items]
Fixed-maturity securities	$ 30,189	$ 27,699	$ 29,131
Trading securities	16	24	24
Policy loans	22	18	17
Other invested assets, includes cash and cash equivalents	165	24	7
Total	30,392	27,765	29,179
Less: Investment expenses	834	378	320
Total interest and similar income, net	$ 29,558	$ 27,387	$ 28,859

Carrying Amount and Maximum Exp

Carrying Amount and Maximum Exposure to Loss Related to VIEs (Detail) - USD ($) $ in Thousands		Dec. 31, 2016	Dec. 31, 2015
Variable Interest Entity [Line Items]
Carrying amount		$ 188,091	$ 142,054
Maximum exposure to loss	[1]	188,091	142,054
Corporate Securities
Variable Interest Entity [Line Items]
Carrying amount		5,700	6,451
Maximum exposure to loss	[1]	5,700	6,451
Mortgage-backed securities
Variable Interest Entity [Line Items]
Carrying amount		182,391	135,603
Maximum exposure to loss	[1]	$ 182,391	$ 135,603

[1]	The maximum exposure to loss is equal to the carrying amount for fixed-maturity securities.

Aggregate Notional Amounts and

Aggregate Notional Amounts and Fair Values of Freestanding Derivative Instruments (Detail) - USD ($) $ in Thousands		Dec. 31, 2016	Dec. 31, 2015
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross Fair value, Assets		$ 32,993	$ 15,064
Gross Fair value, Liabilities		(15,416)	(7,956)
Over the Counter
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional	[1]	1,480,324	1,088,207
Gross Fair value, Assets		27,147	8,553
Gross Fair value, Liabilities		(14,073)	(7,112)
Interest Rate Swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional	[1]	502,000	508,000
Gross Fair value, Assets		5,846	6,511
Gross Fair value, Liabilities		(1,343)	(844)
Futures
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional	[1]	165,112	$ 494,534
TRS [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional	[1]	$ 23,000

[1]	Notional amounts are presented on a gross basis.

Derivative and Hedging Instru57

Derivative and Hedging Instruments - Additional Information (Detail) - Futures - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Designated by exchange
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Collateral securities, fair value	$ 55,611	$ 49,007
OTC Derivatives
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Collateral securities, fair value	$ 0	$ 1,866

Fair Value of Embedded Derivati

Fair Value of Embedded Derivatives (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Embedded Derivative [Line Items]
Total embedded derivative instruments	$ (177,121)	$ (193,394)
Guaranteed Minimum Withdrawal Benefit
Embedded Derivative [Line Items]
Total embedded derivative instruments	(144,631)	(147,290)
Guaranteed Minimum Accumulation Benefit
Embedded Derivative [Line Items]
Total embedded derivative instruments	(16,594)	(27,579)
Market Value Liability Options
Embedded Derivative [Line Items]
Total embedded derivative instruments	$ (15,896)	$ (18,525)

Gain Loss Recognized In Income

Gain Loss Recognized In Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Change in fair value of annuity embedded derivatives	$ 13,191	$ (60,876)	$ (112,364)
Policy fees	68,839	65,756	58,599
Derivative loss, net	(15,681)	(48,088)	(44,473)
Policyholder benefits	(5,612)	(87,511)	(143,893)
Over the Counter
Derivative Instruments, Gain (Loss) [Line Items]
Derivative loss, net	(4,497)	692	232
Market Value Liability Options
Derivative Instruments, Gain (Loss) [Line Items]
Change in fair value of annuity embedded derivatives	1,688	5,292	3,969
Policy fees	745	534	681
Policyholder benefits	196	127	98
Interest Rate Swap
Derivative Instruments, Gain (Loss) [Line Items]
Derivative loss, net	5,690	23,296	93,758
Futures
Derivative Instruments, Gain (Loss) [Line Items]
Derivative loss, net	(32,111)	(11,861)	(26,878)
TRS [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative loss, net	1,105	0	0
Guaranteed Minimum Withdrawal Benefit
Derivative Instruments, Gain (Loss) [Line Items]
Change in fair value of annuity embedded derivatives	2,659	(54,413)	(101,961)
Guaranteed Minimum Accumulation Benefit
Derivative Instruments, Gain (Loss) [Line Items]
Change in fair value of annuity embedded derivatives	$ 8,844	$ (11,755)	$ (14,372)

Derivatives Assets And Liabilit

Derivatives Assets And Liabilities Subject To Enforceable Master Netting Arrangement (Detail) - USD ($) $ in Thousands		Dec. 31, 2016	Dec. 31, 2015
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross amounts recognized, derivatives assets		$ 32,993	$ 15,064
Net amounts presented in the balance sheet, derivatives assets		32,993	15,064
Gross amounts recognized, derivatives liabilities		(15,416)	(7,956)
Net amounts presented in the balance sheet, derivatives liabilities		(15,416)	(7,956)
Derivative Assets
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross amounts recognized, derivatives assets		32,993	15,064
Gross amounts offset in the balance sheet, derivatives assets		0	0
Net amounts presented in the balance sheet, derivatives assets		32,993	15,064
Gross amounts not offset in the balance sheet, financial instruments, derivative assets	[1]	(15,416)	(7,907)
Gross amounts not offset in the balance sheet, collateral pledged/received		(10,674)	(4,121)
Net amount, derivatives assets		6,903	3,036
Derivative Liabilities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross amounts recognized, derivatives liabilities		(15,416)	(7,910)
Gross amounts offset in the balance sheet, derivatives liabilities		0	0
Net amounts presented in the balance sheet, derivatives liabilities		(15,416)	(7,910)
Gross amounts not offset in the balance sheet, financial instruments, derivative liabilities	[1]	15,416	7,907
Gross amounts not offset in the balance sheet, collateral pledged/received		0	0
Net amount, derivatives liabilities			(3)
Net Derivatives
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross amounts recognized, net derivatives		17,577	7,154
Net amounts presented in the balance sheet, net derivatives		17,577	7,154
Gross amounts not offset in the balance sheet, collateral pledged/received		(10,674)	(4,121)
Net amount		$ 6,903	$ 3,033

[1]	Represents the amount of assets or liabilities that could be offset by liabilities or assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Balance Sheets.

Assets and Liabilities Measured

Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) - USD ($) $ in Thousands		Dec. 31, 2016	Dec. 31, 2015
Assets accounted for at fair value:
Fixed-maturity securities, available-for-sale		$ 751,531	$ 674,562
Derivative asset		32,993	15,064
Equity securities, trading		7,539	4,368
Separate account assets		2,255,576	2,205,548
Total assets accounted for at fair value		3,047,639	2,899,542
Liabilities accounted for at fair value:
Derivative liabilities		15,416	7,956
Separate account liabilities		2,255,576	2,205,548
Reserves at fair value	[1]	399,260	265,884
Total liabilities accounted for at fair value		2,670,252	2,479,388
U.S. government
Assets accounted for at fair value:
Fixed-maturity securities, available-for-sale		49,217	73,223
States and political subdivisions
Assets accounted for at fair value:
Fixed-maturity securities, available-for-sale		10,644	11,044
Corporate Securities
Assets accounted for at fair value:
Fixed-maturity securities, available-for-sale		509,279	454,182
Mortgage-backed securities
Assets accounted for at fair value:
Fixed-maturity securities, available-for-sale		182,391	135,603
Foreign Government
Assets accounted for at fair value:
Fixed-maturity securities, available-for-sale			510
Fair Value, Inputs, Level 1
Assets accounted for at fair value:
Equity securities, trading		7,539	4,368
Separate account assets		2,255,576	2,205,548
Total assets accounted for at fair value		2,312,332	2,283,139
Liabilities accounted for at fair value:
Separate account liabilities		2,255,576	2,205,548
Total liabilities accounted for at fair value		2,255,576	2,205,548
Fair Value, Inputs, Level 1 \| U.S. government
Assets accounted for at fair value:
Fixed-maturity securities, available-for-sale		49,217	73,223
Fair Value, Inputs, Level 2
Assets accounted for at fair value:
Derivative asset		32,993	15,064
Total assets accounted for at fair value		734,265	615,356
Liabilities accounted for at fair value:
Derivative liabilities		15,416	7,956
Total liabilities accounted for at fair value		15,416	7,956
Fair Value, Inputs, Level 2 \| States and political subdivisions
Assets accounted for at fair value:
Fixed-maturity securities, available-for-sale		10,644	11,044
Fair Value, Inputs, Level 2 \| Corporate Securities
Assets accounted for at fair value:
Fixed-maturity securities, available-for-sale		508,237	453,135
Fair Value, Inputs, Level 2 \| Mortgage-backed securities
Assets accounted for at fair value:
Fixed-maturity securities, available-for-sale		182,391	135,603
Fair Value, Inputs, Level 2 \| Foreign Government
Assets accounted for at fair value:
Fixed-maturity securities, available-for-sale			510
Fair Value, Inputs, Level 3
Assets accounted for at fair value:
Total assets accounted for at fair value		1,042	1,047
Liabilities accounted for at fair value:
Reserves at fair value	[1]	399,260	265,884
Total liabilities accounted for at fair value		399,260	265,884
Fair Value, Inputs, Level 3 \| Corporate Securities
Assets accounted for at fair value:
Fixed-maturity securities, available-for-sale		$ 1,042	$ 1,047

[1]	Reserves at fair value are reported in Account balances and future policy benefit reserves on the Balance Sheets.

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment contracts, carrying value	$ 448,009	$ 465,891
Investment contracts, fair value	448,876	466,527
Scenario, Previously Reported
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment contracts, carrying value		729,819
Investment contracts, fair value		730,455
Restatement Adjustment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment contracts, carrying value		(263,928)
Investment contracts, fair value		(263,928)
Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment contracts, fair value	448,876	466,527
Private Placement \| Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Private placement securities	$ 1,042	$ 1,047

Reconciliation of the Beginning

Reconciliation of the Beginning and Ending Balances for the Company's Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Available-for-sale Securities \| Corporate Securities
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation Calculation [Roll Forward]
Balance, beginning of year	$ 1,047	$ 1,072
Other comprehensive income (loss)	(5)	(25)
Balance, end of year	1,042	1,047
Losses included in net income (loss) related to financial instruments still held at the end of the year	0	0	[1],[2]
Derivative Assets
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation Calculation [Roll Forward]
Net income (loss)	7,774
Sales and settlements	(7,774)
Derivative Liabilities
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation Calculation [Roll Forward]
Net income (loss)	(7,189)
Sales and settlements	7,189
Reserve
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation Calculation [Roll Forward]
Balance, beginning of year	(265,884)	(150,251)
Net income (loss)	(8,708)	15,670
Purchases and issuances	(140,054)	(138,736)
Sales and settlements	15,386	7,433
Balance, end of year	(399,260)	(265,884)
Losses included in net income (loss) related to financial instruments still held at the end of the year	$ (8,708)	$ 15,670	[1],[2]

[1]	The Company classifies realized and unrealized gains (losses) on Reserves at fair value as unrealized gains (losses) for purposes of disclosure in this table because it is impracticable to track the realized gains (losses) on a contract-by-contract basis.
[2]	The previously issued 2015 financial statements improperly disclosed losses included in net income (loss) related to Reserves at fair value still held at December 31, 2015 by including issuances of $138,736. The December 31, 2015 amount has been corrected to conform with current year presentation.

Reconciliation of the Beginni64

Reconciliation of the Beginning and Ending Balances for the Company's Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis (Parenthetical) (Detail) - Reserve - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation Calculation [Roll Forward]
Realized gains (losses) included in net Income related to financial instruments	$ (8,708)	$ 15,670	[1],[2]
Restatement Adjustment
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation Calculation [Roll Forward]
Realized gains (losses) included in net Income related to financial instruments		$ 138,736

[1]	The Company classifies realized and unrealized gains (losses) on Reserves at fair value as unrealized gains (losses) for purposes of disclosure in this table because it is impracticable to track the realized gains (losses) on a contract-by-contract basis.
[2]	The previously issued 2015 financial statements improperly disclosed losses included in net income (loss) related to Reserves at fair value still held at December 31, 2015 by including issuances of $138,736. The December 31, 2015 amount has been corrected to conform with current year presentation.

Assets and Liabilities Measur65

Assets and Liabilities Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
variable-Indexed Annuities
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Fair value		$ (222,139)
Valuation technique	[1]	Contract value
Available-for-sale Securities \| Corporate Securities
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Fair Value		$ 1,042	$ 1,047	$ 1,072
Fair value		$ 1,042
Valuation technique		Discounted cash flow
Unobservable Input, option adjusted spread	[2]	72
Reserve
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Fair Value		$ (399,260)	$ (265,884)	$ (150,251)
Reserve \| Market Value Liability Options
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Fair value		$ (15,896)
Valuation technique		Discounted cash flow
Unobservable Input, Annuitizations, minimum		0.00%
Unobservable Input, Annuitizations, maximum		25.00%
Reserve \| Guaranteed Minimum Withdrawal Benefit and Guaranteed Minimum Accumulation Benefit
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Fair value		$ (161,225)
Valuation technique		Discounted cash flow
Weighted Average [Member] \| Available-for-sale Securities \| Corporate Securities
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Unobservable Input, option adjusted spread	[2]	72
Minimum \| Reserve \| Market Value Liability Options
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Unobservable Input, surrenders		0.00%
Unobservable Input, Mortality	[3]	0.00%
Unobservable Input, withdrawal benefit election		0.00%
Minimum \| Reserve \| Guaranteed Minimum Withdrawal Benefit and Guaranteed Minimum Accumulation Benefit
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Unobservable Input, surrenders		0.50%
Unobservable Input, Mortality	[3]	0.00%
Maximum \| Reserve \| Market Value Liability Options
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Unobservable Input, surrenders		25.00%
Unobservable Input, Mortality	[3]	100.00%
Unobservable Input, withdrawal benefit election		50.00%
Maximum \| Reserve \| Guaranteed Minimum Withdrawal Benefit and Guaranteed Minimum Accumulation Benefit
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Unobservable Input, surrenders		35.00%
Unobservable Input, Mortality	[3]	100.00%

[1]	Unobservable inputs are not applicable as the fair value of the variable-indexed annuity reserve is held at contract value.
[2]	No range is applicable due to only one security within classification.
[3]	Mortality assumptions are derived by applying management determined factors to the Annuity 2000 Mortality Table.

Fair Value of Financial Assets

Fair Value of Financial Assets and Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Financial assets, Carrying amount:
Policy loans	$ 338	$ 275
Financial liabilities, Carrying amount :
Investment contracts	448,009	465,891
Financial assets, Fair value:
Policy loans	338	275
Financial liabilities, Fair value:
Investment contracts	448,876	466,527
Fair Value, Inputs, Level 2
Financial assets, Fair value:
Policy loans	338	275
Fair Value, Inputs, Level 3
Financial liabilities, Fair value:
Investment contracts	$ 448,876	$ 466,527

Nontrade Receivables and Allowa

Nontrade Receivables and Allowance for Credit Losses (Detail) - Non Trade Receivable - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Financing Receivable, Allowance for Credit Losses [Line Items]
Nontrade receivables	$ 97	$ 91
Allowance for credit losses	(43)	(33)
Net nontrade receivable	54	58
Agents
Financing Receivable, Allowance for Credit Losses [Line Items]
Nontrade receivables	43	41
Allowance for credit losses	(43)	(33)
Net nontrade receivable		8
Reinsurer
Financing Receivable, Allowance for Credit Losses [Line Items]
Nontrade receivables	54	50
Net nontrade receivable	$ 54	$ 50

Financial Receivables - Additio

Financial Receivables - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Increase in provision	$ 10	$ 13

Aging Analysis of Past Due Fina

Aging Analysis of Past Due Financing Receivables (Detail) - Non Trade Receivable - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	$ 66	$ 62
Current	31	29
Total	97	91
31-60 days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	22	29
61-90 days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	1
Greater than 90 days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	$ 43	$ 33

Reinsurance - Additional Inform

Reinsurance - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Minimum
Effects of Reinsurance [Line Items]
Reinsurance retained amount per individual	$ 50	$ 50
Maximum
Effects of Reinsurance [Line Items]
Reinsurance retained amount per individual	$ 1,500	$ 1,500

Deferred Acquisition Costs (Det

Deferred Acquisition Costs (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Deferred Policy Acquisition Costs [Line Items]
Balance, beginning of year	$ 134,374	$ 118,319	$ 104,002
Capitalization	6,406	13,531	16,906
Interest	6,471	6,197	5,541
Amortization	(17,691)	(11,563)	(7,383)
Change in shadow DAC	308	7,890	(747)
Balance, end of year	$ 129,868	$ 134,374	$ 118,319

Pretax Impact on Assets and Lia

Pretax Impact on Assets and Liabilities as Result of Unlocking (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Liabilities:
Net (decrease) increase	$ 708	$ (2,929)	$ 2,473
Deferred income tax (benefit) expense	248	(1,025)	866
Net (decrease) increase	460	(1,904)	1,607
Unlocking Of Assumptions
Assets:
Total increase (decrease) in assets	(1,242)	2,978	1,212
Liabilities:
Total increase (decrease) in liabilities	(1,950)	5,907	(1,261)
Account balances and future policy benefit reserves \| Unlocking Of Assumptions
Liabilities:
Total increase (decrease) in liabilities	(1,954)	5,867	(1,259)
Unearned Premiums \| Unlocking Of Assumptions
Liabilities:
Total increase (decrease) in liabilities	4	40	(2)
DAC \| Unlocking Of Assumptions
Assets:
Total increase (decrease) in assets	(1,030)	2,641	856
DSI \| Unlocking Of Assumptions
Assets:
Total increase (decrease) in assets	$ (212)	$ 337	$ 356

Schedule of Deferred Sales Indu

Schedule of Deferred Sales Inducement Activity (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016		Dec. 31, 2015		Dec. 31, 2014
Movement in Deferred Sales Inducements [Roll Forward]
Balance, beginning of year		$ 21,148	[1]	$ 19,510	[1]	$ 18,345
Capitalization		566		1,492		2,370
Interest		1,004		1,020		971
Amortization		(2,939)		(2,924)		(1,762)
Change in shadow DSI		101		2,050		(414)
Balance, end of year	[1]	$ 19,880		$ 21,148		$ 19,510

[1]	Deferred sales inducements is located in Other assets on the Balance Sheets.

Income Tax (Benefit) Expense (D

Income Tax (Benefit) Expense (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income tax (benefit) expense attributable to operations:
Current tax expense (benefit)	$ 21	$ 9,567	$ 4,774
Deferred tax (benefit) expense	2,922	(14,008)	(7,907)
Total income tax (benefit) expense attributable to operations	2,943	(4,441)	(3,133)
Income tax effect on equity:
Attributable to unrealized losses gains for the year	1,184	(6,277)	3,397
Total income tax effect on equity	$ 4,127	$ (10,718)	$ 264

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Line Items]
Statutory income tax rate	35.00%
Income taxes paid	$ 9,714	$ 4,405	$ 2,271
Accrued interest and penalties related to unrecognized tax benefits	0	0
AZOA
Income Tax Disclosure [Line Items]
Tax payable	$ 180	$ 9,874

Reconciliation of Income Tax Ex

Reconciliation of Income Tax Expense (Benefit) Computed at Statutory Rate (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Components Of Income Tax Expense Benefit [Line Items]
Income tax (benefit) expense computed at the statutory rate	$ 5,734	$ (1,996)	$ (1,504)
Dividends-received deductions and tax-exempt interest	(2,803)	(2,455)	(1,447)
Other	12	10	(182)
Income tax (benefit) expense as reported	$ 2,943	$ (4,441)	$ (3,133)

Significant Components of Net D

Significant Components of Net Deferred Tax Asset (Liability) (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Deferred tax assets:
Future benefit reserves	$ 151,608	$ 113,361
Expense accruals	711	241
Total deferred tax assets	152,319	113,602
Deferred tax liabilities:
Deferred acquisition costs	(41,247)	(42,684)
Due and deferred premium	(13)	(14)
Net unrealized gains on investments	(5,801)	(4,763)
Investment income	(75,704)	(32,481)
Total deferred tax liabilities	(122,765)	(79,942)
Net deferred tax asset	$ 29,554	$ 33,660

Separate Accounting and Annuity

Separate Accounting and Annuity Product Guarantees - Additional Information (Detail) - Investment	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Guaranteed Minimum Death Benefit and Guaranteed Minimum Income Benefit
Significant Accounting Policies [Line Items]
Stochastically generated investment performance scenarios	100	100
Mean investment performance assumption	6.50%	6.50%
Volatility assumption	13.40%	13.40%
Mortality assumption	For 2016 and 2015, the mortality assumption is based on the Annuity 2000 mortality table for all variable products. The 2016 past mortality improvement is based on gender distinct mortality loads varying by attained age, and future mortality improvement factors are based on gender distinct projection scales varying by attained age and subject to grading factors.	The 2015 mortality assumption was 87% of the Annuity 2000 mortality table with a constant mortality improvement.
Lapse rates, spike rates	40.00%	40.00%
Lapse rates, ultimate rate	15.00%	15.00%
Description of discount rates	Discount rates vary by contract type and equal an assumed long-term investment return (6.5%), less the applicable mortality and expense rate.	Discount rates vary by contract type and equal an assumed long-term investment return (6.5%), less the applicable mortality and expense rate.
Guaranteed Minimum Accumulation And Withdrawal Benefit
Significant Accounting Policies [Line Items]
Stochastically generated investment performance scenarios	1,000	1,000
Mortality assumption	For 2016 and 2015, the mortality assumption is based on the Annuity 2000 mortality table for all variable products. The 2016 past mortality improvement is based on gender distinct mortality loads varying by attained age, and future mortality improvement factors are based on gender distinct projection scales varying by attained age and subject to grading factors.	The 2015 mortality assumption was 87% of the Annuity 2000 mortality table with a constant mortality improvement.
Lapse rates, spike rates	40.00%	40.00%
Lapse rates, ultimate rate	15.00%	15.00%
Volatility assumption period	4 years	4 years

Market Volatility Assumption Va

Market Volatility Assumption Varies by Fund Type and Grades From a Current Volatility to Long-Term Assumption (Detail) - Guaranteed Minimum Accumulation And Withdrawal Benefit	Dec. 31, 2016	Dec. 31, 2015
Large Cap
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Volatility rate	16.30%	17.60%
Large Cap \| Maximum
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Volatility rate	18.10%	18.10%
Bonds
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Volatility rate	3.40%	3.40%
Bonds \| Maximum
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Volatility rate	3.90%	3.90%
International
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Volatility rate	16.80%	17.90%
International \| Maximum
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Volatility rate	21.40%	23.10%
Small Cap
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Volatility rate	20.30%	20.80%
Small Cap \| Maximum
Long-Duration Contracts, Assumptions by Product and Guarantee [Line Items]
Volatility rate	21.50%	21.30%

Guaranteed Minimums (Detail)

Guaranteed Minimums (Detail) - USD ($) $ in Thousands	12 Months Ended
Guaranteed Minimums (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Guaranteed Minimum Death Benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 2,521,458	$ 2,323,270
Net amount at risk	28,742	57,300
Guaranteed Minimum Death Benefit \| Return of premium
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	1,816,268	1,609,269
Net amount at risk	$ 7,444	$ 17,498
Weighted age (years)	63 years 1 month 6 days	62 years 7 months 6 days
Guaranteed Minimum Death Benefit \| Ratchet and return of premium
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 620,999	$ 625,964
Net amount at risk	$ 20,606	$ 38,380
Weighted age (years)	65 years 8 months 12 days	65 years
Guaranteed Minimum Death Benefit \| Reset
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 84,191	$ 88,037
Net amount at risk	$ 692	$ 1,422
Weighted age (years)	65 years 8 months 12 days	75 years 8 months 12 days
Guaranteed Minimum Income Benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 135,867	$ 149,030
Net amount at risk	26,033	32,266
Guaranteed Minimum Income Benefit \| Return of premium
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	7,717	8,756
Net amount at risk	$ 133	$ 143
Weighted age (years)	67 years 9 months 18 days	66 years 8 months 12 days
Guaranteed Minimum Income Benefit \| Ratchet and rollup
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 128,150	$ 140,274
Net amount at risk	$ 25,900	$ 32,123
Weighted age (years)	65 years 1 month 6 days	64 years 2 months 12 days
Guaranteed Minimum Accumulation Benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 466,877	$ 465,804
Net amount at risk	8,962	24,592
Guaranteed Minimum Accumulation Benefit \| Five years
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	17,899	19,420
Net amount at risk	$ 61	$ 549
Weighted age (years)	69 years 9 months 18 days	68 years 10 months 24 days
Guaranteed Minimum Accumulation Benefit \| Target date retirement - 7 year
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 44,589	$ 48,571
Net amount at risk	$ 69	$ 1,636
Weighted age (years)	64 years 1 month 6 days	63 years 3 months 18 days
Guaranteed Minimum Accumulation Benefit \| Target date retirement - 10 year
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 19,140	$ 20,690
Net amount at risk	$ 331	$ 1,307
Weighted age (years)	64 years 3 months 18 days	63 years 2 months 12 days
Guaranteed Minimum Accumulation Benefit \| Target date with management levers
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 385,249	$ 377,123
Net amount at risk	$ 8,501	$ 21,100
Weighted age (years)	63 years 7 months 6 days	63 years
Guaranteed Minimum Withdrawal Benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 1,549,543	$ 1,480,507
Net amount at risk	278,687	247,114
Guaranteed Minimum Withdrawal Benefit \| No living benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 61,926	$ 62,096
Weighted age (years)	67 years 9 months 18 days	67 years 1 month 6 days
Guaranteed Minimum Withdrawal Benefit \| Life benefit with optional reset
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 72,366	$ 78,108
Net amount at risk	$ 6,887	$ 8,170
Weighted age (years)	67 years 9 months 18 days	70 years 8 months 12 days
Guaranteed Minimum Withdrawal Benefit \| Life benefit with 8% rollup
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 28,562	$ 30,070
Net amount at risk	$ 6,286	$ 6,520
Weighted age (years)	70 years 2 months 12 days	69 years 1 month 6 days
Guaranteed Minimum Withdrawal Benefit \| Life benefit with management levers
Net Amount at Risk by Product and Guarantee [Line Items]
Account value	$ 1,386,689	$ 1,310,233
Net amount at risk	$ 265,514	$ 232,424
Weighted age (years)	61 years 2 months 12 days	60 years 8 months 12 days

Account Balances of Variable An

Account Balances of Variable Annuity Which are Invested in Separate Account (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	$ 2,255,576	$ 2,205,548
Bond
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	310,976	291,103
Domestic equity
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	1,179,744	1,164,383
International equity
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	61,096	71,227
Specialty
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	665,294	646,452
Money market funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	37,065	31,191
Other funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	$ 1,401	$ 1,192

Summary of Liabilities for Vari

Summary of Liabilities for Variable Contract Guarantees (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Beginning balance	$ 181,131	$ 114,563
Incurred guaranteed benefits	(11,222)	68,186
Paid guaranteed benefits	(3,482)	(1,618)
Ending balance	166,427	181,131
Guaranteed Minimum Death Benefit
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Beginning balance	2,239	1,658
Incurred guaranteed benefits	528	1,111
Paid guaranteed benefits	(782)	(530)
Ending balance	1,985	2,239
Guaranteed Minimum Income Benefit
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Beginning balance	4,023	3,158
Incurred guaranteed benefits	(246)	907
Paid guaranteed benefits	(560)	(42)
Ending balance	3,217	4,023
Guaranteed Minimum Accumulation Benefit
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Beginning balance	27,579	16,870
Incurred guaranteed benefits	(8,845)	11,755
Paid guaranteed benefits	(2,140)	(1,046)
Ending balance	16,594	27,579
Guaranteed Minimum Withdrawal Benefit
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Beginning balance	147,290	92,877
Incurred guaranteed benefits	(2,659)	54,413
Ending balance	$ 144,631	$ 147,290

Activity in Accident and Health

Activity in Accident and Health Claim Reserves (Detail) - Accident and health - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease) [Abstract]
Balance at January 1, net of reinsurance recoverables of $497, $360, and $264, respectively	$ 3,504	$ 2,136	$ 1,032
Current year	1,504	2,173	1,251
Prior years	(361)	(154)	283
Total incurred	1,143	2,019	1,534
Current year	85	42	49
Prior years	685	609	381
Total paid	770	651	430
Balance at December 31, net of reinsurance recoverables of $544, $497, and $360, respectively	$ 3,877	$ 3,504	$ 2,136

Activity in Accident and Heal84

Activity in Accident and Health Claim Reserves (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accident and health
Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease) [Abstract]
Reinsurance recoverable period adjustment	$ 544	$ 497	$ 360	$ 264

Future Minimum Lease Payments R

Future Minimum Lease Payments Required under Operating Leases (Detail) $ in Thousands	Dec. 31, 2016USD ($)
Operating Leased Assets [Line Items]
2,017	$ 24
2,018	24
2,019	24
2,020	13
2021 and beyond	0
Total	$ 85

Employee Benefit Plans - Additi

Employee Benefit Plans - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Matching percentage of eligible employee pre tax contributions	80.00%
Defined contribution plan, employer matching contribution, percent of match	7.50%
Defined contribution plan, employers matching contribution, vesting percentage after three years of service	100.00%
Defined contribution plan, employers matching contribution, service period	3 years
Defined contribution plan employers matching contribution	$ 228	$ 205	$ 214

Related-Party Transactions - Ad

Related-Party Transactions - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Related Party Transaction [Line Items]
General and administrative expenses	$ 17,925	$ 17,816	$ 14,514
Allianz Life Insurance Financial Service
Related Party Transaction [Line Items]
Related party transaction, commission expense	21,607	23,410	24,771
Expense in Other liabilities	1,747	1,771
Related party transaction, revenue from related party	4,264	4,332	3,860
Related party transaction, expenses from related party	4,348	4,198	1,454
Affiliates \| Office Space Leases
Related Party Transaction [Line Items]
Rent expense	27	27	32
Allianz Life
Related Party Transaction [Line Items]
Service fee	10,135	9,437	8,368
Accrued service fee	1,086	839
Affiliated companies
Related Party Transaction [Line Items]
Service fee	491	272	212
Accrued service fee	40	22
Related Party Transactions
Related Party Transaction [Line Items]
General and administrative expenses	1,097	1,115	$ 1,182
Payable to affiliates	$ 176	$ 181

Statutory Financial Data and 88

Statutory Financial Data and Dividend Restrictions - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Statutory Accounting Practices [Line Items]
Statutory capital and surplus	$ 202,130	$ 198,759
Statutory restrictions on dividend	In accordance with New York statutes, the maximum amount of ordinary dividends that can be paid by the Company is the greater of 10% of prior year-end capital and surplus, or the prior year net gain from operations, but is limited by the amount in unassigned surplus.
Ordinary dividend which can be paid without approval	$ 20,213

Components Of Accumulated Other

Components Of Accumulated Other Comprehensive Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ 5,000
Ending balance	7,197	$ 5,000
Net unrealized gain on securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	5,000	16,656
OCI before reclassifications	2,216	(11,280)
Amounts reclassified from AOCI	(19)	(376)
Net OCI	2,197	(11,656)
Ending balance	$ 7,197	$ 5,000

Reclassifications From Accumula

Reclassifications From Accumulated Other Comprehensive Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amount Reclassified from AOCI, Net unrealized gain on securities, available-for-sale-securities	$ (182)	$ (767)	$ (77)
Amount Reclassified from AOCI, Net unrealized gain on securities, available-for-sale-securities, tax	2,943	(4,441)	$ (3,133)
Net unrealized gain on securities
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total amounts reclassified from AOCI	19	376
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Net unrealized gain on securities
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amount Reclassified from AOCI, Net unrealized gain on securities, available-for-sale-securities	30	578
Amount Reclassified from AOCI, Net unrealized gain on securities, available-for-sale-securities, tax	$ 11	$ 202

Unconsolidated Segment Results

Unconsolidated Segment Results (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenue:
Net premiums and policy fees	$ 71,907	$ 68,870	$ 61,716
Interest and similar income, net	29,558	27,387	28,859
Change in fair value of assets and liabilities	(41,554)	11,373	66,806
Realized investment gains, net	(205)	583	77
Fee, commission, and other revenue	7,051	7,221	6,864
Total revenue	66,757	115,434	164,322
Benefits and expenses:
Net benefits	5,612	87,511	143,893
General and administrative expenses and commissions	39,948	41,792	39,789
Change in deferred acquisition costs, net	4,814	(8,165)	(15,064)
Total benefits and expenses	50,374	121,138	168,618
Pretax income (loss)	16,383	(5,704)	(4,296)
Annuity
Revenue:
Net premiums and policy fees	68,752	65,603	58,727
Operating Segments \| Annuity
Revenue:
Net premiums and policy fees	68,752	65,603	58,728
Interest and similar income, net	27,462	25,378	27,293
Change in fair value of assets and liabilities	(41,554)	11,374	66,806
Realized investment gains, net	(192)	549	73
Fee, commission, and other revenue	7,051	7,221	6,869
Total revenue	61,519	110,125	159,769
Benefits and expenses:
Net benefits	2,441	81,697	138,957
General and administrative expenses and commissions	39,355	41,145	38,886
Change in deferred acquisition costs, net	3,933	(8,687)	(15,088)
Total benefits and expenses	45,729	114,155	162,755
Pretax income (loss)	15,790	(4,030)	(2,986)
Operating Segments \| Other
Revenue:
Net premiums and policy fees	3,155	3,267	2,988
Interest and similar income, net	2,096	2,009	1,566
Change in fair value of assets and liabilities		(1)
Realized investment gains, net	(13)	34	4
Fee, commission, and other			(5)
Total revenue	5,238	5,309	4,553
Benefits and expenses:
Net benefits	3,171	5,814	4,936
General and administrative expenses and commissions	593	647	903
Change in deferred acquisition costs, net	881	522	24
Total benefits and expenses	4,645	6,983	5,863
Pretax income (loss)	$ 593	$ (1,674)	$ (1,310)

Schedule I Investments Other Th

Schedule I Investments Other Than Investments in Related Parties (Detail) $ in Thousands	Dec. 31, 2016USD ($)
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost	$ 775,752
Fair value	792,401
Amount at which shown in the consolidated balance sheets	792,401
Fixed-maturity securities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost	734,957
Fair value	751,531
Amount at which shown in the consolidated balance sheets	751,531
Fixed-maturity securities \| U.S. government
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost	48,676
Fair value	49,217
Amount at which shown in the consolidated balance sheets	49,217
Fixed-maturity securities \| States and political subdivisions
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost	10,546
Fair value	10,644
Amount at which shown in the consolidated balance sheets	10,644
Fixed-maturity securities \| Corporate Securities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost	491,518
Fair value	509,279
Amount at which shown in the consolidated balance sheets	509,279
Fixed-maturity securities \| Mortgage-backed securities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost	184,217
Fair value	182,391
Amount at which shown in the consolidated balance sheets	182,391
Equity Securities \| Trading Securities Equity
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost	7,464
Fair value	7,539
Amount at which shown in the consolidated balance sheets	7,539
Other Investments
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost	33,331
Fair value	33,331
Amount at which shown in the consolidated balance sheets	33,331
Other Investments \| Policy loans
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost	338
Fair value	338
Amount at which shown in the consolidated balance sheets	338
Other Investments \| Net Derivatives
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Cost	32,993
Fair value	32,993
Amount at which shown in the consolidated balance sheets	$ 32,993

Schedule III Supplementary Insu

Schedule III Supplementary Insurance Information (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016		Dec. 31, 2015		Dec. 31, 2014		Dec. 31, 2013
Supplementary Insurance Information, by Segment [Line Items]
Deferred acquisition costs		$ 129,868		$ 134,374		$ 118,319
Deferred sales inducements		19,880	[1]	21,148	[1]	19,510	[1]	$ 18,345
Account balances and future policy benefit reserves		879,251		762,986		691,011
Unearned premiums		1,652		1,571		1,518
Policy and contract claims		4,771		4,157		2,787
Net premium and policy fees		71,907		68,870		61,716
Interest and similar income, net		29,558		27,387		28,859
Net benefits	[2]	4,243		87,099		145,472
Net change in deferred sales inducements	[3]	1,369		412		(1,579)
Net change in deferred acquisition costs	[4]	4,814		(8,165)		(15,064)
Other operating expenses		39,948		41,792		39,789
Annuity
Supplementary Insurance Information, by Segment [Line Items]
Deferred acquisition costs		128,128		131,754		115,271
Deferred sales inducements	[1]	19,880		21,148		19,510
Account balances and future policy benefit reserves		852,430		738,333		670,265
Net premium and policy fees		68,752		65,603		58,728
Interest and similar income, net		27,462		25,378		27,293
Net benefits	[2]	1,072		81,285		140,536
Net change in deferred sales inducements	[3]	1,369		412		(1,579)
Net change in deferred acquisition costs	[4]	3,933		(8,687)		(15,088)
Other operating expenses		39,355		41,145		38,886
Other Investments
Supplementary Insurance Information, by Segment [Line Items]
Deferred acquisition costs		1,740		2,620		3,048
Account balances and future policy benefit reserves		26,821		24,653		20,746
Unearned premiums		1,652		1,571		1,518
Policy and contract claims		4,771		4,157		2,787
Net premium and policy fees		3,155		3,267		2,988
Interest and similar income, net		2,096		2,009		1,566
Net benefits	[2]	3,171		5,814		4,936
Net change in deferred acquisition costs	[4]	881		522		24
Other operating expenses		$ 593		$ 647		$ 903

[1]	Deferred sales inducements is located in Other assets on the Balance Sheets.
[2]	(2) Excludes net change in deferred sales inducements.
[3]	* See note 10 for aggregate gross amortization of deferred sales inducements.
[4]	** See note 9 for aggregate gross amortization of deferred acquisition costs.

Schedule IV Reinsurance (Detail

Schedule IV Reinsurance (Detail) - USD ($) $ in Thousands	12 Months Ended
Schedule IV Reinsurance (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Life insurance in force, Direct amount	$ 66,299	$ 71,620	$ 77,593
Life insurance in force, Ceded to other companies	57,082	61,791	67,376
Life insurance in force, Assumed from other companies	0	0	0
Life insurance in force, Net amount	$ 9,217	$ 9,829	$ 10,217
Life insurance in force, Percentage of amount assumed to net	0.00%	0.00%	0.00%
Premiums and policy fees, Direct amount	$ 73,236	$ 70,217	$ 63,158
Premiums and policy fees, Ceded to other companies	1,329	1,347	1,442
Premiums and policy fees, Assumed from other companies	0	0	0
Premiums and policy fees, Net amount	$ 71,907	$ 68,870	$ 61,716
Premiums and policy fees, Percentage of amount assumed to net	0.00%	0.00%	0.00%
Life
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Premiums and policy fees, Direct amount	$ 1,025	$ 1,144	$ 902
Premiums and policy fees, Ceded to other companies	836	842	916
Premiums and policy fees, Assumed from other companies	0	0	0
Premiums and policy fees, Net amount	$ 189	$ 302	$ (14)
Premiums and policy fees, Percentage of amount assumed to net	0.00%	0.00%	0.00%
Annuity
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Premiums and policy fees, Direct amount	$ 68,752	$ 65,603	$ 58,727
Premiums and policy fees, Ceded to other companies	0	0	0
Premiums and policy fees, Assumed from other companies	0	0	0
Premiums and policy fees, Net amount	$ 68,752	$ 65,603	$ 58,727
Premiums and policy fees, Percentage of amount assumed to net	0.00%	0.00%	0.00%
Accident and health
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Premiums and policy fees, Direct amount	$ 3,459	$ 3,470	$ 3,529
Premiums and policy fees, Ceded to other companies	493	505	526
Premiums and policy fees, Assumed from other companies	0	0	0
Premiums and policy fees, Net amount	$ 2,966	$ 2,965	$ 3,003
Premiums and policy fees, Percentage of amount assumed to net	0.00%	0.00%	0.00%